Reactions and Ligand Binding Properties of Cytochrome P450. by Ridd, Thomas Ian.
REACTIONS AND LIGAND BINDING PROPERTIES 
OF CYTOCHROME P450
A thesis presented for the Degree of Doctor of Philosophy
by
Thomas Ian Ridd M.Sc.
July 1995
Department of Chemistry, 
University of Surrey, 
Guildford,
Surrey GU2 5XH.
ProQuest Number: U551653
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest U551653
Published by ProQuest LLC (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
ABSTRACT.
One of the most interesting and characteristic reactions catalysed by cytochrome 
P450 is the hydroxylation of alkanes and unactivated alkyl groups (O2 + 2H + 
RH => ROH + H2 O), which is always accompanied by some degree of 
"uncoupling" to produce hydrogen peroxide (O2 + 2H => H2Q2); added hydrogen 
peroxide can also be used by some cytochrome P450 enzymes for the 
hydroxylation of alkanes (H2 O2 + RH => ROH + H2 O). Major unanswered 
questions concerning these reactions include: the nature of the key hydroxylating 
intermediate and the possible role of the two conformers observed in the 
reduced state with ligands such as isocyanides and pyridine (corresponding to 
Soret bands at 440-450 and 420-430 nm). These questions were investigated by 
studying (i) the reactions of oxidised CYP2B4 with H2O2 and lauric acid and 
(ii) equilibria involving reduced CYP2B4 with a range of nitrogen bases.
It was shown that purified CYP2B4 catalysed the hydroxylation of lauric acid 
by hydrogen peroxide producing the 00-1 and cd-2 hydroxymetabolites against a 
background of bleaching of the porphyrin ring with no detectable intermediate in 
either reaction. lodosobenzene on the otherhand, which is known to produce the 
ferryl FeO3* derivative, does not support hydroxylation or bleaching and further 
inhibits bleaching by added hydrogen peroxide and that the rates of both 
bleaching and hydroxylation increase with the concentration of H2Q2 (pK 11.7) 
but are essentially pH-independent. The available evidence indicates that the key 
intermediate in both hydroxylation and bleaching is the undissociated hydrogen 
peroxide (H2O20) coordinated to the Fe3+ ion.
The nature of the equilibrium between conformers I and II, reported for 
complexes of reduced cytochrome P450, was further investigated through the 
use of three families of nitrogenous bases in order to test the relative
importance of a  donor and n acceptor capacity and the a  effect. Equilibrium 
was systematically shifted in favour of II by increasing the pK in all three 
families, indicating the predominance of a  donor over n acceptor capacity, as 
well as by lowering the pH. This is in agreement with the postulated 
equilibrium between thiol/thiolate as the proximal ligand in conformers II and I 
respectively. Ligands such as hydroxylamine and pyridazine, which exhibit the a  
effect were anomalous in showing an unexpectedly high stabilisation of 
conformer II, which was observed with CYP4A1 and CYP2E1 as well as 
CYP2B4 and provides a model for the similar anomalous behaviour of oxygen 
as a ligand.
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CHAPTER 1
General Introduction
1
1.1 Cytochrone P450 nomenclature.
The cytochromes P450 (EC 1. 14. 14. 1) comprise a family of b-type 
haemoproteins (Sato et al 1965), with an identical prosthetic group (a thiolate- 
bound haem) and mechanism of catalysis (activation of oxygen without activating 
the substrates), but widely different apoprotein structures which are responsible 
for their different substrate spécificités. The term cytochrome P450 actually 
refers to a group of haemoproteins, which includes the enzyme chloroperoxidase 
whose Fe2+-carbon monoxide complexes show an absorption spectrum with a 
maximum near 450 nm. This characteristic is attributed to the unique ligation of 
the haem by a cysteinyl thiolate (Guengerich 1992). The cytochrome P450 
enzymes are mainly classed as monooxygenases or mixed function oxidases, i.e 
they are oxygenases which catalyse the incorporation of only one atom of 
molecular oxygen into another substrate and yield a molecule of water with the 
other oxygen atom (equation 1) (Schenkman et al 1981), where RH represents 
the substrate and ROH the product.
RH + O2 + 2H => ROH + H20  (1)
Cytochrome P450 may be divided into 2 classes, depending on the nature of 
their redox partner. Class I cytochrome P450s are found in the mitochondrial 
membranes of eukaryotes and in most bacteria and require a flavin adenine 
dinucleotide (FAD) containing reductase and an iron-sulphur protein for catalysis. 
Class II cytochrome P450s, on the other hand, are located on the endoplasmic 
reticulum and interact directly with a reductase moiety containing FAD and flavin 
mononucleotide (FMN) (Boddupalli et al 1992). The actual term cytochrome 
P450 is a misnomer, as these proteins are not " cytochromes" in the true 
meaning of this terminology. The actual term to describe these proteins, as 
emphasised by the Nomenclature Committee of the International Union of 
Biochemistry (NC-IUB) is "haem-thiolate proteins" (Palmer and Reedijk 1991).
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The cytochrome P450 enzymes are ubiquitous and are even found in bacteria. 
According to the most recent update, there are currently 221 P450 genes and 12 
putative pseudogenes which have been described in 31 eukaryotes (including 11 
mammalian and 3 plant species) and in 11 prokaryotes (Nelson el al 1993). Of 
the 36 gene families so far identified, 12 exist in all mammals examined to 
date, and comprise 22 mammalian subfamilies. Cytochrome P450s are considered 
to be in the same family if they share greater than a 40% sequence homology, 
whilst subfamilies are constituted by cytochrome P450s which share at least 60 
% sequence homology. Cytochrome P450's are named with the root symbol 
"CYP" followed by an arable number designating the P450 family. A letter is 
used to indicate the subfamily when two or more subfamilies are known to 
exist within the family, and an arable number to represent the individual gene.
1.2 Multiplicity of cytochrome P450.
In the untreated animal, levels of the P450 enzymes are very low; they 
comprise approximately 5 % of the total hepatic microsomal protein content. The 
levels of these enzymes can be increased dramatically by treatment with chemical 
inducers such as phénobarbital and 3-methylcholanthrene. The induction of 
cytochrome P450 by the administration of phénobarbital and related compounds is 
generally more pronounced in the liver than in nonhepatic tissues. In the rat, 
rabbit and mouse, treatment with phénobarbital causes a significant increase in 
total hepatic cytochrome P450 concentration, proliferation of smooth endoplasmic 
reticulum, and increased liver weight (Remmer et al 1983). The major inducible 
subfamilies of cytochrome P450 are CYP1A, CYP2B, CYP2E, CYP3A and 
CYP4A. The CYP2 family is recognised as the largest and most diverse of the 
cytochrome P450 families. To date, the CYP2 family consists of eight 
subfamilies (Nelson el al 1993), with the CYP2B gene subfamily the largest 
with at least 10 members (Gonzalez 1990; Nebert et al 1989). Phénobarbital- 
type inducers are known to regulate levels of the various CYP2 isoforms and
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can increase by 15 - 40 % the amount of enzyme present. At least five different 
forms of cytochrome P450 have been purified from phenobarbital-induced 
rabbits, the major inducible form being CYP2B4, which has been characterised 
by many laboratories (Dean and Coon 1977; Guengerich 1977; Haugen and 
Coon 1976). The molecular weight of the CYP2B4 subunit has been calculated 
to range from 48,500 to 50,000, with an absorption maximum of 451 nm for 
the reduced-carbon monoxide complex. The dramatic increase in the amount of 
enzyme present on induction by phénobarbital and the large number of 
purification methods available advocate the use of this enzyme in future 
experiments.
1.3 The Active site.
The active site of all cytochrome P450s contains an iron (HI) protoporphyrin IX, 
where the iron is linked to the apoprotein by a cysteine residue as the proximal 
ligand. To date, the structure of three bacterial cytochrome P450s (P450Cam> 
P450BM3 and P450terp), have been elucidated using X-ray studies. Initial 
studies on the active site of cytochrome P450 were carried out on P450cam> a 
class I soluble enzyme from Pseudomonas putida and has yielded the most 
complete 3D information on the cytochrome P450 active site (Poulos and Raag 
1992; Poulos et al 1987). The crystal structure of P450Cam has provided 
guidelines for understanding the stereospecificity of the hydroxylation reaction, 
changes in redox potential, and spin equilibria on substrate binding. However, 
the lack of definitive amino acid sequence similarity between P450cam and 
eukaryotic P450s limits its usefulness as a general model for all cytochrome 
P450s (Poulos 1992). The only well characterised class II bacterial P450 is 
P450BM-3 from Bacillus megaterium, which is involved in the monooxygenation 
of fatty acids producing the co-l, to-2 and o)-3 hydroxymetabolites (Fulco 1991). 
Cytochrome P450BM-3 and P450cam both possess conserved residues (threonine
4
and glutamine) in the binding site, which are identical to other cytochrome 
P450s. The conserved threonine in P450BM-3 may play an important role in 
proton transfer via a charge relay mechanism (Gerber and Sligar 1992). 
Comparison of the active site of cytochromes P450terp and P450cam shows that 
both active sites contain a conserved threonine residue, which is hydrogen 
bonded to carbonyl oxygen, and an aspartate residue which is -1 base from the 
threonine residue which links surface residues and/or solvent molecule to the 
catalytic centre of both proteins (Hasemann et al 1994). So far, no mammalian 
active site has been completely described, although computer modelling has 
proposed that homology does exist between P450cam and mammalian P450s. 
However this is limited to a single 8 residue region (Schwarse et al 1988) 
which is proposed to contain important residues including threonine, serine, and 
aspartate which are all involved in the binding of oxygen. The nature of the 
proximal (fifth) ligand in all cytochrome P450s is known to be a Cys residue 
in its anionic RS“ form (Cramer et al 1978). However, it is possible that an 
equilibrium exists between this Cys residue in its RS~ (thiolate) or RSH (thiol) 
form indicated by the following equilibrium:-
[RS~ => Fe(ii) <= X]i + H+ <=> [RSH° => Fe(n) <= X]n 
where X denotes the distal ligand and subscripts I and II the two conformers; 
H+ could represent either a free proton in solution or a proton transferred from 
some neighbouring site (Kahl et al 1976). Some of the other enzyme systems 
classed as P450s, namely thromboxane synthase and allene oxide synthase lack 
the threonine and serine residues in the active site and are involved in reactions 
which do not involve oxygen, thus suggesting that these residues are important 
for the binding of oxygen.
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1.4 Reactions of cytochrome P450.
The substrates metabolised by cytochrome P450 include a whole host of 
xenobiotics, synthetic organic chemicals, steroids and physiological lipids (Black 
and Coon 1987; Ryan and Levin 1990; Guengerich 1991; Coon and Koop 
1983). The reactions catalysed by cytochrome P450 include hydroxylation 
(aromatic and aliphatic), epoxidation, deamination (amphetamine => phenylacetone 
and ammonia), dehalogenation, dealkylation and reduction as well as peroxidase 
type reactions (equation 2), where AH2 is the reducing substrate.
ROOH + AH2 => ROH + A + H20  (2)
The initial stage of the cytochrome P450 catalysed monooxygenase reaction 
involves the transfer of electrons from NAD(P)H to either NADPH-cytochrome 
P450 reductase in the microsomal system or a ferrodoxin reductase and a 
nonhaem iron protein in the mitochondrial and bacterial systems, followed by 
transfer to the Fe3-1" ion of cytochrome P450. This subsequently leads to the 
splitting of the dioxygen bond followed by the insertion of one oxygen into the 
substrate. Hydroxylation reactions are known to be carried out with the 
following stoichiometry, where RH is the substrate and ROH is the product:
RH + O2 + NADPH + H+ => ROH + H20  + NADP+
Our interest in this reaction is when RH represents a simple alkane or some 
equivalent unactivated alkyl group as in the more soluble lauric acid. Not all 
alkanes can be hydroxylated by cytochrome P450, for example methane. The 
hydroxylation of methane is catalysed by the enzyme, methane monooxygenase 
(MMO), which like cytochrome P450 can utilise oxygen, NADPH, and a 
reductase or hydrogen peroxide on its own (Froland et al 1992). Controversy 
still surrounds the nature of the key intermediate involved in the hydroxylation 
reaction. Two main theories have been proposed for the nature of the key 
intermediate involved in the hydroxylation reaction viz (1) a single oxygen unit 
(Guengerich 1990), or (2) a two oxygen (peroxide) unit (White and Coon
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1980). The most popular theory is the one involving a single oxygen unit in 
the form of a ferryl intermediate (FeO)3+. A postulated mechanism for 
microsomal cytochrome P450 catalysis is depicted in figure 1.1.
ROH
Fe RH
HoO-
2e-
XOOHXOH
2H
HoOo-------
Fig 1.1 Proposed scheme for the mechanism of action of cytochrome P450. Fe represents 
the haem iron atom in the active site, RH a substrate, and RO H  the corresponding 
monooxygenation product. XOOH represents a peroxy compound that serves as a oxygen 
donor, (adapted from Coon et al 1992).
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Although the various steps of this cycle have been examined in some detail, 
only steps 1-3 are well understood with controversy still surrounding steps 4-7. 
The binding of the substrate to the ferric form of cytochrome P450 is thought 
to be very rapid and is the first stage of the cycle (step 1). The binding of the 
substrate changes the iron spin-state (d electrons) from low spin to high spin in 
some cases, but not in others (where the iron moiety already exists in the high 
spin state without substrate binding) (Guengerich 1983). Step 2 involves the 
first electron reduction of the substrate-bound ferric cytochrome P450 to the 
ferrous form of the haemoprotein. The reducing equivalent in the microsomal 
system is derived from NADPH and H+ and is transferred by the flavoprotein, 
NADPH cytochrome P450 reductase. This is followed by the binding of 
molecular oxygen to the ferrous cytochrome P450 substrate adduct and is 
thought to be rapid due to the (Fe^Qz) complex being very unstable (step 3). 
Steps (4-7) are not well understood, but are thought to involve transfer of a 
second electron either from NADPH cytochrome P450 reductase or b$, to 
generate an activated iron-oxygen complex (step 4) (Schenkman 1976). This is 
followed by the splitting of the 0 -0  bond with the uptake of 2 protons and the 
generation of an "activated oxygen" species, with the simultaneous release of a 
water molecule (step 5). Oxygen is then incorporated into the substrate (steps 6 
and 7). Finally, the oxygenated product dissociates (step 8) to leave the iron in 
its original ferric state.
The overall hydroxylation reaction (equation 1) is always accompanied by the 
production of hydrogen peroxide via reaction 3, which eventually leads to the 
degradation of the porphyrin ring.
O2 + 2H =^ > H2Q2 (3)
The production of hydrogen peroxide is enhanced in the presence of uncouplers 
such as C6F12 (Hawkins and Dawson 1982). This degradation of the porphyrin 
ring of cytochrome P450 by hydrogen peroxide has similar parallels to the
8
degradation of haem oxygenase by hydrogen peroxide. Haem oxygenase, which 
contains histidine (His) as its proximal ligand functions to degrade haemin and 
requires either NADPH, molecular oxygen and a reductase, or hydrogen 
peroxide on its own. Cytochrome P450 can also catalyse the reaction of 
hydrogen peroxide with alkanes (RH) (equation 4).
RH + H2Q2 => ROH + H2O (4)
The occurrence of (3) and (4), involving the formation and further reaction of 
hydrogen peroxide can in principle allow for the study of the overall reaction 
(1) in two segments, and investigation into the nature of the key intermediate 
and the possible role of the reduced iron conformers in the enzymic cycle.
1.5 Reactions with other oxygen donors.
Cytochrome P450 enzymes are usually activated by the sequential addition of an 
electron (via NADPH-cytochrome P450 reductase), molecular oxygen and another 
electron followed by protonation and loss of water. However, this process can 
be circumvented by the use of artificial oxidants, such as hydroperoxides 
(cumene hydroperoxide and hydrogen peroxide) (Kadlubar et al 1973), 
iodosobenzene (Lichenberger et al 1976), sodium periodate and sodium chlorite 
(Gustafsson and Bergman 1976) leading to a shortened P450 cycle. It is 
generally assumed that this shortened cycle or peroxide shunt proceeds via a 
common intermediate, bearing a single activated oxygen atom, which is similar 
to compound I of the peroxidase enzyme (Sligar et al 1977). However, this 
view is not supported by all workers in this field (White and Coon 1980). 
Hydrogen peroxide supports the peroxygenase activity of cytochrome P450 less 
effectively than cumene hydroperoxide with some substrates (Kadlubar et al 
1973; Nordblom et al 1976) but not with others (Vaz et al 1991). Furthermore 
hydrogen peroxide is a very poor supporter of the peroxidase activity (Hrycay 
and O'Brien 1974). The most useful oxygen donor has been found to be
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iodosobenzene, a lipophilic agent that readily interacts with the membrane bound 
enzymes, it is a single oxygen donor and is uncharged unlike IO4 " and CIQ2'. 
The rates of oxidation by these artificial donors has been found to be much 
higher than those observed with NADPH, reductase and molecular oxygen 
(Macdonald et al 1989).
1.6 Nature of the reactive intermediate.
Initially it was assumed that the intermediate in these reactions, especially in the 
case of iodosobenzene was the same as for peroxidases, namely Fe03+; due to 
the observation of spectra of the intermediate complexes when iodosobenzene 
was added to a sample of purified cytochrome P450 (Blake and Coon 1989). 
The cleavage of the 0 -0  bond in the catalytic cycle is extremely rapid and has 
never been observed. The nature of the intermediate formed after this cleavage 
is open to speculation. It is thought that the intermediate consists either of a 
single oxygen unit, termed the ferryl intermediate (FeO)3+, or a two oxygen 
unit (FeO^H/H^O^), although neither has been conclusively proved or disproved.
Both these theories concerning the key intermediate seem reasonable since it has 
been shown that a simple protonated hydrogen peroxide molecule (H3 O2"*") can 
hydroxylate alkanes (Olah et al 1977). The hydroxylation of these alkanes with 
hydrogen peroxide in the presence of strong acids such as FSOgH-SbFs, 
FSO3H, H2SO4  and HF was studied under typical electrophilic conditions, 
where it was concluded that the reactions proceded via initial electrophilic 
hydroxylation of the appropriate a  bond of the alkanes by the incipient hydroxyl 
cation which is formed through protolytic cleavage of hydrogen peroxide through 
the hydroperoxonium ion H sC ^. It is therefore reasonable to assume that 
hydrogen peroxide attached to another Lewis acid (eg. Fe3"1") might be able to 
also hydroxylate alkanes. It is possible that the key intermediate could exist as
10
both forms, but used under different circumstances.
The reaction of cytochrome P450 with iodosobenzene has been shown to 
produce the ferryl intermediate, although this intermediate is never seen during 
the catalytic reaction (Blake and Coon 1989). The use of iodosobenzene as the 
oxygen donor in the absence of molecular oxygen and NADPH, but in the 
presence of cytochrome P450 catalyses the oxygen transfer reaction:- 
RH + PhIO => ROH + Phi (5)
where RH represents a variety of substrates and PhIO a variety of 
iodosobenzene derivatives that serve as oxygen donors, and neither molecular 
oxygen nor an external electron source is required (Nordblom et al 1976). The 
reaction of CYP2B4 with iodosobenzene has previously been shown to lead to 
the reversible formation of three spectral intermediates, termed E, F and G, 
where E represents the iodosobenzene-dependent partial shift of the low spin 6 - 
coordinate form of the ferric enzyme to the high spin 5 -coordinate form. 
Complex F represents a transient intermediate, whose spectrum cannot be 
determined, whilst G represents a blue shifted (shorter wavelength) intermediate 
with an absorption maximum at ~ 390 nm in the absolute spectrum. The 
spectrum of complex G has been found not to vary when different derivatives 
of iodosobenzene were used, which is in contrast to the reactions of peroxy 
compounds (cumene hydroperoxide) with CYP2B4 (Blake and Coon 1989). 
Complex G was found to exhibit spectral properties which maybe associated 
with an iron-oxo intermediate (FeO)3+, which contains one oxygen derived from 
the starting compound (resembles compound I of peroxidases), with a blue 
shifted Soret band of less intensity.
Recent studies carried out using distal ligand mutants of CYP1A2, where the 
Glu ligand was replaced by either Ala, Val, Gin or Asp, and the Thr ligand 
replaced by either Ala, Gin, Val, Asp, or Ser (Shimizu et al 1994) suggested
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the formation of a ferryl intermediate which can be observed spectrally at a 
wavelength of ~ 423 nm, when butyl hydroperoxide and cumene hydroperoxide 
were used as the oxygen donor. The intermediate observed at this wavelength 
was proposed to be similar to that of compound I of the peroxidases. 
However, these experiments were carried out in the presence of 1 mM 
dithiothreitol, which would have most certainly reduced the intermediate formed. 
Thus, due to the presence of this thiol no conclusive proof can be drawn from 
these experiments.
The two oxygen theory, although not currently the most popular, is gaining 
support. The presence of a two oxygen unit intermediate has been proposed to 
be involved in the reaction involving cytochrome P450 and cyclohexane 
carboxyaldehyde which yields formic acid and cyclohexene as the products 
(R.CHO + H2Q2 => (R-H) + HCOOH + H20) (Vaz et al 1991). This reaction 
was found to be dependent on NADPH, molecular oxygen and a reductase in a 
reconstituted system; in the absence of these reducing equivalents, only hydrogen 
peroxide and not other oxidants such as iodosobenzene, m-chloroperoxidase and 
cumene hydroperoxide could initiate the reaction. The inability of iodosobenzene 
to support the reaction involving cyclohexane carboxyaldehyde and cytochrome 
P450 suggested that the pentavalent "iron oxene" was not the key intermediate 
and that a peroxide type intermediate may be involved. Further support for the 
existence of a peroxide type intermediate has been proposed by workers 
involved in the study of haem oxygenase, which destroys haemin (Wilks and 
Ortiz de Montellano 1993; Wilks et al 1994) and studies involving cytochrome 
P450i7a (Akhtar et al 1994; Robichaud et al 1994). The reactions involving 
haem oxygenase will be expanded later (see 1:13), but the general consensus is 
that the degradation of haemin by haem oxygenase does not involve a ferryl 
intermediate but proceeds via a two oxygen unit.
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Cytochrome P450i7a is involved in steroid biosynthesis as well as in acyl- 
cleavage for which the participation of an iron peroxide intermediate (FeOOH) 
has been suggested. It was found that the reaction involving the formation of 
17a hydroxyandrogen from the C-C bond cleavage process did not go via a 
ferryl intermediate, unlike the reaction with other steroid enzymes such as 14a- 
demethylase, but did proceed via some peroxide intermediate. The proposed 
existence of this peroxide species, although it has never been seen and the 
inability of iodosobenzene to support the cyclohexane carboxyaldehyde reaction 
suggests that reactions involving hydrogen peroxide involve a two rather than one 
oxygen unit as the key intermediate. The existence of some common features 
between cytochrome P450 and haem oxygenase provided further motivation to 
investigate whether a one oxygen or two oxygen unit was involved in the 
hydroxylation reactions of alkanes.
1.7 Nature of the sixth ligand in the resting state.
In the ferric low spin state, the CYP2B4 haem iron atom is hexacoordinated 
and contains a solvent molecule which occupies the axial sixth coordination 
position trans to the thiolate fifth ligand (Poulos et al 1987). Controversy 
surrounds the nature of this solvent molecule as the sixth ligand; some authors 
advocate the presence of a hydroxide ion (Banci et al 1994), whilst other 
propose a water molecule (Hilderbrandt et al 1994).
NMR signals from camphor free cytochrome P450 in the presence of aromatic 
bases such as pyridine, imidazole and N-methylimidazole showed that the bases 
bind both in the hydrophobic cavity and at the metal. It is thought the nature, 
size and steric crowding of the ligand determines the displacement or the 
presence of the axial solvent ligand and its protonation state (Raag and Poulos 
1989). In the presence of the natural substrate, camphor, the iron (III) is
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pentacoordinated and is in a high spin state, due to the displacement of the 
solvent molecule by the substrate molecule. The simultaneous binding of 
pyridine and imidazole in the cavity was found not to occur in the presence of 
the substrate.
The existence of a water molecule as the sixth ligand has been proposed by 
Hilderbrandt and co-workers (1994), using Resonance Raman spectroscopy. This 
technique was used to study mitochondrial cytochrome P450scc and microsomal 
cytochrome CYP2B4 in the ferric substrate-free and substrate-bound states. The 
spectra of cytochrome P450Scc showed the existence of two conformational 
states, known as A and B. Each of these states constituted an equilibrium 
between a six coordinated low spin and a high spin form. Both the 
conformational and the spin equilibria were found to be pH and temperature 
dependent (Lange et al 1992). The pH dependency between the low spin and 
high spin states of cytochrome P450SCc suggests that the sixth ligand was a 
water molecule, and the transition between the 6  coordinated high spin and 6  
coordinated low spin states of conformer A is initiated by a proton transfer 
step. In contrast to cytochrome P450SCc the Resonance Raman spectra of 
microsomal CYP2B4 provided no indications for multiple conformers at a 
temperature of 22 °C (Hildebrandt et al 1994). The binding of certain substrates 
(benzphetamine) to ferric CYP2B4 can convert the low spin state to the high 
spin state, but this conversion is only partial (28%). The Resonance Raman 
spectra of this conversion produced similar values to that obtained for the high 
spin state of P450scc, suggesting that a water molecule is present as the sixth 
ligand.
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1.8 Binding of ligands to ferric cytochrome P450.
As previously stated CYP2B4 exist essentially in the low spin 6 -coordinate state 
with a ferric Soret absorption at around 418 nm. When certain substrates such 
as carbon tetrachloride and halothane, which are termed type I substrates, bind 
to low spin (s=l/2) cytochrome P450, they usually bind to the protein part of 
the molecule and change the conformation, and hence the ligation of the haem 
prosthetic group to the 5-coordinate high spin (s=5/2) state, although this 
conversion is not complete. The change from low spin to high spin causes a 
characteristic spectral change termed the type I spectral change (Schenkman et al 
1967), with an absorption maximum at around 390 nm and minimum around 
420 nm in the difference spectrum. In contrast to type I substrates, certain 
substrates such as, nitrogenous bases termed type II substrates are thought to 
ligate to the haem iron of cytochrome P450, resulting in a 6 -coordinated, low 
spin haemoprotein, which is characterised by an increase in absorbance at 425 - 
435 nm and a trough at 390 - 405 nm (Schenkman et al 1967). The position of 
the absorbance maximum in the Soret spectrum of the ferric protein is related to 
the spin state of its iron centre as measured by resonance techniques such as 
EPR and Mossbauer spectroscopy (Sligar 1976; Lange et al 1980). A 
characteristic of the low spin ferric state of cytochrome P450 is that the a  band 
is more intense than the p band (Schenkman et al 1967).
1.9 Binding of ligands to ferrous cytochrome P450.
The term cytochrome P450 is derived from the observation that ferrous-CO state 
of the enzyme displays a Soret absorption maximum at approximately 450 nm. 
This spectral feature is rather unique among CO-binding protohaem proteins in 
that all ferrous-CO protohaem systems other than cytochrome P450 and 
chloroperoxidase absorb at 420 nm. The formation of this band is associated
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with the presence of Cys in its anionic form RS" as the proximal ligand 
(Guengerich 1991). Unusual features of the ferrous carbon monoxide spectra 
include coalescence of the normally discrete a  and p bands into a single feature 
at 550 nm and the presence of an especially intense ô transition near 370 nm, 
which were matched by thiolate-ligated ferrous carbon monoxide haem models 
(Gaul and Kassner 1988).
The interaction of certain ligands with ferrous cytochrome P450 produces 
complexes with two absorption peaks in the Soret region of the visible 
spectrum. This type of spectrum was first observed with the isocyanide 
derivatives which produced peaks at 430 nm and 455 nm (Imai and Sato 1966a- 
b). The formation of these two peaks was associated with the presence of pH- 
dependent interconvertible states or conformers (Imai and Sato 1967a) which 
were later denoted II and I, with conformer I (455 peak) favoured by higher 
pH (Tsubaki et al 1989). The equilibrium between I and II may vary between 
isozymes (Sladek and Mannering 1966); with the ratio between the two 
conformers varying depending on animal pretreatment. Pretreatment of animals 
with phénobarbital produced peaks at 430 and 455 nm, whilst pretreatment with 
3-methylcholanthrene produced peaks at 430 and 453 nm. Equilibrium between 
the two conformers was also seen between wild types and mutants (Kraniev et 
al 1991), where the peaks were at 451 and 423 nm (conformer I and II 
respectively), and is displaced in favour of II by a conformational change 
induced by the binding of adrenodoxin to the mitochondrial P450Scc (Tsubaki et 
al 1989). However, in the bacterial P450Cam> the presence of substrate 
(camphor) is known to impose greater rigidity on the active site and appears to 
stabilise conformer I and/or inhibit any pH-dependent equilibrium (Greschner et 
al 1993). This type of double spectrum can also be produced with compounds 
such as pyridine (Imai and Sato 1967a), aniline (Imai and Sato 1967a-b) and 
phosphites (Dahl and Hodgson 1976a).
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The binding of oxygen to reduced cytochrome P450 is different from the 
binding observed with other ligands. Whilst most ligands produce a red-shifted 
spectrum, the binding of oxygen produces a spectrum with a Soret band 
maximum at 419 nm (Ishimura et al 1971). This Soret band at 419 nm is close 
to that observed with myoglobin (418 nm), but very different from 
chloroperoxidase, which contains a Cys group in the anionic form (RS") as the 
proximal ligand, where the band is at 430 nm. Based on these observations, it 
seems reasonable to assign oxy P450 to conformer II (see also section 4.1). 
This is further supported by the evidence that in microsomal cytochrome P450 
oxygen reacts preferentially with conformer II of the ethyl isocyanide complex 
(Imai and Sato 1966b; 1968b-c) and that lowering the pH promotes the reaction 
of oxygen in competition with carbon monoxide (Ichikawa et al 1967). It has 
also been suggested that this conformational change is involved in a transfer of 
the second electron (Tsubaki et al 1989).
1.10 Thromboxane synthase and allene oxide synthase.
Both thromboxane and allene oxide synthase enzymes lack the conserved amino 
acids Thr/Ser close to the active site and are involved in reactions that do not 
involve molecular oxygen. It therefore suggests that the Thr residue plays an 
important role in the binding of oxygen in the cytochrome P450 enzymes.
Thromboxane A% is a potent substance synthesised in the body by blood 
platelets and is responsible for the constriction of blood vessels as well as 
platelet aggregation. Thromboxane A2 is derived from prostaglandin H2 by the 
action of the enzyme thromboxane synthase as indicated by the following 
reaction:-
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O -
OH
PGH2
TxA2 synthetase
c o 2h
TxA2
Thromboxane synthase is classed as a cytochrome P450 type enzyme due to its 
ability to display a broad spectrum with a band at 450 nm when it is reduced 
with sodium dithionite in the presence of carbon monoxide (Ullrich et al 1981). 
The binding of carbon monoxide to reduced purified enzyme produced a single 
peak at 450 nm, whilst the microsomal preparation produced a spectrum 
consisting of two peaks at 427 and 450 nm (Haurand and Ullrich 1985), with 
the formation of these peaks occurring very slowly (30 minutes). As well as 
carbon monoxide, many nitrogen containing compounds such as pyridine and 
imidazole have been shown to bind to thromboxane synthase both in the ferric 
and ferrous forms (Hecker et al 1986).
Allene oxide synthase is located in chloroplasts and is responsible for the 
conversion of lipoxygenase derived fatty acid hydroperoxides to unstable allene 
epoxides as indicated by the following reaction:-
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Linolenic acid Cjg.3co3
Lipoxygenase
H20
c o 2h
13-Hydroperoxide
OOH
%
Allene oxide synthase
C 02H
Allene oxide
1.11 Cytochrome P420.
The pH-dependent conformational changes observed when isocyanides and 
pyridine bind to reduced cytochrome P450 are distinct from the almost 
irreversible change from P450 to the so called P420, which probably involves 
replacing the Cys ligand with His as the proximal ligand (Wells et al 1992). 
The conversion of microsomal cytochrome P450 to cytochrome P420 has been 
shown to occur with a variety of reagents, including urea, proteases, sulfhydryl 
reagents or detergents (Cooper et al 1965; Mason et al 1965). Cytochrome P420 
is classed as the denatured form of cytochrome P450 and was first observed by 
Omura and Sato in 1964. Cytochrome P420 can bind carbon monoxide like 
cytochrome P450, except that the Soret peak is at 420 nm and not at 450 nm. 
Cytochrome P420 can also bind ethyl isocyanide in the reduced state, but unlike 
cytochrome P450 only one Soret peak was observed at 430 nm and appeared to
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be pH independent regardless of the preparation (Peisach and Mannering 1985). 
Detailed Raman and absorption spectra have suggested that cytochrome P420 
haem is in equilibrium between a high spin five coordinate state and a low spin 
state both in the ferric and ferrous oxidation states (Wells et al 1992).
1.12 Chloroperoxidase.
Much of our understanding of the peroxidase enzymes has been based on 
studies of the pH dependency of rate constants and ligand binding constants 
with horseradish peroxidase, chloroperoxidase, mutants of cytochrome c 
peroxidase and protein free microperoxidase 8  (MP8 ).
Chloroperoxidase like cytochrome P450 contains a Cys residue in its anionic 
form (RS-); all other known peroxidases possess a proximal histidine. The 
spectral properties of chloroperoxidase are more akin to those of the cytochrome 
P450 enzymes than to other peroxidases (Ortiz de Montellano 1987). These 
spectral properties include the presence of a red shifted Soret band at 430 nm in 
the reduced spectrum. Equilibrium binding studies of exogenous ligands and 
halides to the active site haem iron of chloroperoxidase have been carried out 
over the pH range 2 to 7 (Sono et al 1986). The titration results showed that 
for the ferric enzyme and weak acidic ligands (pKa > 3), such as cyanide, 
binding to the enzyme occurred in their neutral (protonated) form followed by 
deprotonation upon ligation to the haem iron. In contrast, strongly acidic ligands 
(pKa < 0) such as thiocyanate bind in their anionic (deprotonated) form with an 
additional proton to the acid form of the enzyme.
In addition to being a typical peroxidase, chloroperoxidase can catalyse the 
peroxide dependent halogénation of organic substrates utilising halide anions such 
as Cl", B r and I" as the source of the halogen atom (Thomas et al 1970), and
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can act as a catalase by disproportionating hydrogen peroxide to oxygen and 
water (equation 6). All these reactions involve the formation of an intermediate 
termed compound I
Catalase + H2O2 => Compound I + H2O
Compound I + H2O2 => Catalase + O2 + H2O (6)
It has been shown that there is a clear distinction between cytochrome P450
reactivity and those of peroxidases (McCarthy and Coon 1983). Thus, if both 
of these enzyme classes were to operate through a similar iron-oxo intermediate, 
then these intermediates are somehow profoundly different from one another, 
both in their modes of formation and in their intrinsic reactivities.
1.13 Haem oxygenase.
The general hydroxylation reaction (equation 1) is always accompanied by the 
formation of hydrogen peroxide. The further use of this hydrogen peroxide by 
cytochrome P450 has prompted comparison of the degradation of cytochrome 
P450 with the haem oxygenase enzyme.
RH + H2Q2 (0 2 + 2H) => ROH + H20  (1)
Haem oxygenase is a membrane bound enzyme which is involved in the 
oxidation of haem to biliverdin, and can exist in two forms (haem oxygenase 1 
and 2). The reaction of haem oxygenase with haem requires NADPH, molecular 
oxygen and a reductase, or hydrogen peroxide on its own. Hydrogen peroxide 
on its own leads to the production of verdoheme, but cannot produce biliverdin 
from the verdoheme unless NADPH and molecular oxygen are present. In 
contrast, the reaction of the haem-haem oxygenase complex with meta- 
chloroperbenzoic acid or tert—butyl hydroperoxide yields a ferryl (Fe(iv)=0) 
species and a transient protein radical, but does not result in oxidation of haem 
to verdoheme or biliverdin (Wilks and Ortiz de Montellano 1993). Evidence that 
the intermediate involved in the reaction of haem oxygenase with hydrogen
21
peroxide or molecular oxygen and NADPH is a peroxide (FeOOH) was 
provided by the spectra produced by the action of hydrogen peroxide on this 
enzyme. The spectrum showed a decrease in intensity of the Soret band, but 
without a detectable shift in wavelength, while when hydroperoxides such as 
meta chloroperbenzoic acid and t-butylhydroperoxide were used, a wavelength 
shift of 1-3 nm (417-414 nm) was observed, which is comparable to the shift in 
wavelength observed by the action of iodosobenzene on cytochrome P450 (Blake 
and Coon 1989). The evidence produced by Wilks and Ortiz de Montellano 
suggest that the degradation of haem oxygenase occurs via a peroxide type 
intermediate and not a ferryl intermediate.
1.14 Aims.
One of the most intriguing and characterising reactions of cytochrome P450 is 
the hydroxylation of substrates, in particular alkanes. Two major questions are 
still unanswered about this reaction;
1) The nature of the intermediate involved
2) The possible role of the Fe2+ conformers in these reactions
Since the general hydroxylation reaction is always accompanied by the generation 
of hydrogen peroxide (0% + 2H + 2e" => H2O2), and the hydrogen peroxide 
produced can react with alkanes (RH + H2O2 => ROH + H2O), the overall 
reaction can in principle be studied in two segments. The aim of the work in 
this thesis was to endeavour to elucidate the nature of the intermediate and to 
test the effect on the equilibrium stated by Kahl and co-workers (1976),
([RS" => Fe(ii) <= X]i + H+ o  [RSH° => Fe(ii) <= X]n), firstly, of increasing the
electron density on the iron by increasing the pK of the base (ie comparing o  
donor power and jc acceptor qualities of the bases) and secondly, of ligands 
which may model a key feature of coordinated oxygen.
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In order to investigate the nature of the key intermediate, a suitable source of 
cytochrome P450 was required. The enzyme chosen for use was the P450 
isoform derived from rabbit liver induced with phénobarbital (CYP2B4). Rabbit 
CYP2B4 enzyme was used due to its ease of extraction and purification and the 
fact that apart from cytochrome P450cam, it is the most studied. The substrate 
chosen for studying the hydroxylation reaction was lauric acid which is 
hydroxylated in the to, oo-l and a>-2 positions and can be considered as a 
solubilised alkane. The change in ratio between these metabolites may provide 
an additional useful probe of changes around the active site, including the nature 
of the key intermediate.
The reaction of lauric acid with iodosobenzene and hydrogen peroxide is known 
to be accompanied by the degradation of the haem (Blake and Coon 1989; Vaz 
et al 1991). The intermediate involved in this reaction is thought to vary 
depending on the oxygen donor used. In order to test this theory, 
iodosobenzene was used to produce the intermediate which exhibited a spectral 
absorbance maximum at ~390 nm, which was proposed to be the ferryl 
intermediate (Blake and Coon 1989). This ferryl intermediate will then be used 
in the hydroxylation reaction, and the products generated would then be 
compared to those produced by hydrogen peroxide. The action of hydrogen 
peroxide on cytochrome P450 has remarkable similarities to the action of 
hydrogen peroxide on haem oxygenase, where the enzyme is degraded without a 
shift in wavelength and the formation of a spectral intermediate (Wilks and Ortiz 
de Montellano 1993). It has been suggested that the degradation of haem 
oxygenase occurs via a peroxide type intermediate and not via a ferryl 
intermediate. pH-dependent studies involving hydrogen peroxide might provide 
some additional evidence concerning the nature of the key intermediate, they 
might indicate whether the intermediate is in its neutral or anionic form 
(H2O2YHO2-).
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Cytochrome P450 is also known to catalyse peroxide type reactions, although 
much of our understanding of this mechanism of action is based on studies 
involving peroxidases such as chloroperoxidase, and the study of the p In­
dependent rate constants and ligand binding constants. Such studies involving 
cytochrome P450 are more difficult to carry out and interpret due to a limited 
range of stability (i.e between pH 6.5-8.5), and the ambiguity concerning the 
nature of the sixth ligand in the resting state of the enzyme. Although it is now 
believed that the sixth ligand is a solvent molecule (H2O or OH"), it is 
therefore essential to remove any ambiguity about the nature of this ligand as 
far as possible. The work in this thesis will therefore attempt to identify the 
ligand using pH dependent studies on the binding constant (K) for one or more 
neutral bases and an anion to the ferric (Fe?+) ion.
The binding to reduced cytochrome P450 can either produce spectra containing 
one peak (cyanide or carbon monoxide) or spectra containing two peaks 
(isocyanides or pyridines), which were later denoted conformers I and II. These 
conformers were found to be in a pH dependent equilibrium with conformer I 
favoured by high pH and conformer II by low pH (Imai and Sato 1966a-b). It 
has been proposed by Kahl and co-workers (1976) that the proximal ligand in 
conformer II is the undissociated thiol (RSH) while conformer I contains thiolate 
as its proximal ligand. It was initially suggested that single peaked spectrum 
were produced by hydrophilic compounds (CN or CO) with the peak 
corresponding to conformer I or II, while others have proposed that the 
formation of the two banded spectrum is caused by the more hydrophobic 
compounds which occur in a pH equilibrium (Imai and Sato 1967a). More 
recently it was suggested that compounds such as phosphonites bearing a strong 
jt acceptor ability in conjunction with a lipophilic nature produced the double 
spectra (Dahl and Hodgson 1978a). The suggestion that jt bonding is 
responsible for the production of the double spectra cannot be validated, since it
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is known that amines which cannot n bond can produce double spectra on 
binding to reduced cytochrome P450 (Jefcoate 1969b). The production of the 
double Soret spectra could therefore be due to the nature of the environment in 
the active site and not Jt bonding.
Recent work carried out on the coordination of three families of nitrogen bases 
(amines, azines and azoles) by both an Fe(ni) porphyrin (Hamza and Pratt 
1994a) and a Co(ni) corrinoid (Hamza and Pratt 1994b) have shown that the 
equilibrium constant (K) for coordination increases with the basicity pK of the 
ligand according to the following relationship:- log K = a.pK + b, (with similar 
values of a for all three families but values of b falling in the following order: 
azoles>azines>amines). The values of log K may be further increased in the 
case of hydrazine, hydroxylamine and pyridazine through operation of the so 
called a-effect. This is the term originally applied to the enhanced nucleophilic 
reactivity (in catalysed ester hydrolysis) observed when the donor atom is 
attached directly to another electronegative atom carrying one or more lone pair 
of electrons (Edwards and Pearson 1962). Furthermore, recent work has also 
shown that the binding of thiols and thiolates to Fe(n) produces a value of a=0 
(i.e binding constants are essentially independent of the pK) which indicates that 
both RSH/RS" are readily accessible as ligands in the physiological range in 
support of Kahl’s suggestion (Norris and Pratt in preparation).
The postulated equilibrium between the thiolate/thiol proximal ligands [RS" => 
Fe(n) <=X]i + H+ <=> [RSH° => Fe(ii) <= X]n will be investigated using a series of 
nitrogen bases, firstly by increasing the electron density on the Fe (by 
increasing the pK of the base) and, secondly, using ligands which may model a 
key feature of coordinated oxygen. The binding of oxygen is in fact known to 
be anomalous producing a single peak at 419 nm in the reduced spectrum, 
which is close to that of myoglobin (418 nm). It is expected that coordinated
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oxygen will show the a-effect (Taube 1986) and that strong hydrogen bonding 
may be an associated effect It is thought that hydrazine, hydroxylamine and 
pyridazine may therefore provide "models" for this aspect of coordinated oxygen 
and for investigating the a-effect.
It has been suggested that the conserved distal Thr/Ser residues may be 
involved in the binding of oxygen (Song et al 1993) and the addition of the 
second electron in the catalytic cycle (Gerber and Sligar 1994). In order to 
investigate this, a P450 type enzyme that lacks these two residues will be 
extracted from blood platelets and the binding of certain ligands to this enzyme 
will be investigated. The enzyme used for this will be thromboxane synthase 
which handles endogenous hydroperoxides in reactions which require no oxygen.
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CHAPTER 2
Purification and characterisation CYP2B4
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2.1 INTRODUCTION.
Hepatic microsomal cytochrome P450 plays an important role in the oxidation of 
endogenous substrates such as steroids, in the detoxification of xenobiotics, and 
in the activation of many different drugs and environmental agents to toxic, 
mutagenic and carcinogenic forms (Gillette et al 1972). In untreated animals 
cytochrome P450 is the most abundant membrane protein of liver microsomes. 
Levels of hepatic microsomal cytochrome P450 may be increased by the 
administration of many drugs, pesticides, carcinogens, hydrocarbons and 
anaesthetics (Nebert 1979), so that cytochrome P450 represents greater than 10 
% of the total microsomal protein (Ryan et al 1979).
In order to further investigate the ligand exchange reactions of cytochrome P450 
using optical spectroscopy, and to investigate the action of hydrogen peroxide 
on cytochrome P450, a purified form of the enzyme had to be obtained. This 
form of the enzyme had to have a well defined range of catalytic activity. The 
form of cytochrome P450 that fits the above criteria was CYP2B4, the 
cytochrome P450 isoform induced by pretreatment with phénobarbital. The 
microsomal content of CYP2B4 on induction by phénobarbital is known to 
increase 2 -3  fold, with a concomitant increase in the level of other microsomal 
proteins such as NADPH-cytochrome P450 reductase. This form of cytochrome 
P450 is readily isolated from rabbit liver microsomes by procedures developed 
by Coon and co-workers 1978, and can be obtained in a good yield of high 
purity.
During the purification process outlined in figure 2.1, a few problems were 
encountered, especially with regards to the yield of pure enzyme and in the 
purification of the reductase fraction. The final yield of pure enzyme was less 
than predicted when compared to yields obtained by other authors (Coon el al
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1978). The low yield was mostly due to the loss of protein after the 
hydroxylapatite column step. Due to the poor yield obtained with the 
hydroxylapatite column, it was decided to omit this hydroxylapatite column step 
and to use the protein eluate from the previous chromatography step, termed 
partially purified cytochrome P450 in the experiments outlined in the following 
chapters alongside the pure CYP2B4 already obtained.
The purification of the NADPH-cytochrome reductase fraction was undertaken 
using the methodology employed by a number of different laboratories with no 
major problems (Yasukochi and Masters 1976). However, during the purification 
process outlined in this chapter, the pure reductase fraction remained tightly 
bound to the 2' 5' ADP column obtained from Pharmacia, and could not be 
eluted in-spite of changing the strength or pH of the eluting buffer. A similar 
problem was experienced using the same column by Prof. J. B. Schenkman 
(personal communication 1995).
The characterisation of the pure and partially purified forms of CYP2B4 was 
carried out using an assay specific for CYP2B4 involving the dealkylation of 
pentoxyresorufin in addition to gel electrophoresis. Gel electrophoretic techniques 
were used, especially in the case of the partially purified preparation to assess 
the proportion of the CYP2B4 subunit and CYP1A2 subunit in this preparation. 
The O-depentylation of pentoxyresorufin may be affected by many factors such 
as the absence or presence of detergent in the reconstituted system and 
formation of the lipid micelles. The formation of lipid micelles is crucial for the 
maximum rate of dealkylation to occur, as incomplete micelle formation prevents 
interaction between cytochrome P450, NADPH-cytochrome P450 reductase and 
substrate. The presence of high concentrations of detergent has been shown to 
inhibit the dealkylation of pentoxyresorufin (Rietjens et al 1988), therefore the 
presence of small amounts of detergent may affect the rate of dealkylation.
29
Figure 2.1:
PURIFICATION OF CYTOCHROME CYP2B4
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2.2 MATERIALS.
All reagents used were of at least analytical grade and were obtained from the 
following sources :
Amicon Instruments Company. (USA)
PM 30 Diaflo ultrafilters.
British Drug House Ltd. (Poole, Dorset, UK)
Ammonium persulphate, copper sulphate, dipotassium hydrogen orthophosphate, 
disodium hydrogen orthophosphate, EOT A, glycine, potassium dihydrogen 
orthophosphate, potassium sodium tartrate, sodium carbonate, sodium dihydrogen 
orthophosphate, sodium dithionite, sodium dodecyl sulphate (SDS), sodium 
hydrogen carbonate, sodium pyrophosphate.
British Oxygen Company. (Guildford, UK)
Carbon monoxide.
Calbiochem Biochemicals. (Nottingham, UK)
Aquacide III.
Fisons Scientific Equipment. (Loughborough, Leicestershire, UK)
Acetic acid (glacial), glycerol, hydrochloric acid, methanol, potassium chloride, 
sodium hydroxide.
Gibco. (Paisley, UK)
Bluprint fast page stain.
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Molecular Probes. (Eugene, Oregon, USA)
Pentoxyresorufin.
National Diagnostics. (Aylesbury, Buckinghamshire, UK)
Acrylamide, bisacrylamide.
Pharmacia. (St. Albans, Hertfordshire, UK)
All column equipment.
Sigma Chemical Company LTD (Poole, Dorset, UK)
Butylated hydroxytoluene, bovine serum albumin, cholic acid (sodium salt), CM 
Sepharose, DEAE 52 cellulose, Folin-Ciocalteau reagent, hydroxylapatite 
(granulated), L-a-dilauroyl phosphatidyl choline, NADPH, prestained molecular 
weight markers, polyethylene glycol (6000-8000), sodium phénobarbital, 
TEMED, tergitol (NP-10), tris (trizma base).
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2.3 METHODS.
2.3.1 Preparation of column chromatography media.
DEAE Cellulose Anion exchange.
The required amount of DEAE cellulose anion exchange medium (1 part medium 
to 3 parts distilled water w/v) was suspended in distilled water and gently 
swirled. After allowing the suspension to settle, the 1 fines ' were decanted and 
the procedure repeated twice using 10 mM Tris-HCl buffer pH 7.5. The medium 
was ready for pouring into the column apparatus.
CM-Sepharose.
The above procedure was also used for the preparation of this medium except 
that 10 mM potassium phosphate buffer pH 7.5, was used as the wash medium 
instead of the Tris-HCl buffer.
Hydroxylapatite.
Hydroxylapatite (Type III) medium (1 part medium to 3 parts buffer w/v) was 
prepared by suspending the required amount of the powered matrix in 3 
volumes of the starting buffer, 10 mM phosphate pH 7.5 (4 parts potassium to 
one part sodium). The suspension was gently swirled and after allowing to 
settle, the ' fines ' were decanted and the procedure repeated 3-4 times to 
remove most of these ' fines '. The medium was then poured into the column 
apparatus.
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2.3.2 Column preparation.
All of the column apparatus used during the purification of CYP2B4 were 
prepared in the same way. All the seals were greased with silicon grease to 
prevent leaks and to enable a continuous and steady flow of the eluting buffer.
After the construction of the column apparatus, an aliquot of buffer to be used 
was poured into the bottom of the empty column. The stirred medium was then 
poured into the column at a steady rate to avoid the production of convection 
currents and allowed to settle overnight. A column top was attached and 
connected via a piece of tubing to a reservoir containing the buffer to be used. 
The buffer was now allowed to run through the column at a fixed flow rate 
until a constant column bed height was obtained. The column was washed with 
buffer until the pH of the eluent was identical to the starting pH of the buffer, 
the column was now ready for use.
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2.3.3 Purification of hepatic microsomal CYP2B4 from  
phénobarbital treated rabbits.
Animals and animal pretreatment
Eight male New Zealand white rabbits (Av. wt 2.2 Kg) were obtained from the 
animal breeding unit (University of Surrey). The animals were maintained on 
drinking water containing 0.1 % (w/v) sodium phénobarbital solution (adjusted to 
pH 7.0 with HC1 prior to use) for 5 days. After 5 days the animals were 
fasted overnight prior to killing, in order to minimise the amount of glycogen 
present in the liver.
Preparation of hepatic microsomes.
The methodology employed for the preparation of CYP2B4 was based on a 
procedure developed by Coon et al (1978), and was carried out at a 
temperature of 4 °C. All the buffer solutions contained 20% (v/v) glycerol, 1.0 
mM EDTA and were at pH 7.5, unless otherwise stated.
The animals were killed by cervical dislocation. The livers were removed 
immediately, the gall bladders excised and the livers blotted dry. The livers 
were subsequently pooled and weighed (688g). The combined liver preparation 
was then scissored minced and homogenised in 4 volumes of 0.1 M Tris-HCl 
buffer pH 7.5, containing 0.1 M KC1, (no glycerol) using a Waring blender at 
the highest speed (2 x 30 seconds). The homogenate was then centrifuged at 
12,000g (9000 rpm) for 30 minutes using a 6 x 250 ml aluminium angle head 
rotor in a Beckman J2-21 centrifuge. The supernatant was decanted and 
centrifuged at 100,000 g (38,000 rpm) for one hour in a Beckman LS-65 
ultracentrifuge using a Ti 60 rotor. The resulting pellets were pooled and
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homogenised in 0.1 M sodium pyrophosphate buffer (no glycerol) using a motor 
driven Potter-Elvehjem glass teflon homogeniser. The pyrophosphate wash was 
carried out to remove any remaining haemoglobin present in the sample. The 
pyrophosphate homogenate was centrifuged at 100,000 g (38,000 rpm) for one 
hour using the same rotor as before. The resulting dark red pellets were hand- 
homogenised in 50 mM Tris-HCl buffer containing glycerol to a final volume of 
500 ml. The homogenate was stored in 5 x 100 ml aliquots overnight at -70 °C.
Solubilisation of microsomal proteins.
The thawed homogenate (100 ml) was mixed with 250 ml of 0.2 M Tris-HCl 
buffer pH 7.5, containing EDTA (2.0 mM) and butylated hydroxytoluene (0.04 
mM) and made up to 500 ml after cholate addition. A 10 % (w/v) sodium 
cholate solution was added drop wise from a burette with stirring to the 
microsomes in an ice bath under nitrogen, to give a final cholate to protein 
ratio of 3:1 and the mixture then stirred for a further 30 minutes. The solution 
was centrifuged at 100,000 g (38,000 rpm) for 45 minutes in an ultracentrifuge 
to remove any unsolubilised microsomal protein. The resulting supernatant was 
decanted and 50 % (w/v) polyethylene glycol (PEG) was added slowly from a 
burette to the supernatant on ice with continuous stirring, to obtain a 6 % final 
concentration. Following PEG addition the solution was left to stir for 10 
minutes and then centrifuged at 12,000 g (9,000 rpm) for 20 minutes in a 
Beckman J2-21 centrifuge. Further PEG was then added to the supernatant, and 
the fractions precipitated from 6-8 %, 8-10 %, 10-12 % PEG were collected by 
centrifugation. The resulting pellets were resuspended in 50 ml of 10 mM Tris- 
HCl buffer containing glycerol and EDTA, using a hand held homogeniser. The 
five 8-10 % PEG fractions which contained the most cytochrome P450 (see 
section 2.3.10) were combined and adjusted to 0.5 % (v/v) tergitol. This 
combined fraction was dialysed against 10 mM Tris-HCl buffer containing
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glycerol, EDTA and 0.5 % (v/v) tergitol.
2.3.4 Diethylaminoethyl (DEAE) cellulose anion exchange 
chromatography.
The dialysed fraction resulting from PEG precipitation was concentrated, using 
an Amicon ultrafiltration cell with PM 30 Diaflo ultrafilters, down to a working 
volume (100 ml) and was then loaded onto a DEAE cellulose column (2.6 x 20 
cm) previously equilibrated with 10 mM Tris-HCl buffer pH 7.5. The bound 
cytochrome P450's proteins were eluted using 10 mM Tris-HCl buffer, 
containing 20 % (v/v) glycerol, 0.5 % (v/v) tergitol. The eluate was continually 
monitored at A ^ n m  until the absorbance dropped to 0.18 absorbance units. 
The eluate (600 ml) was pooled into 9 fractions. SDS-polyacrylamide gel 
electrophoresis subsequently revealed that pools 1-6 contained the highest levels 
of CYP2B4.
2.3.5 Hydroxylapatite column chromatography.
The pooled CYP2B4 from the DEAE cellulose column was dialysed against 10 
mM phosphate buffer pH 7.5, containing 20 % (v/v) glycerol, 0.3 % (v/v) 
tergitol and 1 mM EDTA. This dialysate was then applied to two hydroxylapatite 
columns (2.6 x 10 cm) in parallel which had been previously equilibrated with 
the dialysis buffer, but containing only 0.1 mM EDTA. Once loaded, the column 
was washed with 50 mM phosphate buffer, and elution of the protein was 
achieved by increasing the buffer strength to 70 mM with a flow rate of 3 
ml/hr which was achieved using a peristaltic pump. The eluate was monitored 
and all the fractions having an absorbance greater than 0.12 absorbance units at 
A416 nm were pooled. The pooled CYP2B4 fractions were concentrated down 
(see section 2.3.9) to a working volume (20 ml) to ensure that the total protein
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content could be measured. SDS-polyacrylamide gel electrophoresis was then 
carried out to establish the purity of the fraction.
2.3.6 CM-sepharose column chromatography.
This method of chromatography was used to desoap (removal of tergitol) the 
protein fraction. The concentrated fraction from the hydroxylapatite column was 
dialysed against 20 % (v/v) glycerol and then applied to a CM-sepharose column 
( 1 x 5  cm), which had been previously equilibrated with 10 mM potassium 
phosphate buffer containing 20 % (v/v) glycerol. The column was washed with 
the equilibrium buffer until the absorbance of the eluent at A28O nm reached 
zero absorbance units, indicating that all the tergitol had been removed from the 
sample. The protein was eluted from the column using 300 mM potassium 
phosphate buffer containing glycerol 20% (v/v). The eluted CYP2B4 was pooled 
by eye as it was eluted from the column in four distinct phases:- a) A very 
concentrated red phase (5 ml), b) A yellow / orange phase (25 ml), c) A pale 
yellow phase (30 ml) and d) colourless buffer. This indicated that most of the 
CYP2B4 was present in fraction a, whilst fractions b and c contained minor 
amounts. Fractions a, b and c were combined and concentrated down (see 
section 2.3.9) under nitrogen divided into 1 ml aliquots and then stored at - 70 
0 C until required.
At each stage of the purification process, 1 ml samples were taken for the 
determination of total cytochrome P450 content and protein content. SDS- 
polyacrylamide gel electrophoresis was carried out on the final fraction to assess 
purity of the purified fraction. In addition, densitometry was used to quantify 
the purity of the purified fraction using a Shimadzu CS-900 Dual-wavelength 
flying spot scanner linked to a Qume 835 personal computer and Citizen Swift 
24 printer.
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2.3.7 Purification of NADPH cytochrome P450 reductase.
NADPH cytochrome P450 reductase was routinely purified as a by-product from 
the purification of phénobarbital-induced CYP2B4. The methodology devised was 
similar in principle to that described by Yasukochi and Masters (1976). All 
procedures were carried out at 4 ° C.
NADPH cytochrome P450 reductase and cytochrome bs were eluted from the 
DEAE cellulose column after the CYP2B4 had been removed, by washing the 
column with 10 mM Tris-HCl buffer pH 7.5, containing 20% (v/v) glycerol, 
0.5% (v/v) tergitol, 1.0 mM EDTA, 0.05 mM dithiothreitol (DTT) and 350 mM 
KC1. The eluate was continually monitored at A417 nm, and those fractions that 
contained 30% of the highest reductase value were pooled and concentrated to 
20 mis. The pooled fractions were then dialysed against two successive 3 litre 
volumes of 10 mM potassium phosphate buffer pH 7.7, containing 20% (v/v) 
glycerol, 0.1% tergitol (v/v), 0.01 mM EDTA, 0.2 mM DTT over a 24 hour 
period.
2.3.8 N6-(6-Aminohexyl)-adenosine 2’,5’-diphosphate sepharose 4B 
affinity chromatography (2’,5’-ADP-Agarose)
A portion of the dialysate (1 ml) was loaded onto a 2’,5’-ADP-Agarose column 
( 1 x 8  cm) previously equilibrated with the dialysis buffer. On loading a very 
faint yellow band appeared at the top of the column indicating the binding of 
the reductase, whilst cytochrome bs was eluted. On completion of loading, the 
column was washed with 200 mM potassium phosphate buffer pH 7.7 
containing 20% (v/v) glycerol, 0.02 mM EDTA, 0.2 mM DTT, until the 
absorbance at A280 nm reached zero (tergitol removed). The reductase was then 
eluted with the 10 mM potassium phosphate buffer containing 20% (v/v)
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glycerol, 0.02 mM EDTA, 0.2 mM DTT and 0.7 mM 2’ AMP. The concentration 
of 2’ AMP was increased to 4.0 mM to ensure all the reductase had been 
eluted. The eluate was monitored at 451 nm and the fractions containing the 
most reductase were pooled and concentrated to approximately 5 ml. The 2’ 
AMP was removed by successive dialysis against 3 litres of 50 mM potassium 
phosphate buffer, pH 7.7 containing 20% (v/v) glycerol. The reductase was 
then divided into 1 ml aliquots and stored at -70 ° C.
2.3.9 Concentration of the various protein fractions obtained 
during the purification procedure.
Cytochrome P450 fractions were routinely concentrated during the purification 
procedure in order to obtain usable stock concentrations, using a) Amicon 
ultrafiltration for large volumes (500 ml), b) aquacide for small volumes (50 ml).
a) A fresh membrane of the required molecular weight exclusion was placed in 
an ultrafitration cell (capacity 500 ml) obtained from Amicon instruments Co, 
USA. The cell was filled with distilled water and under a steady stream of 
nitrogen at a pressure of 30 psi, the water was forced through the membrane in 
order to displace the glycerol contained in the membrane pores. This procedure 
was repeated 2-3 times to ensure complete removal of the glycerol. Once this 
had been achieved, the protein preparation was introduced to the cell and 
ultrafiltration was carried out at 30 psi.
b) Visking dialysis tubing (5-24 /32 ") obtained from Medicell international 
limited, London, UK. was boiled three times in distilled water and stored at 4 
°C prior to use. The required length of tubing was filled with the protein 
preparation and placed in a petri dish and then subsequently liberally sprinkled 
with aquacide (modified polymer of high molecular weight). The petri dish 
containing the tubing was covered in foil and stored at 4 °C until concentration
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of the protein fraction had been achieved.
2.3.10 Spectrophotometric enzyme assays.
All spectrophotometric determinations were carried out using a Kontron-Uvikon 
model 860 split beam spectrophotometer.
Determination of total cytochrome P450.
Total cytochrome P450 content was determined using the method of Omura and 
Sato (1964a) based on the Fe2+ carbon monoxide adduct. Purified protein 
fractions were diluted (1:6)  with 0.1 M potassium phosphate buffer, pH 7.4. 
Reduction of the ferric form to the ferrous form was achieved by adding a few 
granules of sodium dithionite. The protein suspension was divided equally
between two 1.5 ml cuvettes and a baseline scan was recorded between 500 -
400 nm. Carbon monoxide was bubbled into the sample cuvette at approximately 
one bubble per second for 30 seconds and the spectrum between 500 - 400 nm 
was recorded. Total cytochrome P450 concentration was determined employing 
the extinction coefficient of 91 mM ^ c n r1 for the absorbance difference A4 5 0- 
490nm.
Determination of the total protein content.
Total protein content was determined by the Lowry et al (1951) method using
bovine serum albumin (fraction V) as the standard.
Reagents : - 2 % (w/v) sodium carbonate
2 % (w/v) sodium potassium tartrate 
1 % (w/v) copper sulphate 
Folin-Ciocalteau phenol reagent
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Bovine serum albumin solution (500 pig / ml) was diluted with sodium hydroxide 
(0.5 M) to give a range of standards (0 -250 ^g) in a total volume of 1.0 ml 
sodium hydroxide. The purified fractions were diluted (2 - 20 fold) with sodium 
hydroxide to give an appropriate concentration in a final volume of 1.0 ml. 
Copper sulphate, sodium potassium tartrate and sodium carbonate were mixed in 
the ratio (1:1: 100 by volume) immediately before use. A portion (5 ml) of this 
was added to each tube and allowed to stand for 10 minutes at room
temperature. An aliquot (0.5 ml) of Folin-Ciocalteau phenol reagent (50 % v/v) 
was then added to each tube, which was then immediately vortexed and
incubated at room temperature for 30 minutes. After 30 minutes the absorbance
was read at 720 nm. The protein concentration was calculated from the standard
curve.
Most of the purified preparations assayed by this procedure contained glycerol 
and tergitol, which are known to cause turbidity. On such occasions, the tubes 
were centrifuged at 1,800 g (3000 rpm) for 10 minutes to remove the turbidity 
caused by these compounds. After centrifugation the samples were read as 
previously described.
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2.3.11 Characterisation of the purified CYP2B4 fraction.
Alkoxyresorufm O-dealkylase assay.
The O-depentylation of pentoxyresorufin was carried out using the method of 
Burke and Mayer (1974). The assay system comprised the following reagents:-
Stock
concentration
Component Final
concentration
300 pig / ml
6.9 nmol / ml 
40 units / ml
150 mM 
400 mM
1 mM 
50 mM
L-a-dilauroyl phosphatidyl 
choline.
Purified CYP2B4. 
NADPH-cytochrome P450 
reductase.
Magnesium chloride.
Potassium phosphate buffer, 
pH 7.8.
Pentoxyresorufin.
NADPH in 1 % (w/v) NaHCOg.
30 jiglml
0.09 nmol/ml 
0.5 units/ml
15 mM 
50 mM
5 pM 
0.25 mM
Components were added in the order given above at 4 6C and made up to a 
final volume of 2 ml with distilled water. All components in the above 
incubation system were pre-incubated at 37 °C for 5 minutes. After 5 minutes 
the reaction was initiated by the addition of NADPH. The fluorimetric assay 
was performed on a Perkin Elmer LS-5 luminesence spectrophotometer set at an 
excitation wavelength of 510 nm and emission wavelength of 586 nm with 
excitation and emission slit widths of 10 nm and 2.5 nm respectively. A baseline 
of fluoresence was recorded prior to the initiation of the reaction by the addition 
of NADPH. The reaction was continually monitored until a measurable gradient
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was obtained. Initial rate was ascertained from the slope. Calibration was carried 
out using aliquots (10/d) of 0.1 mM resorufin.
Discontinuous SDS-polyacrylamide slab gel electrophoresis.
Discontinuous SDS-polyacrylamide slab gel electrophoresis was carried out as 
described by Laemmli et al (1970), using the following buffers:-
Lower gel buffer : 1.5 M Tris-HCl pH 8.8, containing 0.4 % (w/v) sodium 
dodecyl sulphate (SDS).
Upper gel buffer: 0 .5M Tris-HCl pH 6.8, containing 0.4% (w/v) SDS.
Electrode buffer : 25 mM Tris-HCl pH 8.3, containing 192 mM glycine and 0.1 
% (w/v) SDS.
Sample buffer : 62.5 mM Tris-HCl pH 6.8, containing 2.3 % (w/v) SDS, 15 % 
(v/v) glycerol, 0.001 % (w/v) bromophenol blue and 5 % (v/v) 
mercaptoethanol.
Discontinuous SDS-polyacrylamide slab gel electrophoresis was carried out using 
a Hœfer SE 400 slab gel unit. The glass electrophoresis cassette was cleaned 
using acetone, assembled and greased with vaseline to aid the formation of a 
leakproof seal at the bottom edge of the unit. The unit was placed in a vertical 
casting stand and tightened onto a silicon gasket to achieve a leakproof seal. 
The lower gel was prepared using acrylamide gel (8.11 ml), bisacrylamide (3.38 
ml), lower gel buffer (6.25ml), 10 % (w/v) ammonium persulphate (125/d) and 
distilled water (7.14 ml). Immediately prior to pouring the gel into the cassette, 
20 /d of the polymerising agent TEMED was mixed into the gel solution. The
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gel was then pipetted into the cassette to a depth of about 10 cm and left to 
set. A layer of distilled water was placed on top of the gel to ensure an even 
surface. Once set, the water was removed and an upper gel was prepared using 
acrylamide gel (1.0 ml), bisacrylamide (0.4 ml), upper gel buffer (2.5 ml), 10 % 
(w/v) ammonium persulphate (100/d) and distilled water (6.0ml). TEMED (20 
/d) was added to the gel immediately before it was pipetted into the cassette. A 
nine well comb was immediately inserted into the upper gel and the gel was 
allowed to polymerise. When set, the comb was removed carefully revealing 
nine wells which were then filled with electrode buffer. Samples were diluted to 
a protein concentration of 0.5 mg / ml with sample buffer and boiled for three 
minutes in a water bath to ensure dénaturation of the protein prior to use. 
Samples were loaded (20 /d per well) using a 50 /d Hamilton syringe, 
molecular markers were also loaded. The cassette was then placed into an 
electrophoresis tank. Electrode buffer was poured into the upper and lower 
reservoirs of the tank. Electrophoresis was established with a constant current of 
20 mA for two hours. Once the dye front was within 3 cm of the bottom of 
the unit, the cassette was dismantled and the gel removed for staining using the 
following reagents
Wash buffer : 45 % (v/v) methanol, 10 % (v/v) acetic acid, 45 % (v/v)
distilled water
Staining solution : 8 ml Bluprint fast stain stock solution, 32 ml distilled
water, 10 ml wash buffer
Destaining solution : 10 % (v/v) aqueous acetic acid
45
Prior to staining, the gel was washed in the wash buffer for 10 minutes. This 
was repeated twice. After the final wash, the gel was submerged in the staining 
solution and agitated for 20 minutes. After 20 minutes the staining solution was 
then removed, and the gel was destained using the 10 % solution of acetic acid. 
The destaining process was continued until all traces of stain were removed. 
The percentage purity of the protein was determined by densitometery on the 
gel, using a Shimadzu densitometer set to Zig-Zag scan mode.
Preparation of CYP4A and CYP2E microsomal fractions.
Hepatic microsomes of male Wistar albino rats (150-200g, University of Surrey 
Breeders), which had been pretreated with either clofibrate (250 mg kg"1 i.p. 
for 3 days), or isoniazid (100 mg kg"1 gavage for 3 days) and killed 24 hours 
after the last dose were prepared according to a procedure developed by Coon 
et al (1978).
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2.4 RESULTS
2.4.1 Purification of rabbit CYP2B4
CYP2B4 was purified from rabbits pretreated with phénobarbital as described in 
section 2.3.1. The purification protocol is represented schematically in figure 2.1 
and yields from the purification process are shown in table 2.1.
The total amount of pure CYP2B4 produced during this purification was calculated to 
be 165 nmol/688g liver, which compares favourably with the yields obtained by other 
authors which ranged from between 74 nmol to 246 nmol from 300g-868g of liver , 
(Gibson et al 1982, Koop et al 1982 ). The total amount of pure CYP2B4 produced in 
this purification process corresponds to a final yield of 0.4% which although low, 
compares favourably with yields reported by other authors (Van der Hœven et 
al 1974, Haugen and Coon 1976, Coon et al 1978, Gibson et al 1982, Koop 
et al 1982), where the yields ranged from 1.1 to 4.6%. Higher yields may be 
obtained by either omitting the final desoaping step or by taking all the fractions 
from PEG precipitation through the purification process. The specific activity of 
the final preparation was found to be 11.5 nmol CYP2B4/mg protein, whereas 
the specific activity reported by the authors named above ranged from 11.3 to 
20 nmol of cytochrome P450/mg protein. The final yield of CYP2B4 in this 
purification was lower than that reported by other authors and may be attributed 
to a substantial loss of the enzyme at the hydroxylapatite column 
chromatography stage, where a large amount of the partially purified CYP2B4 
remained tightly bound to the column. The protein remained bound to the 
column, even though the ionic strength of the buffer was increased to 500 mM. 
A possible explanation for the difficulties encountered on elution of the CYP2B4 
from this column is that protein-protein interactions may have occurred between 
the CYP2B4 and CYP1A2 proteins, thus preventing the complete elution and
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separation of the CYP2B4 from the other cytochrome P450 isozyme (Tamburini 
et al 1984). Furthermore, it must also be taken into account that the carbon 
monoxide assay for determination of cytochrome P450 content does not 
differentiate between different forms of cytochrome P450, so that the value 
obtained for the steps 1 to 3 (homogenate to hydroxylapatite column) takes into 
account all cytochrome P450s present and not just the amount of CYP2B4 
present. Due to the substantial loss of the CYP2B4 protein on the 
hydroxylapatite column, all subsequent purification processes were taken to be 
complete after the DEAE-cellulose step, which gave a final yield of 12 % (10 - 
14 %) with a specific activity of 7.9 nmol. This preparation was named the 
partially purified fraction. Similar experimental results have been obtained with 
partially purified preparations of CYP2B4 from phenobarbital-induced animals 
containing up to 95 % of the CYP2B4 protein, with the remaining 5 % 
CYP1A2, as with preparations containing 6 or 18 nmol/mg of pure protein 
(Guengerich et al 1975). The 5 % of CYP1A2 present in the partially purified 
fraction has been shown to have no affect on the binding spectra produced by 
CYP2B4 in either the reduced or oxidised state (White and Coon 1982).
After the cytochrome P450 proteins had been eluted from the column, 
purification of the cytochrome b$ and NADPH-cytochrome c reductase which 
had remained bound to the top of the column was undertaken using the 
methodology of Yasukochi and Masters (1976). The initial yield of NADPH- 
cytochrome c reductase from the purification process was found to be very low 
(0.1 %). This portion of NADPH-cytochrome c reductase was subsequently used 
for the reconstitution experiment. When the bulk of the concentrated 
reductase/cytochrome b$ mixture was applied to the same column, after elution 
of the bs fraction, elution of the pure reductase fraction was carried out using 
2' AMP. However, inspite of using 2* AMP at various concentrations (0.7 - 5 
mM), the reductase remained bound to the column. Subsequently, different
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methods of elution were attempted; these included NADP at a concentration of 
1.0 mM, pH gradient (7.7 - 4.4), salt gradient (0.2 M - 1.0 M), addition of 
tergitol, and finally 6  M urea. All of these elution methods failed to remove the 
reductase which seemed to be irreversibily bound to the ADP agarose column. 
Since the last elution method ( 6  M urea), failed to remove any of the reductase, 
a second attempt was made to purify the reductase using the above method, 
except that purification of the reductase / bs was attempted using different column 
packing materials, namely, Sephadex G-75 (Omura and Takesue 1970), DEAE- 
Sephadex A25 (Dignam and Strobel 1975), hydroxylapatite (lyanagi et al 1978), 
and DEAE-22 cellulose (Lu et al 1972). Inspite of using all these different 
packing materials, the reductase could not be separated from the cytochrome bs 
in significant quantity or purity, for subsequent use in reconstitution 
experiments.
2.4.2 Characterisation of pure and partially purified fractions.
Once all the fractions of partially purified and pure CYP2B4 had been collected 
and concentrated to an appropriate working volume, characterisation of the 
enzyme was carried out using the techniques of SDS-gel electrophoresis, optical 
spectroscopy and fluorimetry.
Examination of the photograph of the gel (figure 2.2) clearly shows the 
presence of one band in the pure sample land three bands ( one major and two minor) in 
the partially purified sample. The single band in the pure sample and the major 
band in the partially purified both correspond to the CYP2B4 subunit and 
appears to have a molecular weight of 49,000, which was calculated using the 
following molecular weight standards
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1 2 3 4
Fig 2.2 A SDS-page gel showing the different stages in the purification of 
CYP2B4.
Track 1 - Molecular weight markers.
2 - Homogenate.
3 - Partially purified CYP2B4.
4 - Pure CYP2B4.
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Protein Approximate Mr 
( dal tons )
Macroglobulin 
p-Galactosidase 
Fructose-6 -phosphate kinase 
Pyruvate kinase 
Fum arase
Lactate dehydrogenase 
Triose phosphate isomerase
180,000
116,000
84.000
58.000
48.000 
36,500 
26,600
The minor band in the partially purified sample corresponds to CYP1A2 which 
has an estimated molecular weight of 54,000. Literature values for these two 
forms of cytochrome P450 range from 48,500 to 50,000 for the CYP2B4 
subunit and from 53,000 to 55,300 for the CYP1A2 subunit (Haugen et al 
1975, Guengerich 1979, Lu and West 1980, Guengerich et al 1982). A spectral 
scan of the reduced purified fraction produced a peak at 451 nm and no peak at 
420 nm. This indicated that the enzyme was active and contain no denatured 
form of the enzyme. The oxidised spectrum produced a peak at 417 nm 
indicating the enzyme was in a low spin state. These observations are in 
agreement with the values quoted in the literature (White and Coon 1982).
The dealkylation of pentoxyresorufin is the specific assay used for the 
identification of the major phenobarbital-induced form of cytochrome P450, 
namely CYP2B4. When the purified CYP2B4 fraction was reconstituted into an 
assay system containing NADPH-cytochrome c reductase and lipid, dealkylation 
of the substrate occurred (table 2.2). However, when NADPH-cytochrome c 
reductase fraction was omitted from the enzyme system, no dealkylation 
occurred. The amount of dealkylation that occurred in the reconstituted system 
(423 pmol resorufin/ml (705 pmol/mg protein)) was comparable to the figure 
reported by other authors (181-1241 pmol resorufin/mg protein) (Lubet et al
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1985) The dealkylation of pentoxyresorufin was used to identify the form of 
cytochrome P450 protein that had been purified rather than to use it to confirm 
CYP2B4 induction.
Cytochrome
P450
Rate of Dealkylation.
Sample nmol / ml pmol resorufin 
produced/ mini ml
pmol resorufin 
produced /min 
/ nmol P450
Homogenate 89.7 1494 16.6
Complete system 
(CYP2B4 and reductase)
6.9 423 61
System with CYP2B4 
but without reductase
6.9 0 0
Table 2.2 Rates of O-dealkylation of pentoxyresorufin by purified CYP2B4 in a
reconstituted system.
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2.5 DISCUSSION.
The purification procedure described in this chapter provided an ideal method for 
the isolation of the major form of phenobarbital-induced rabbit hepatic 
microsomal cytochrome P450, namely, CYP2B4. Furthermore, the protein was 
purified to an approximate purity of 93 % using this procedure.
The estimated molecular weight of the purified protein as determined by SDS 
gel electrophoresis using prestained molecular weight markers as indicators of 
the molecular weight, revealed that the subunit molecular weight of the purified 
cytochrome P450 protein to be 49,000 which corresponds to the molecular 
weight of the CYP2B4 protein (Haugen et al 1975; Lu and West 1980). 
Furthermore, evidence for the purification of the CYP2B4 isozyme was provided 
by analysis of the oxidised and reduced spectra of the purified protein which 
displayed peaks at 417 nm and 451 nm, respectively, indicating that the purified 
protein was CYP2B4 (White and Coon 1982). Conclusive confirmation of the 
purification of the CYP2B4 isozyme was obtained by measurement of the rate 
of O-dealkylation of the substrate; pentoxyresorufin, an activity known to be 
catalysed by CYP2B4 (Lubet et al 1984), when the purified protein was 
incorporated into a reconstituted system in the presence of lipid and purified 
NADPH cytochrome reductase (table 2.2). Dealkylation of the substrate did not 
occur in the absence of NADPH-cytochrome reductase. SDS-gel electrophoresis 
and spectral analysis also revealed that the partially purified fraction contained 
essentially the CYP2B4 protein.
The enzyme system in liver microsomes which is responsible for the 
hydroxylation of various substrates has been solubilised and resolved into three 
components; cytochrome P450, NADPH-cytochrome c reductase and a heat-stable 
substance called factor B (Lu and Coon 1969). The heat-stable factor has been
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identified to be phosphatidylcholine and has been shown to be essential for the 
reductase-catalysed transfer of electrons from NADPH to cytochrome P450 
(Strobel et al 1970). Variations in the rates of reaction using purified 
cytochrome P450 and different substrates in reconstitution systems have been 
known to occur (Koop et al 1982). These variations in the rates of reaction 
between different authors are most likely attributed to the preparation of the 
reconstitution system. In order for maximal rates of catalysis to occur the three 
components in a reconstitution system must form vesicles which resemble the 
initial microsomal environment with regard to bilayer structure, phospholipid 
composition, surface charge, protein:lipid ratio, and cytochrome P450:NADPH- 
cytochrome P450 reductase ratio (Bosterling et al 1979). If this is not achieved 
a variation in the rates of activity can occur. The lipid, phosphatidylcholine is 
used in the majority of reconstituted systems and has been shown to be
effective in stimulating substrate conversion in these systems (Strobel et al
1969). Evidence has also shown that phospholipids, in particular
phosphatidylcholine plays an important role in the binding of substrate to the 
active site of the cytochrome P450 molecule thus indicating that the substrate 
binding site of cytochrome P450 is closely associated with membrane
phospholipids (Taniguchi et al 1984).
The purification of the reductase fraction was undertaken following the 
methodology of Yasukochi and Masters (1976). However, during the purification 
process the isolated reductase fraction remained bound to the 2'5' ADP agarose 
column. This irreversible binding to the 2' 5' ADP agarose column has also 
been reported by other authors (French and Coon 1979, Schenkman personal 
communication 1995). In the case of French and Coon, 15 % of the reductase 
fraction loaded on to the column was found to remain bound after elution with 
2' AMP, but was subsequently eluted using NADP"*". The binding of this 
reductase fraction to the column after 2' AMP treatment was attributed to
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differences in the lipid environment in the column matrix (French and Coon 
1979). However, although in this case the reductase was eluted, in the 
purification process outlined in this chapter and the process attempted by 
Schenkman, the reductase fraction was found to be irreversibily bound to the 
column, inspite of using different elution methods. The irreversible binding was 
most probably due to the formation of an irreversible bond between the column 
matrix and the reductase protein.
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Reactions
CHAPTER 3
oxidised CYP2B4 involving hydrogen peroxide.
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3.1 INTRODUCTION.
Most cytochrome P450 reactions proceed with the stoichiometry characteristic of 
monooxygenases
NAD(P)H + O2 + RH => NAD(P) + H20  + ROH (1) 
where RH is the substrate and ROH the product (Guengerich 1991). The 
substrates available for this hydroxylation reaction include alkanes and long chain 
fatty acids. Cytochrome P450 can also undertake peroxidase type reactions when 
they react with alkyl hydroperoxides and hydrogen peroxide. The mechanism of 
action is represented by the following equation, where R is an alkyl group or a 
hydrogen atom.
RH + ROOH => R'OH + ROH (2)
The nature of the key intermediate involved in the NADPH and molecular 
oxygen mediated catalytic cycle (fig 1.1), has been debated for a number of 
years. There are two main theories concerning this intermediate; the intermediate 
has been proposed to be either a single oxygen unit or a two oxygen unit. The 
single oxygen unit theory involves the formation of a ferry 1 intermediate 
(FeO)3+, which could also be derived from a single oxygen donor such as 
iodosobenzene. This ferry 1 derivative can be detected spectrally under certain 
conditions and is similar to compound I formed during peroxidase reactions 
(Blake and Coon 1989). The two oxygen unit intermediate theory was initially 
developed by White and Coon in 1980 and investigated further by studying 
reactions involving 17a -hydroxyandrogen and cytochrome P450 17a  (Akhtar el
al 1994). In both these cases the reactions involved the formation of a two 
oxygen unit which possess the structure of an iron-bound peroxide (FeIn -OOH).
The single oxygen unit theory is reasonable since a metal double bonded to an 
oxygen atom such as Ru=CP+ is known to hydroxylate alkanes (Che el al
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1991). The two oxygen unit theory is also reasonable since simple protonated 
hydrogen peroxide (H3Q2+) is known to hydroxylate alkanes in the presence of 
superacids such as FSOgH-SbFg, FSO3H, H2SO4  and HF (Olah et al 1977). 
With this in mind hydrogen peroxide attached to a Lewis acid (eg. Fe3+) could
also probably hydroxylate alkanes. The possibility exists that the key
intermediate could be either and that both may be used in different 
circumstances. Therefore the need exists for a direct test of the single oxygen 
unit against a two oxygen unit in one or more reactions.
The characteristic monooxygenase reaction (1) is always accompanied by the 
production of hydrogen peroxide and degradation of the porphyrin ring.
0 2 + 2H+ + 2e- => H2Q2 (3)
H2Q2 + RH => H2O + ROH (4)
Cytochrome P450 can also catalyse the reaction of hydrogen peroxide directly 
with alkanes (4). This reaction is also accompanied by self-degradation by the 
hydrogen peroxide of the porphyrin ring (Karinuza and Mengazetdinov 1991). 
Due to the destructive nature of hydrogen peroxide very little work has been 
carried out on the degradation of the porphyrin ring. This is probably because 
the degradation was thought to be a nuisance, and its presence has detracted 
from studying reaction (4). The reactions (3) and (4) involved in the formation 
and further use of the hydrogen peroxide allows the study of reaction (!) as 2  
segments and hence emphasises the need to pursue further the investigation of 
the porphyrin ring degradation by hydrogen peroxide.
The reactions of hydrogen peroxide involving cytochrome P450 allow one to 
compare the reactions of cytochrome P450 with peroxidases such as 
chloroperoxidase, which also contains a Cys residue as its proximal ligand, and 
an oxygenase, namely haem oxygenase, which contains a His residue as its 
proximal ligand. The comparison of cytochrome P450 with chloroperoxidase led
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to the proposal for a ferryl intermediate which is similar in structure to 
compound I in peroxidases. This in turn led to a search for other oxygen 
donors other than hydrogen peroxide such as iodosobenzene. It must be 
remembered that the ferryl intermediate is never observed during the reaction due 
to its very short half-life, although it can be prepared by the reaction of 
cytochrome P450 alone with iodosobenzene (Blake and Coon 1989). The 
reaction of hydrogen peroxide with haem oxygenase has recently been found not 
to involve the ferryl intermediate but occurs via a two oxygen unit (Wilks and 
Ortiz de Montellano 1993). The demonstration of some common features 
between haem oxygenase and cytochrome P450 could provide indirect evidence 
for the involvement of a two oxygen unit. While preparation of the ferryl 
intermediate using iodosobenzene provides a more direct means of testing the 
proposed single oygen unit, which rather surprisingly has never been reported 
with either negative or positive results.
The understanding of the peroxidase mechanism of action has been based on 
studies of the pH-dependent rate constants and ligand binding constants, of 
chloroperoxidase (Sono et al 1986), cytochrome c peroxidase mutants and 
protein free MP8 . Such pH-dependent studies involving cytochrome P450 are 
more difficult because of the limited range of stability (pH 6.5-8.5); both high 
and low pH cause dénaturation of cytochrome P450 (Ichikawa et al 1967). One 
ongoing debate concerns the nature of the sixth ligand present in the resting 
state of cytochrome P450. The nature of this ligand is now agreed to be either 
a water molecule or hydroxide ion. Some authors have advocated that the sixth 
ligand is the hydroxide ion, although no direct evidence has been forwarded 
(Banci et al 1994). Therefore in order to remove as far as possible any 
ambiguity about the nature of the sixth ligand, the pH-dependency of the 
binding constants using one or more bases and an anion should be studied.
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The aim of the work carried out in this chapter was to study the reactions of 
hydrogen peroxide involving both the degradation of the porphyrin ring and 
hydroxylation of an alkane by looking directly at equation (4). The 
hydroxylation reaction was investigated using what is effectively a solubilised 
alkane, namely lauric acid. Laurie acid is known to produce different products 
(to, co-1, to-2) depending on which oxygen donor is used ( Romano et al 1988; 
Ortiz de Montellano et al 1992). Furthermore, it has been shown that lauric acid 
possesses a finite solubility, which allows one to quantitatively study the effect 
of substrate concentrations. In addition the production of metabolites and the 
change in ratio of co:o)-l:a)-2 may also provide an additional probe for the 
changes occurring in the active site, which may include identification of the 
intermediate involved in the hydroxylation reaction. However, the pKa of lauric 
acid which is thought to be between 4.5 - 5.0 (cf. hexanoic, heptanoic, octanoic 
acid all 4.9), may affect the pH-dependency of the rate constant and will have 
to be taken into account when the data is examined. The use of iodosobenzene 
as an oxygen donor has been investigated by other authors (Blake and Coon
1989), and iodosobenzene will therefore be used to prepare and test the ferryl 
derivative as a possible intermediate.
The identity of the sixth ligand in the resting state of the enzyme is agreed to 
be either a water molecule or hydroxide ion. It seems appropriate to undertake 
work in this chapter to identify the sixth ligand, because if any pH-dependent 
change is ignored any equilibrium involving the substitution of coordinated water 
by an anion or base would be expected to be pH-independent. It is however 
difficult to envisage such an equilibium involving the substitution of the 
coordinated hydroxide ion would be pH-independent for both bases and anions. 
Therefore the identity of the sixth ligand will be investigated using the anion 
CN" and the bases N-acetylimidazole and pyridine.
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3.2 MATERIALS
These were as cited in section 2.2. Additional chemicals not previously 
mentioned are given below:-
British Drug House (Poole, Dorset, UK)
Potassium cyanide, pyridine
Fisons Scientific Equipment. (Loughborough, Leicestershire, UK)
Diethylether
Radiochemicals Ltd (Amersham, Buckinghamshire, UK)
[1-14C] Lauric acid
Sigma Chemical Company (Poole, Dorset, UK)
Benzphetamine, hydrogen peroxide, iodosobenzene diacetate, lauric acid, N- 
acetylimidazole
NADPH-cytochrome c reductase was a kind gift from Professor J. B. 
Schenkman (University of Connecticut Health Center, Connecticut, USA).
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3.3 METHODS.
3.3.1 Preparation of pure and partially purified cytochrome P450
The cytochrome P450 used in the following experiments was prepared as 
previously described in section 2.3.3. The removal of the detergent (desoaping) 
from the partially purified samples was achieved as described in section 2.3.6.
3.3.2 The binding of nitrogen containing compounds to oxidised 
cytochrome P450.
Investigations into the binding of nitrogen containing compounds to oxidised 
cytochrome P450 was carried out using partially purified cytochrome P450 at a 
concentration of 1.0 pM, using 0.2 M potassium phosphate buffer pH 7.5. After 
the baseline had been recorded, the P450 suspension was placed in a sample 
cuvette, autozeroed and the spectrum recorded. The ligand was then added to 
the sample cuvette, so that the final concentration was 50 mM unless otherwise 
stated, then the spectrum was re-recorded.
3.3.3 Determination of the binding constant.
In order to obtain the greatest accuracy possible, the bases that produced the 
greatest shift in wavelength on binding were chosen.
a) nitrogen compounds
The binding constants were determined for the nitrogen containing compounds 
with ferric cytochrome P450 using the following procedure; Partially purified 
cytochrome P450 was diluted to give a final concentration of 1.0 pM. After the
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baseline had been recorded using buffer, the partially purified cytochrome P450 
suspension was placed in the sample cuvette and the spectrum recorded. Various 
amounts of the ligand were added to the sample cuvette, whilst equal volumes 
of buffer were added to the reference cuvette. Titration of ligand to oxidised 
cytochrome P450 was carried out at the following pHs 6.5, 7.5 and 8.5 for all 
the ligands.
b) cyanide
The following procedure was used to determine the binding constant for 
potassium cyanide. Partially purified cytochrome P450 was diluted in 0.2 M 
potassium phosphate buffer, to give a final concentration (1 pM) in the cuvette. 
A baseline was recorded with buffer, in both the sample and reference cuvettes. 
Diluted cytochrome P450 was subsequently placed in the sample cuvette, 
autozeroed and then the absolute (oxidised) spectrum was recorded. Potassium 
cyanide (KCN) from a 1 M stock solution was subsequently added to the 
sample, so that the final concentration in the cuvette was 1 mM and the 
spectrum recorded. Further amounts of KCN were added to the cuvette so that 
the final concentration was increased by 2.0 mM after each addition. This 
procedure was carried out at the following pHs : 6.5, 7.0, 7.5, 8.0, 8.5 and 
9.0. Similar experiments were carried out for pure CYP2B4, both in the 
presence and absence of phosphatidylcholine at a concentration of 30 pg/ml.
3.3.4 The effect of hydrogen peroxide on cytochrome P450.
A series of experiments using the oxidised cytochrome P450 spectrum were 
undertaken to investigate the effect of hydrogen peroxide on cytochrome P450. 
All the experiments were carried out on a Uvikon 860 dual beam 
spectrophotometer.
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These experiments were carried out to ascertain the effect of temperature on the 
action of hydrogen peroxide on cytochrome P450. The temperatures used were 
room temperature (25 °C) and the incubation temperature for the measurement of 
lauric acid activity (37 °C). Furthermore, the effects of hydrogen peroxide 
concentration on cytochrome P450 was investigated.
Partially purified cytochrome P450 samples, either in the presence or absence of 
tergitol, were diluted in Tris-HCl buffer, pH 7.0, so that the final concentration 
was approximately 1.0 pM. An oxidised spectrum of the sample was recorded 
and hydrogen peroxide was added to the sample cuvette, and the spectrum re­
recorded. Scans were repeated at approximately 4 minute intervals for about 40 
minutes. This procedure was repeated for all the concentrations of hydrogen 
peroxide used and at both temperatures under investigation.
The effect of pH and substrate concentration on the action of hydrogen peroxide 
was carried out using the above experimental procedure. The experiment was 
carried out at two additional pHs ; 6.5 and 7.5. Both the addition of substrates 
either before or after the addition of hydrogen peroxide was investigated. The 
substrates investigated included benzphetamine, guaiacol, pentoxyresorufin and the 
ligand pyridine, all compounds were used at varying concentrations.
3.3.5 The action of iodosobenzene on cytochrome P450.
The effect of low concentrations of iodosobenzene (0.02 - 0.2 mM) was initially 
investigated at two temperatures, namely 25 °C and 37 °C. These experiments 
were carried out using both pure and partially purified samples of cytochrome 
P450. A sample of cytochrome P450 was diluted in buffer pH 7.0, so that the 
final concentration in the sample cuvette was 1.0 pM. An oxidised spectrum was 
then recorded between the wavelengths 350 and 500 nm. Various concentrations
65
of iodosobenzene were subsequently added to the sample, with an equal volume 
of buffer added to the reference cuvette. The spectrum was repeatedly scanned 
for up to a period of 4 hours.
3.3.6 The action of hydrogen peroxide on lauric acid 
hydroxylation.
The identification of the metabolites produced by the action of hydrogen 
peroxide on lauric acid was determined using the method of Orton and Parker 
(1982). An incubation system comprising of the following was set up in 
triplicate.
Final concentration
Magnesium chloride 1 0 0  pi 15 mM
Phosphatidylcholine (freshly sonicated) 1 0 0  pi 30pg/ml
Lauric acid (12C) 50 pi 0.05 mM
[1-14Q lauric acid 1 0  pi 0.1 pCi
Pure CYP2B4 50 pi 1.0 pM
Tris-HCl buffer, pH 7.5 690 pi 50 mM
1 ml
Tubes were preincubated at 37 °C for 5 minutes in a shaking waterbath. The 
reaction was then initiated by the addition of 15 mM hydrogen peroxide. The 
tubes were then further incubated for 10 minutes at 37 °C in the shaking 
waterbath. Termination of the reaction was achieved by the addition of 3 M HC1 
(200 /d). Metabolites were subsequently extracted into diethylether, this was 
achieved by the addition of diethylether (1 0  ml) to each tube. Tubes were then 
shaken for 10 minutes on an end over end shaker. In order to clarify the 
phases, the tubes were centrifuged at 2,000 rpm for 15 minutes in a Beckman 
J-6 B centrifuge. Aliquots of the organic phase (8.0 ml) were removed into clean
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glass tubes and evaporated to dryness under a stream of nitrogen. The resulting 
dried residues were then capped and stored at - 20 °C until required. The dried 
residue was later reconstituted in 150 pi\ of a reconstitution mixture comprising 
45 % (v/v) methanol, 55 % (v/v) water and 0.05 % (v/v) acetic acid. An 
aliquot ( 1 0 0  /d) of this reconstituted mixture, was subsequently injected into a 
HPLC column (p bondapak CIS 3.9 x 300 mm), which had been previously 
equilibrated with a methanol / 0.1% acetic acid mixture (45/55% ).
In the absence of standards, metabolite identification was carried out by HPLC 
analysis of the hydroxylaurate metabolites produced by a combination of the 
NADPH dependent lauric acid hydroxylation system, using clofibrate-induced 
microsomes and hydrogen peroxide supported pure cytochrome P450 catalysed 
lauric acid hydroxylation. An aliquot (100 /ri) of the hydroxylaurate metabolites 
and lauric acid, produced by clofibrate-induced microsomes was added to an 
equal volume of hydroxylaurate metabolites and lauric acid produced by the 
action of hydrogen peroxide on pure cytochrome P450, and then 100 }A of this 
mixture was injected into the HPLC. Since it is known that the microsomal 
system produces the oo and (oo-l) hydroxylaurate metabolites, and the hydrogen 
peroxide supported pure cytochrome P450 hydroxylations of lauric acid produces 
(oo-l) and (co-2) ( Romano et al 1988), the oo and (oo-2) positions were identified 
in relation to the (oo-l) peak.
3.3.7 The effect of various parameters on the action of hydrogen 
peroxide supported cytochrome P450 catalysed lauric a c i d  
hydroxylation.
The effect of a) incubation time was essentially carried out as outlined in 
section 3.3.6 using pure CYP2B4 with hydrogen peroxide and b) varying 
hydrogen peroxide concentration with an incubation time of 10  minutes and c)
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varying 12C lauric acid concentration with an incubation time of 10 minutes and 
a hydrogen peroxide concentration of 15 mM.
3.3.8 Lauric acid hydroxylation using a reconstituted system.
component 
Phosphatidylcholine 
Pure CYP2B4
NADPH cytochrome c reductase 
Magnesium chloride 
Tris-HCl buffer pH 7.5 
[1-14C] lauric acid 
12C lauric acid
final concentration 
30p,g/ml 
1.0 pM 
1 unit 
15 mM 
50 mM 
0.1 pCi 
0.05 mM
Incubations were carried out in duplicate. The components were added in the 
order stated above at 25 °C to give a final incubation volume of 1 ml. The 
incubation mixture was preincubated at 37 °C for 5 minutes prior to the 
initiation of the reaction by the addition of 40 pi of NADPH (40 mM). Tubes 
were incubated for a further 2 0  minutes to ensure that complete hydroxylation 
had taken place. The reaction was terminated by the addition of 0.2 ml of HC1 
(3 M). Diethylether (10 ml) was added to each tube and shaken on an end over 
end shaker for 20 minutes to ensure the maximum extraction. Clarification of 
the phases was achieved by centrifugation at 2,000 rpm in a Beckman J-6 B 
centrifuge. After removal of the organic phase (8.0 ml) to clean tubes, 
evaporation of the diethylether extracts was carried out under nitrogen in order 
to obtain a dried residue. The residue was subsequently reconstituted and 
analysed on a HPLC as previously described in section 3.3.6.
68
3.3.9 The effect of pH on the hydrogen peroxide supported 
hydroxylation of lauric acid.
The effect of pH on the hydrogen peroxide supported hydroxylation of lauric 
acid was carried out using pure, and microsomal (phénobarbital induced) 
cytochrome P450 together with the assay outlined in section 3.3.6. The results 
from the initial experiments suggested that the optimal experimental conditions 
were; a 10 minute incubation period, 12C lauric acid concentration of 0.05 mM 
and a final hydrogen peroxide concentration of 15 mM. However, when pH 6.5 
and 7.0 were used, the concentration of the stock solution of 12C lauric acid 
was decreased to 0.5 mM from 1.0 mM due to the insolubility of the substrate 
at these low pHs. In these experiments the hydroxymetabolites and lauric acid 
were extracted into diethylether for 30 minutes instead of 10 minutes in order to 
ensure maximum extraction of the hydroxylaurate metabolites and parent 
compound.
3.3.10 The effect of tergitol on hydrogen peroxide supported 
hydroxylation of lauric acid.
Prior to experimental use, tergitol was removed from the partially purified 
cytochrome P450 samples using the method described in section 2.3.6. The 
effect of tergitol on the hydroxylation of lauric acid was investigated using the 
experimental systems outlined in section 3.3.6, except that the pure cytochrome 
P450 was replaced with samples of partially purified. The cytochrome P450 
systems used were:
a) Desoaped samples of partially purified
b) Partially purified samples containing tergitol
c) Desoaped samples with tergitol added at a final concentration of 0.1 % (v/v).
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3.3.11 The effect of iodosobenzene on lauric acid hydroxylation.
The hydroxylation of lauric acid by iodosobenzene was carried out using the 
incubation system outlined in section 3.3.6, except that iodosobenzene at a final 
concentration of 1.0 mM was used to initiate the reaction.
70
3.4 RESULTS
3.4.1 The binding of ligands to oxidised CYP2B4.
Oxidised CYP2B4, both in the pure and partially purified forms, produces a 
spectrum with a Soret band at 417 nm (416 - 418), as determined by 
spectrophotometry. The addition of ligands to the oxidised cytochrome P450 
caused the Soret band to be red-shifted (increase in wavelength). The binding of 
a selection of nitrogen ligands to CYP2B4 was undertaken to determine which 
ligands would produce the greatest shift in wavelength, and therefore exhibit the 
greatest accuracy. The ligand that caused the greatest shift in wavelength was 
the anion cyanide, followed by the azoles, azines and amines (table 3.1). 
Different concentrations of ligand were used in order to achieve the maximum 
shift in wavelength possible. The binding of these ligands to CYP2B4 was 
examined at various pHs and the binding constants determined.
Compound Concentration
(mM)
Wavelength
observed
Pyridine 50 420
Pyridazine 10 417
Imidazole 50 421
N-acetylimidazole 50 422
Hydroxylamine 250 421
Tiifluoroethylamine 27 418
Cyanide 50 436
Table 3.1: The wavelength shift observed when nitrogen bases and cyanide bind to oxidised
partially : purified CYP2B4 at pH 7.0.
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3.4.2 The determination of binding constants for various ligands 
to oxidised CYP2B4.
Cyanide.
The binding of cyanide (KCN) to oxidised CYP2B4 produced the greatest shift 
in wavelength (417 - 435), and implied a greater sensitivity in spectral data. 
These binding experiments were carried out using both partially purified and 
pure forms of the enzyme. The spectra obtained on the binding of KCN to 
partially purified CYP2B4 at various pHs are shown in fig 3.1 (A-E). From 
these spectra good isosbestic points were found at 430 nm. In contrast, the 
binding of KCN to the pure form of the enzyme produced broken isosbestic 
points (fig 3.1 (F)). The quantitative determination of the log K was carried out 
at various pHs by the rapid titration of KCN (1 mM) to CYP2B4; the binding 
of KCN to the enzyme was instantaneous with no further shift in wavelength 
with time. These experiments were carried out at least in duplicate and the log 
K values were determined from log-log plots for several pHs (table 3.2) which 
gave slopes of n=l (eg pH 8.5 fig 3.2). From the results obtained a correlation 
was found between log K and pH for the partially purified form of the 
enzyme, whilst only values of log K for pure enzyme at pH 8.0 and 8.5 gave 
the same slope. There was deviation below pH 8.0 and also above pH 8.5 (fig 
3.3).
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F ig  3.1 Spectra produced on the binding of potassium cyanide to oxidised partially purified 
CYP2B4 at various pHs. Curve A, pH 7.0, Curve B, pH 7.5, Curve C, pH 8.0, Curve D, 
pH 8.5, Curve E, pH 9.0, and on the binding to pure CYP2B4 at pH 8.5 (Curve F).
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Fig 3.2 Log-log plot of cyanide concentration against change in absorbance (AA) using 
partially purified samples of CYP2B4 at pH 8.5.
Log K values (M)
pH Partially
purified
CYP2B4
Av.value 
log K
Corrected
K
Pure CYP2B4 Av. value 
log K
Corrected
K
7 -4.82,
-4.94
-4.88 -776 - - -
7.5 -4.30,
-4.51
-4.41 -225 -4.24, -4.05 -4.15 -212
8 -3.76,
-4.00
-3.88 -66 -3.94, -3.90 -3.92 -67
8.5 -3.27,
-3.44
-3.36 -20 -3.55, -3.27, -3.56, 
-3.5, -3.45
-3.47 -21
9 -2.90,
-3.09
-3.0 -9 -3.33, -3.32 -3.32 -10
Table 3.2 The effect of pH on the calculated log K values for the titration of cyanide to
partially purified and pure CYP2B4.
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Fig 3 .3 . A graph of average log K (M) values against pH for the binding of potassium 
cyanide to partially purified (o) and pure samples (+) of oxidised CYP2B4 over the pH range 
7.0 - 9.0.
B ases.
The binding of a selection of bases to oxidised partially purified CYP2B4 was 
undertaken in order to determine the base which would produce the greatest 
shift in wavelength. Partially purified CYP2B4 was used because of the very 
good isosbestic points observed on the binding of cyanide compared to those 
obtained for the pure enzyme (fig 3.1 (F)). The bases investigated included the 
azines, azoles and amines, with the azoles producing the greatest shift in 
wavelength followed by the azines and then the amines. The apparent binding 
constants for these bases were calculated from log-log plots and are shown in 
table 3.3. The binding of the amines, tiifluoroethylamine and hydroxylamine to 
CYP2B4 produced the smallest shift in wavelength with a correspondingly low 
log K value (table 4.12). The log K value for both tiifluoroethylamine and 
hydroxylamine was deemed too low for an accurate study of the equilibria, thus 
these investigations were not carried out for these two bases. Of the azines
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studied, pyridine was the only azine that produced a shift in wavelength (417 - 
420), in addition to giving reproducible results for the calculation of log K. 
Although the shift in wavelength on the binding of pyridine to CYP2B4 was 
smaller than that exhibited by the azoles, it was thought appropriate to compare 
results obtained for oxidised CYP2B4 and pyridine, with those obtained for 
reduced CYP2B4 and pyridine (chapter 4). Due to the small shift in wavelength 
obtained on the binding of pyridine to CYP2B4, it is most likely that a greater 
error maybe incurred, especially when corrected for dilution, although binding is 
valid for up to 50 %. The binding of N-acetylimidazole and imidazole to
: I
oxidised P450 produced the greatest shift in wavelength (table 3.1), but only N- 
acetylimidazole produced good isosbestic points (fig 3.4). The binding of this 
base to CYP2B4, like all the others was instantaneous with no further shift in 
wavelength observed on standing with time. Furthermore, the calculated average 
log K values (table 3.3) for both pyridine and N-acetylimidazole (N-Aclm) were 
found to be pH-independent (fig 3.5-6).
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Fig 3.4 A spectrum produced on the binding of N-acetylimidazole to oxidised CYP2B4 at 
pH 8.5, clearly showing iso sb es tic  points.
Binding constant values (M-l)
Compound / pH 6.5 7 8.5
Pyridine 31 — 24
N-acetylimidazole 562 302 416
Table 3.3 A table showing the apparent binding constants for the binding of pyridine and 
N-acetylimidazole to oxidised CYP2B4.
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Fig 3 .5  Log-log plots of N-acetylimidazole concentration against AA using a partially 
purified sample of oxidised CYP2B4 at pH 6.5 (o) and pH 8.5 (+).
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F ig  3 .6  Log-log plots of pyridine concentration against AA using a partially purified sample 
of oxidised CYP2B4 at pH 6.5 (o) and pH 8.5 (+).
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3.4.3 Action of hydrogen peroxide on CYP2B4.
It is known that hydrogen peroxide can destroy cytochrome P450 (Guengerich
1990), thus in order to study the effect of hydrogen peroxide on CYP2B4, it 
was necessary to choose a concentration of hydrogen peroxide that would allow 
the spectrum to be studied over a suitable period of time without the rapid 
degradation of the enzyme. In order to achieve these conditions, a final 
concentration of 15 mM hydrogen peroxide was chosen which gave a half-life of 
12 minutes. It can be seen from the spectrum that hydrogen peroxide completely 
degrades CYP2B4 without the production of a spectral intermediate or a shift in 
wavelength (fig 3.7. The kinetics of this degradation were found to be of a first 
order (value of Aoo was extrapolated) at both pH 6.5 and 7.5 over at least 1 
half-life (fig 3.8). The half-life for this degradation at these pHs was found to 
be 12 minutes for both, and shows that the degradation of CYP2B4 by 
hydrogen peroxide is pH-independent.
0.115-
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Abs values
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Fig 3 .7  A spectrum showing the effect of 15 mM hydrogen peroxide concentration on 
oxidised pure CYP2B4 at pH 7.5, over a time period of 40 minutes.
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Fig 3.8 A graph showing first order kinetics for the destruction of oxidised CYP2B4 at a 
temperature of 25 °C at pH 7.5 (+).
3.4.4 Effect of hydrogen peroxide concentration.
The effect of hydrogen peroxide concentration on the degradation of CYP2B4 
was carried out at two temperatures, 25 °C and 37 °C, using partially purified 
samples of CYP2B4. A few experiments were also carried out using pure 
CYP2B4 for comparison purposes with reactions involving lauric acid. The 
presence of the detergent, tergitol in the partially purified samples had little 
effect on the rate of degradation at both temperatures (table 3.4). The pseudo 
first order rate constant (ki) at a given hydrogen peroxide concentration (1 M) 
was derived from the following equation k% = 0 .7 /t%/2, (0.7 conversion factor) 
with the second order rate constant (k^) calculated from the equation kz = 
ki/[H2 0 2 ]. It can be concluded from the results in table 3.4 that the value of 
log k2  at 25 °C was 0.2 ±0.2, whilst at 37 °C this value was 0.5 ±0.1 and 
was the same for both pure and partially purified samples and independent of 
whether tergitol was absent or present.
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Temperature Hydrogen peroxide 
Concentration 
(mM)
Tergitol
present
t 1/2 
(minutes)
Calculated 
rate constant 
(ki) min'1
k2
M"1
min'1
Log k2
25 °C 15 yes 36 0.02 1.3 0.1
(partially 30 yes 25 0.03 1.0 0
purified)
50 yes 14 0.05 1.0 0
60 yes 8 0.09 1.5 0.2
15 no 38 0.02 1.3 0.1
50 no 16 0.04 0.8 - 0.1
150 no 7 0.10 0.67 - 0.2
300 no 4 0.175 0.58 - 0.2
600 no 2 0.35 0.58 - 0.2
37 °C 15 no 12 0.06 4.0 0.6
(partially 25 no 8 0.09 3.6 0.6
purified)
50 no 6 0.12 2.4 0.4
15 yes 25 0.03 2.0 0.3
25 yes 12 0.06 2.4 0.4
30 yes 8 0.09 3.0 0.5
25°C
(pure) 30 no 14 0.05 1.7 0.2
60 no 8 0.09 1.5 0.2
Table 3 .4  : The effect of temperature and hydrogen peroxide concentration on the rate of
degradation of oxidised partially purified CYP2B4. The table also shows the calculated rate 
constant (ki) and (k2 ) values for this degradation of CYP2B4.
3.4.5 Effect of substrates and ligands on the rate of degradation 
(ti/2) of CYP2B4 by hydrogen peroxide.
The rate of cytochrome P450 degradation by hydrogen peroxide in the presence 
of substrates which may protect against the action of hydrogen peroxide was 
investigated using potential substrates such as benzphetamine, guaiacol, lauric 
acid and pentoxyresorufin and the ligand pyridine. Pyridine and the substrate 
guaiacol were the only compounds to affect the rate of degradation. Normally 
the half-life of CYP2B4 in the presence of 15 mM hydrogen peroxide was 
found to be 12 minutes, however, in the presence of 10 mM pyridine this was 
increased to 30 minutes. In the presence of guaiacol, a substrate for cytochrome
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P450 peroxidase activity, the half-life increased from 12 to 30 minutes.
The substrates benzphetamine and lauric acid at 
concentrations of 1 mM and 0.05 mM respectively, both had no significant 
effects on the rate of degradation. The effect of the substrate pentoxyresorufin 
on the rate of degradation could not be determined due to background 
interference.
3.4.6 Lauric acid hydroxylation.
Initial experiments were carried out using iodosobenzene to establish a 
concentration of iodosobenzene that would produce a convenient rate of reaction 
(table 3.5). High concentrations of iodosobenzene (5 mM) caused a rapid 
decrease in absorbance at 417 nm (table 3.5). As a consequence, it was decided 
to use a concentration of 0.1 mM to investigate the hydroxylation of lauric acid 
by the ferryl intermediate.
Temperature Iodosobenzene
concentration
(mM)
Apparent half-life 
at 417 nm 
(minutes)
Time taken for 
peak to shift to 
414 nm
25 °C 0.10 (a) 4-6, (b) 8 < 1 minute
0.15 7 (b) < 1 minute
0.20 6 (b) < 1 minute
5 < 30 seconds (b) < 30 seconds
37 °C 0.01 20 (b) 5 minutes
0.15 6-8 (b) < 1 minute
Table 3.5 I The action of iodosobenzene on cytochrome P450; duplicate experiments were carried 
out using partially purified samples at pH 7.5.
(a) pure CYP2B4
(b) partially purified CYP2B4
The spectrum produced by the action of iodosobenzene on partially purified 
CYP2B4 showed that the initial rate of reaction was very rapid, but did not go
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to completion (fig 3.9). This rapid initial rate of reaction was also repeated 
using a pure sample of CYP2B4 and produced the same results. The plot of 
change in absorbance vs time shows that this reaction was of a first order 
which is similar to the reaction of hydrogen peroxide with CYP2B4 (fig 3.10). 
The reaction of iodosobenzene on CYP2B4 caused a shift in wavelength from 
417 to 414 nm and the production of a new weak band at 385-390 nm which 
corresponds to the ferryl intermediate (fig 3.11). The production of this ferryl 
intermediate and the first order kinetics of the rate of reaction had been
previously shown by Blake and Coon in 1989. The addition of hydrogen
peroxide (15 mM) 8  minutes after the addition of iodosobenzene produced no
significant increase in the rate of degradation (fig 3.10). This indicated that the
iodosobenzene was blocking the action of hydrogen peroxide.
0 .1 0  -I
0.08 -
0.06 -
Abs values
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0.02  -
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430400 460 490370
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Fig 3.9 A spectrum produced by the action of 0.1 mM iodosobenzene on pure CYP2B4.
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Fig 3 .1 0  A plot of AA against time for the action of (a) 15 mM hydrogen peroxide ( • )
(b) 0.1 mM iodosobenzene (o) and (c) 0.1 mM iodosobenzene then 15 mM hydrogen peroxide, 
8 minutes after the addition of the iodosobenzene (+) using a partially purified sample of 
CYP2B4 at a temperature of 25 °C.
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Fig 3.11  A spectrum showing the production of the ferryl intermediate by the action of 
iodosobenzene on pure CYP2B4. §  intermediate
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3.4.7 Identification of the metabolites of lauric acid
hydroxylation.
Peak identification ideally should be carried out using hydroxylaurate standards 
or a system which generates all three hydroxylaurate metabolites, namely, co, 
(m-l) and (m-2) hydroxylaurate. Since neither were available, a combination of 
systems was used to produce the three hydroxylaurate metabolites. The systems 
used were metabolites produced by microsomal clofibrate-induced CYP4A1 in the 
presence of NADPH and the metabolites produced by the action of hydrogen 
peroxide on lauric acid using pure CYP2B4. Clofibrate-induced microsomes were 
used as the source of CYP4A1, since clofibrate is the prototype inducer of this 
cytochrome P450 isozyme with lauric acid as its model substrate. The results 
from this experiment are shown in table 3.6. It can be seen from these results, 
that clofibrate-induced microsomes when utilising NADPH and molecular oxygen 
produced m and (m-l) hydroxymetabolites in the ratio 5:1. While purified 
CYP2B4 produced on reaction with hydrogen peroxide the hydroxymetabolites 
(m-l) and (m-2), in the ratio 3:1. Thus by combining the extracts from both 
systems a three metabolite mixture in the ratio 10:4:1 was produced. The 
metabolites produced by hydrogen peroxide with CYP2B4 were identified to be 
the (m-l) and (m-2) hydroxymetabolites.
Sample co (%) rt 34' 
Values Av. value
co-1 (%) rt 32' 
Values Av. value
co-2 (%) rt 37' 
Values Av. value
Clofibrate microsomes 
(a)
23.00,
22.90,
20.20
22.03 4.00,
6.00, 
4.70
4.90 <0.01 <0.01
Pure CYP2B4 
(b)
<0.01 <0.01 4.40,
4.30
4.35 1.70,
1.50
1.60
Clofibrate 
and Pure
24.00,
23.80
23.90 9.60,
9.40
9.50 3.20,
2.40
2.80
Table 3.6: The metabolites produced by the hydroxylation of lauric acid by either (a) NADPH or 
(b) hydrogen peroxide. Incubations were carried out in duplicate with an incubation period of 5 
minutes, at 37 0 C. (rt = retension time, ' minutes)
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3.4.8 The effect of incubation time on lauric acid hydroxylation.
The graphs in figures 3.12 and 3.13 show the effect incubation time has on 
(m-l) and (m-2) hydroxylation. It can be seen that an increase in the length of 
incubation time, resulted in an increase in the amount of (m-l) and (m-2) 
hydroxylaurate metabolites produced (table 3.7). This increase was apparent for 
up to 10 minutes. After 10 minutes there was no substantial increase in (m-l) 
or (m-2) hydroxylation. The reaction of hydrogen peroxide with CYP2B4, when 
followed spectrophotometrically showed the degradation of the cytochrome P450 
(fig 3.7). Therefore, the levelling off of the production of the 
hydroxymetabolites after 10  minutes is due to the degradation of the enzyme.
Time
(minutes)
(co-1)
% values
(co-1) 
Av. value
(co-2)
% values
(co-2) 
Av. value
ratio 
(co-1)/(co-2)
0.5 1.1, 1.3, 1.4 1.3 0.7, 0.9, 0.7 0.8 1.6
1 2.0, 1.6, 1.1 1.6 1.0, 1.2, 1.1 1.1 1.5
2 2.7, 2.8, 2.0 2.5 1.3, 1.2, 1.1 1.2 2.1
3 4.0, 2.5, 2.2 2.9 1.6, 1.0, 1.3 1.3 2.2
4 2.7, 3.6, 3.2 3.2 1.3, 1.3, 1.0 1.2 2.7
5 4.4, 4.0, 3.7, 
3.8, 3.1, 3.9
3.8 1.3, 1.5, 1.5, 
1.2, 1.4, 1.5
1.4 2.7
10 4.7, 4.6, 3.8, 
3.5, 3.6, 4.2
4.1 1.7, 1.4, 1.6, 
1.6, 1.2
1.5 2.8
20 5.8, 3.5, 4.8, 3.3 4.4 1.8, 1.4, 1.7, 1.6 1.6 2.9
40 4.6, 4.4, 4.2, 4.0 4.3 1.7, 1.5, 13, 1.6 1.5
Table 3 .7  The effect of incubation time on the amount of (co-1) and (co-2) 
hydroxymetabolites formed during the hydroxylation of lauric add by 15 mM hydrogen 
peroxide at pH 7.5 in the presence of 0.05 mM lauric add and IpM pure CYP2B4. All 
results are expressed as percentage of total lauric add added.
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F ig .3 .1 2  A graph showing the effect of incubation time on the production of the (co-1) 
metabolite from lauric arid hydroxylation supported by 15 mM hydrogen peroxide at 37 ° C, 
pH 7.5 in the presence of 0.05 mM lauric arid. The amount of metabolite formed is 
expressed as a percentage of the total lauric arid added.
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F ig .3 .1 3  A Graph showing the effect of incubation time on the production of the (co-2) 
metabolite from lauric arid hydroxylation supported by 15 mM hydrogen peroxide at 37 °C, 
pH 7.5, in the presence of 0.05 mM lauric arid. The amount of metabolite formed is 
expressed as a percentage of the total lauric arid added.
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Fig 3.14 A graph showing the ratio of hydroxymetabolites (co-l)/(co-2) formed from lauric 
add hydroxylation by 15 mM hydrogen peroxide against time for pure CYP2B4 at 37 °C, pH
When the ratio of yields of the products formed from the hydroxylation of 
lauric acid by hydrogen peroxide is plotted against time, and extrapolated back 
to time 0, a ratio of approximately 1:1 for the products is achieved (fig 3.14). 
Thus, the ratio of products is seen to increase from 1:1 to approximately 3:1 
(m-l:(0-2) (table 3.7), suggesting that the conformation of the enzyme may be 
being relaxed, probably due to the reaction of hydrogen peroxide at some other 
site.
7.5.
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3.4.9 The products of lauric acid hydroxylation supported by 
either NADPH, hydrogen peroxide, cumene hydroperoxide and 
iodosobenzene.
a) NADPH
Microsomes from various sources fortified with NADPH were shown to 
hydroxylate lauric acid, at the œ and (co-1) positions (table 3.8). Both control 
microsomes and microsomes derived from animals pretreated with different 
inducers were found to hydroxylate lauric acid, but to different extents. Control 
microsomes produced co and (co-l) hydroxymetabolites in a ratio of 1:1 , which 
is the same ratio reported by other authors (Bjorkhem and Danielsson 1970; 
Azerad et al 1990). While microsomal samples from clofibrate treated animals, 
which is rich in CYP4A1 produced the co and (co-1) metabolites in the ratio 
14:1, these values compare favourably with those cited in the literature, where 
the ratio between the two products have been quoted as high as 17:1 (Cajacob 
et al 1988). Microsomes derived from phénobarbital treated animals, 
hydroxylated lauric acid at the co and (co-1) positions in the ratio 1:5, whilst 
purified CYP2B4 produced the metabolites in the ratio 1:2. Literature values 
show that phenobarbital-induced microsomes produced these metabolites in a 
ratio of 1:3 (Bjorkhem and Danielsson 1970; Azerad et al 1990 and Tanaka et 
al 1990), whilst pure CYP2B4 generated the metabolites in a ratio ranging from 
1:4 to 1:8 (Cajacob et al 1988; Tanaka et al 1990). The variation in the ratio 
of products formed from lauric acid hydroxylation when clofibrate and 
phénobarbital induced microsomes were used, can be ascribed to the rate of 
reaction. CYP4A1 oxidises lauric acid much faster than CYP2B4 when the 
reaction is initiated by NADPH and molecular oxygen (Ortiz de Montellano et al 
1992).
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Oxygen donors
Enzyme source o 2 + 2H H2O2 CuOOH
(0 : to-1 : to-2 to : (0-1 : (0-2 (0 co-l : (0-2
Control Microsomes 1 : 1 : 0 0 : 5 : 1 1 : 7 : 0
(1 : 1 : 0) (0 : 6 : 1) (1 : 9 : 0)
Clofibrate-induced 14 : 1 : 0 0 : 0 : 0 1 : 3 : 0
Microsomes (17 : 1 : 0)
Phenobarbital-induced 1 : 5 : 0 0 : 2 : 1
Microsomes (1 : 3 : 0)
Pure CYP2B4 1 : 2 : 0 0 : 2 : 1 1 : 7 : 0
(1 : 4 : 0)
to (1 8 : 0)
Table 3 .8  A table showing the ratio of products (co, m -l, m-2) formed from the 
hydroxylation of lauric add using various oxygen donors. Results are expressed as a ratio of 
the metabolites with published values in parenthesis. The experiment was carried out in 
duplicate using a 10 minute incubation period.
b) Hydrogen peroxide versus iodosobenzene.
The hydroxylation of lauric acid with hydrogen peroxide and iodosobenzene was 
used as a test for any degradation occuring during the hydroxylation reaction. 
Hydrogen peroxide was found to support the hydroxylation of lauric acid when 
CYP2B4 in the microsomal or pure form, or control microsomes were used as 
the source of cytochrome P450. However, the products formed from this 
hydroxylation were the (m-l) and (m-2) hydroxymetabolites (table 3.8). When 
CYP2B4 was used as the enzyme source the products were formed in a 2:1 
ratio, whilst, with control microsomes the ratio of the products was 5:1, which 
compares to the ratio (4:1) reported in the literature (Romano et al 1988). 
Hydrogen peroxide was found not to support the hydroxylation of lauric acid 
when microsomes from clofibrate induced animals were used as the source of 
the enzyme, suggesting that with hydrogen peroxide as the enzyme source the
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reaction is faster with CYP2B4 than with CYP4A1.
When iodosobenzene was used as the oxygen source with pure CYP2B4, no 
hydroxylation of lauric acid occurred, which is in contrast to results reported by 
other authors, where hydroxylation occurred only at the (co-2) position 
(Gustafsson and Bergman 1976). The lack of hydroxylation could be attributed 
to the rapid degradation observed spectrophotometricall y when iodosobenzene 
was added to CYP2B4. As previously stated the action of iodosobenzene on 
CYP2B4 produces a spectral intermediate at 380-390 nm. This ferry 1 intermediate 
was thought to be involved in the hydroxylation reaction, and the lack of 
hydroxylation when iodosobenzene was added at the start of the reaction 
suggests that the initial rapid degradation of the enzyme blocks the hydroxylation 
reaction. It was therefore decided to form the ferryl intermediate first and then 
add lauric acid after this formation (after approximately 8  minutes), however no 
hydroxylation of the lauric acid was observed.
c) Different oxygen donors
The use of the different oxygen donors was used as a test for determining
whether the production of different ratios of products was linked to
conformational change occurring in the active site or a change in the reaction 
mechanism. The use of other hydroperoxides as the oxygen source, namely 
cumene hydroperoxide also resulted in the hydroxylation of lauric acid, but only 
at the (o)-l) position, when control and clofibrate microsomes were used, with 
more hydroxylation occurring with the control microsomes. This result suggests 
that the ratio of products of lauric acid hydroxylation cannot be used to decide
whether the intermediate in this reaction is neutral hydrogen peroxide or the
ferryl intermediate. As a general rule it can be stated that CYP2B4 produces 
more (œ-1) hydroxyproduct than (co-2) or co whether oxygen, hydrogen peroxide
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or cumene hydroperoxide are used as the oxygen source, whereas CYP4A1 
produces the to metabolite in greater amounts than the (co-l) metabolite.
3.4.10 Effect of hydrogen peroxide concentration on lauric acid 
hydroxylation.
An increase in hydrogen peroxide concentration from 7.5 to 30 mM, led to a 
non-linear increase in both (co-l) and (co-2) hydroxylation (table 3.9; Fig 3.15). 
However, the ratio of the hydroxymetabolites for each hydrogen peroxide 
concentration used remained the same. These observations may be attributed to 
an increase in the rate of degradation of the enzyme at the higher concentrations 
of hydrogen peroxide.
Hydrogen peroxide 
concentration (mM)
(co-l)
values
(co-l) 
Av. values
(co-2)
values
(co-2) 
Av. values
Ratio of 
(co-l): (co-2)
7.5 1.45, 0.97 1.21 0.97, 0.65 0.81 1.49
15 2.10, 1.13 1.62 1.13, 1.2 1.12 1.45
30 2.42, 2.26 2.34 1.45, 1.61 1.53 1.53
Table 3.9: The effect of varying hydrogen peroxide concentration on (co-l) and (co-2) hydroxylation 
of lauric acid at pH 7.5 with an incubation period of 1 minute. All results are expressed as nmol 
product produced I nmol P450 I minute.
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Fig 3 .1 5  The effect of increasing hydrogen peroxide concentration on the rate of product 
formation (• co-l) and (o co-2), using pure CYP2B4 in the presence of 0.05 mM lauric add
at pH 7.5.
3.4.11 The effect of pH on hydrogen peroxide supported 
hydroxylation of lauric acid.
In the presence of pure and microsomal samples of CYP2B4, hydrogen
peroxide was found to support the hydroxylation of lauric acid. This
hydroxylation was found to be pH independent for the (co-l) and (co-2 )
hydroxylation products over the pH range 7.5 -9.0 (table 3.10). Furthermore, at 
pH below 7.0, there was a substantial increase in both (co-l) and (co-2 )
hydroxylation with all P450 samples used, although the ratio between the 
products formed remained constant (~ 2) at all the pHs investigated. Since lauric 
acid has a pK of between 4.5-5.0, it would be expected that the uncharged 
lauric acid (HLA°) would bind more strongly than the charged lauric acid (LA"). 
The increase in rate of hydroxylation and the absence of change in ratio can be 
explained by a higher binding of HLA° without any significant changes in the 
relative orientations of the co end of the enzyme and the Fe-H^C^ complex.
94
pH Pure CYP2B4 
(co-l) ((0-2 ) ratio
Microsomal 
CYP2B4 
(co-l) (co-2) ratio
6.5 22.6 10.6 2.13 5.7 3.0 1.9
7 16.7 6.9 2.42 4.4 2.0 2.2
7.5 4.6 2.2 2.1 1.0 0.5 2.0
8 4.3 2.2 2.0 1.2 0.5 2.4
8.5 4.2 2.3 1.8 1.2 0.5 2.4
9 2.4 1.9 1.3 0.6 ND ND
Table 3 .10  The effect of pH on the hydroxylation of lauric add by hydrogen peroxide, 
using pure and microsomal samples of CYP2B4. All results are expressed as nmol product 
produced I nmol P4501 10 minutes, (ND not determined).
3.4.12 The effect of varying the lauric acid concentration on 
lauric acid hydroxylation.
Variation in 12C lauric acid concentration produced a concentration dependent 
effect on (co-l) and (co-2) hydroxylation, as reflected by the levels of the (co-l) 
and (co-2) hydroxylaurate product shown in table 3.11. As the concentration of 
lauric acid was increased, the rate of product formation (co-l, co-2 ), also 
increased linearly up to a lauric acid concentration of 0.1 mM. Thoughout this 
increase in product formation, the ratio between the hydroxymetabolite products 
remained constant (Fig 3 .16). This linear increase in (co-l) and (co-2 ) 
hydroxymetabolites is expected due to an increase in the occupancy of the 
substrate site.
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L A .
Concentration
(mM)
((0-1)
values
((0-1) 
Av. value
(co-2)
values
((0-2) 
Av. value
Ratio of
(co-l)/(00-2 )
0.025 1.37, 1.94, 
1.61
1.64 0.81, 1.13, 
1.29
1.08 1.52
0.05 1.78, 3.87, 
2.80
2.82 1.45, 1.94, 
1.78
1.72 1.65
0.1 7.08, 5.48, 
5.48
6.02 3.23, 4.19, 
3.23
3.55 1.70
Table 3.11 The effect of varying lauric arid concentration on the hydroxylation of lauric
acid by hydrogen peroxide (15 mM) at pH 7.5. The incubation time was 1 minute. All 
results are expressed as nmol product produced I nmol P4501 minute.
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Fig 3 .16  The effect of increasing lauric arid concentration on the rate of product formation, 
(• co-l) and (o co-2) using pure CYP2B4 at 37 °C, pH 7.5 using 15 mM hydrogen
peroxide.
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3.4.13 The effect of tergitol on hydrogen peroxide supported
hydroxylation of lauric acid.
Tergitol, the detergent used for the solubilisation of CYP2B4 in the purification 
of this enzyme, inhibited hydroxylation of lauric acid by hydrogen peroxide 
(table 3.12). However, when samples of cytochrome P450 which did not 
contain tergitol (desoaped) were used as the cytochrome P450 source, the
production of the (co-l) and (co-2) hydroxylaurate metabolites was detected. In
addition, to samples containing tergitol inhibiting hydroxylation, the same effect 
was observed when 0.1 % tergitol was added to "desoaped" CYP2B4. These 
results suggest that tergitol enters the binding site and inhibits lauric acid 
hydroxylation.
P450 Sample Hydroxymetabolites 
(co-l) (co-2)
Partially purified 
(desoaped)
Partially purified 
(contains tergitol)
Partially purified 
(tergitol added)
18.2 3.6 
<0.01 <0.01 
<0.01 <0.01
Table 3.12: The effect of tergitol on the hydroxylation of lauric add by 15 mM hydrogen 
peroxide at pH 7.5. Results are expressed as nmol product produced I nmol P450 I minute.
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3.5 DISCUSSION.
The nature of the distal ligand (H2O or HO") in the resting ferric state of the 
enzyme was investigated by studying the pH-dependence of the equilibrium 
constants for the coordination of the Fe3*1" ion in CYP2B4 using one anion, 
(CN") and two uncharged bases (pyridine and N-acetylimidazole). The shift in 
the Soret band region from the initial wavelength of 417 nm during the 
spectrophotometric titration of ferric CYP2B4 with the bases (pyridine and N- 
acetylimidazole) and anion (CN") falls in the order CN*» N-acetylimidazole> 
pyridine with Soret bands at 436, 423 and 421 nm respectively (table 3.1). The 
subsequent accuracy of the isosbestic points provides an indicator of conformity 
with the assumed single equilibrium. The titration of the partially purified 
CYP2B4 enzyme with CN" showed good to excellent isosbestic points (fig 3.1), 
together with reasonable log-log plots (fig 3.2) and a good linear increase of 
log Kapp with pH (fig 3.3). However, in contrast when pure CYP2B4 enzyme 
was used, broken isosbestic points (fig 3.1 (f)) and significantly poorer log-log 
plots (data not shown) were obtained, along with an obviously non-linear plot 
of log Kapp versus pH (fig 3.3), although the values of log Kapp at pH 8.0 
and 8 .5  for the pure enzyme agreed with those obtained for the partially 
purified enzyme at these pH's. This suggests the same intrinsic value of log 
Kapp but modified by the occurrence of additional pH-dependent changes at both 
higher and lower pH. The pK of HCN is known to be 9.2 and the observed 
linear increase in log Kapp with pH (below pK) means that the observed 
equilibrium corresponds to the coordination of free CN" with the corrected pH- 
independent values of the true log K given in table 3.2.
The binding of pyridine and N-acetylimidazole to ferric partially purified 
CYP2B4 showed poorer isosbestic points which was probably caused by the 
smaller observed change in spectrum. It has been shown recently using a
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combination of techniques, namely NMR and UV-Vis spectrophotometry, that 
substrate free P450cam will bind two molecules of pyridine (Banci et al 1994). 
The first of which has a value of K of 104 M_1, and is coordinated as a 
ligand to the metal, whilst the second pyridine molecule (K ~ 103 M-1) binds in 
the hydrophobic pocket. This is also true for the binding of two molecules of 
imidazole and N-methylimidazole. Furthermore, substrate free cytochrome 
P450cam can also simultaneously bind one molecule of imidazole which is 
coordinated to the metal and one pyridine molecule which is bound in the 
hydrophobic pocket (Banci et al 1994). In addition, cytochrome P450Cam can 
also form a ternary complex with both CN" and camphor, with the camphor 
molecule having little effect on either the spectrum or the affinity for CN". It 
can be assumed that the deviations observed in the binding of pyridine and N- 
acetylimidazole by CYP2B4 also reflect the binding of an additional molecule in 
the hydrophobic pocket subsequent to the coordination of the first to the Fe3+ 
ion. The anomalies observed on the binding of the hydrophilic cyanide to 
partially purified and pure CYP2B4 maybe related to the amount of detergent 
present in the sample. The binding constants reported for cyanide, N- 
acetylimidazole and pyridine appear to be the first to be reported for the ferric 
state of any mammalian cytochrome P450. These pH-dependent studies show 
that cyanide binds as the anion (CN") while pyridine and N-acetylimidazole bind 
as the neutral base (tables 3.2-33).
As previously mentioned in the introduction controversy still surrounds the 
nature of the distal ligand in the low spin, 6  coordinated ferric state of 
cytochrome P450 as to whether it is water molecule or hydroxide ion (HO"). 
Ignoring any pH-dependent configuration change, equilibria involving the 
substitution of coordinated water by anion or base would be expected to be pH- 
independent as is observed experimentally. However, it is difficult to see how 
such equilibria involving the substitution of coordinated HO" could be pH-
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independent for both anions and bases, since this would require some special 
(presumably not merely coulombic) interaction which could differentiate HO" 
from CN", thiolates and probably most or all other anions. Until definite 
evidence for such a mechanism is produced, it seems logical to conclude that 
the low spin, 6  coordinate forms of ferric cytochrome P450 with a Soret band 
at 417 nm possesses water as the distal ligand.
The binding of many ligands and the calculation of their binding constants 
involving the ferric state have however been reported for the bacterial 
cytochrome P450Cam- pH-independence has been reported for the binding 
constants for the uncharged dimethylsulphide (Me2S) and for three thiolate 
anions RS" over the pH range 7-9 (Sono and Dawson 1982a). The affinity of 
the thiocyanate anion (NCS") for cytochrome P450cam also remains unchanged at 
both pH 7 and 8  although a lower value was reported at pH 6  and 9 (Sono et 
al 1986). However, the possibility of isomérisation between N and S- 
coordinated forms of the ligand prevents any definite conclusions being drawn. 
Binding or dissociation constants have also been reported for other ligands at a 
single pH, these ligands included CN" (Sono and Dawson 1982a), pyridine 
(Banci et al 1994) and imidazole (Lipscomb 1980). Since the 2B4 isozyme 
shows no evidence for the multiple conformers observed with cytochrome 
P450cam and CYP2A1, it would be expected that the observed isosbestic points 
and log-log plots for cytochrome P450Cam show deviations from the simple 
equilibrium at least as great as those observed for CYP2B4. However, no data 
have been reported on either the quality of the observed isosbestic points or on 
the analysis of the absorbance change.
The simple coordination of anions as well as bases by the Fe3+ ion has 
therefore been established for both cytochrome P450cam (RS" and MezS) and 
for CYP2B4 (CN", pyridine and N-acetylimidazole). By contrast, peroxidases
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only coordinate anions with the compulsory uptake of a proton (Sono et al 
1986) according to equation 5, where P represents the protein including the 
binding site of the proton and water (OH2).
P.Fe3(OH2) + X- + H+ <=> +HP.Fe3.X- + H20  (5)
This indicates that the Fe may be either 5 coordinate or 6  coordinate with water
as the ligand. The binding constant for butylisocyanide by the Cys-ligated 
chloroperoxidase remains unchanged at pHs 3, 4.5 and 6 , whilst those for all 
the anions studied, from strong acids such as HI to weak acids such as HCN, 
show a pH-dependence of the apparent binding constant which is related to its 
pK and indicates coordination of the undissociated HX or the equivalent 
coordination of X" to the metal and the binding of H+ at some second site 
(Sono et al 1986). The resulting difference in the pH-independence of log Kapp 
for the coordination of cyanide (pK 9.2) between CYP2B4 (log K rising 
linearily with pH) and those reported for chloroperoxidase (independent of pH) 
indicate a requirement for the binding of the anion (CN") and a proton (H+). 
The compulsory binding of an anion with the uptake of a proton and the 
related proton-coupled reduction of the Fe3+ion by all peroxidases probably 
reflects the mechanism for "activating" hydrogen peroxide. In other words, 
conversion of the relatively unreactive hydrogen peroxide (pK 11.2) into the 
more reactive H 02" ion even at physiological pH by the co-operative
coordination of H02~ to the metal and the binding of H+ at a second site. The 
availability of protein-free models for the proton-coupled reduction of Fe3+ 
porphyrins has clarified the role of coulombic interaction in such proton-coupled 
equilibria.
The evidence of a water molecule as the sixth ligand provided the basis for 
analysing the kinetics, including the pH-dependent reaction of cytochrome P450 
with hydrogen peroxide which eventually leads to bleaching or haem
degradation. When hydrogen peroxide on its own reacts with CYP2B4, complete
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degradation or bleaching of the chromophore is observed with no detectable shift 
in the Soret band or accumulation of any intermediate (fig 3.7), which suggests 
that the first step in the reaction is the rate determining step. A prior reaction 
of cytochrome P450 with iodosobenzene to convert the ferric iron to the ferryl 
intermediate complex, termed compound I, inhibits the subsequent degradation of 
the chromophore by added hydrogen peroxide (fig 3.10). This strongly suggests 
that the ferryl complex is not an intermediate in the bleaching reaction, however, 
this is not conclusive proof, since the presence of iodosobenzene might 
somehow prevent the access of hydrogen peroxide to the active site. 
Furthermore, it is possible that the identification of the ferryl intermediate 
complex assumed here could turn out to be incorrect. The observed fall in 
absorbance at 417 nm with hydrogen peroxide follows first-order kinetics (fig 
3.8), with the rate constants increasing approximately linearly with hydrogen 
peroxide concentration to give the second order rate constant (k%) which was : 
pH-independent at pH 6.5 and 7.5. In other words at pHs below the pK of 
hydrogen peroxide (11.2), the rate-determining step therefore obeys the rate 
equation - d[Por]/dt = k2 [Por]1[H2 C>2 ]1, where Por represents the intact 
chromophore of cytochrome P450 and k2  has the very low value of 0.6 M-1 
min-1. Direct reaction of uncoordinated hydrogen peroxide with the porphyrin 
ring is unlikely both because several studies on porphyrin degradation by 
hydrogen peroxide have indicated the requirement for a redox-active porphyrin- 
chelated metal ion and because inhibition is observed by the known ligand 
pyridine (section 3.4.5). Since the distal ligand has been identified as water, the 
simplest explanation of the observed rate equation involves the initial formation 
according to equation 6 of the ferric iron complex with undissociated hydrogen 
peroxide as the ligand, probably at low concentration under equilibrium 
conditions.
H2Q2 + [H20  =» Fe3] •» H20  + [H2Q2 => Fe3] (6)
The fact that cytochrome P450 does not possess the "peroxidase" mechanism for 
converting hydrogen peroxide to the ferryl derivative through the proton-coupled 
coordination of HO2" and that formation of the ferryl complex by another route 
using iodosobenzene actually inhibits further bleaching by hydrogen peroxide 
together strongly suggests that coordinated hydrogen peroxide is the key 
intermediate directly involved in attacking the porphyrin ring. These studies 
appear to be the first kinetic and mechanistic studies on the reaction of 
cytochrome P450 with hydrogen peroxide alone.
The bleaching of the porphyrin ring of cytochrome P450 has striking parallels 
with the bleaching by haem oxygenase. In comparing the reactions of haem 
oxygenase-bound haem with hydrogen peroxide and other peroxidases Wilks and 
Ortiz de Montellano (1993) found that m-chloroperbenzoic acid and bulky 
hydroperoxides such as butyl and cumyl hydroperoxides caused a shift in the 
Soret band which indicated the formation of a ferryl complex. Hydrogen 
peroxide on the other hand, produced a decrease in the Soret band without a 
corresponding shift in the wavelength and without the regeneration of the 
starting chromophore on addition of phenol. The sterically less hindered 
ethylhydroperoxide caused a small shift in wavelength with a partial recovery of 
the starting chromophore on the addition of phenol which was coupled with the 
formation of a-mejo-ethoxyhaem, which is indicative of some intermediate 
behaviour. It is therefore concluded from this work that a ferryl intermediate 
could not be the intermediate in the reaction with hydrogen peroxide and a 
mechanism involving coordinated HO2" as the key hydroxylating intermediate 
with electrophilic addition of the distal oxygen atom (i.e HO+) to the meso 
carbon atom has been proposed. However, no study of the pH-dependence of 
the rate was reported, no reason was given for assuming that hydrogen 
peroxide was coordinated as HO2 " rather than H2 O2 , and the proposed 
mechanism would leave 0 2 - as the unlikely ligand on the ferric ion. It is
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therefore suggested that in haem oxygenase as in cytochrome P450, the ligand 
is probably present as the undissociated H2O2 , which would both offer a far 
more electrophilic HO+ group for transfer and leave HO' as a more reasonable 
ligand on the Fe3+ion, and thus able to pick up a further proton to reform the 
aquo complex, but this theory needs to be confirmed by studies on the pH- 
dependence of this reaction. The main point that can be conluded from this is, 
that in both haem oxygenase and cytochrome P450 the mechanistic pathway for 
bleaching by hydrogen peroxide involves a complex of iron and a two oxygen 
unit and apparently avoids any complex involving an iron and one oxygen unit 
or ferryl intermediate. This requirement must partly reflect the steric constraints 
of a reaction which involves the transfer of a group or atom and would require 
some intermediate which physically spans the distance between the "activating" 
Fe atom and the receiving carbon atom. Hydroxylation of an added substrate 
would clearly not be subject to such steric constraints. The use of the two 
reagents iodosobenzene and hydrogen peroxide therefore offers the opportunity to 
test whether the hydroxylation of a substrate such as lauric acid involves the 
reaction with an iron and one oxygen unit or iron and a two oxygen unit 
intermediate.
The cytochrome P450 catalysed hydroxylation of lauric acid can produce the co, 
co-l and co-2 isomers (table 3.8). The reaction occurs against a background of 
modification and eventual degradation of the haem enzyme by hydrogen peroxide 
(fig 3.7). The cumulative yields of products (co-l, co-2) levels off at 
approximately 6 % of the total available lauric acid, after approximately 20 
minutes as the enzyme becomes inactivated (fig 3.12-13). The ratio of the 
products changes with time from an extrapolated value of approximately 1.1 at 
t=0 to approximately 3:1 towards the end of the reaction (fig 3.14). This is the 
first case of lauric acid hydroxylation by hydrogen peroxide with any pure 
enzyme. The hydroxylation of lauric acid by four different potential oxygen
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donors (O2  and NADPH, hydrogen peroxide, iodosobenzene and cumene 
hydroperoxide) and the ratio of products formed is shown in table 3.8 The 
results show that CYP2B4 can catalyse the hydroxylation of lauric acid by 
hydrogen peroxide, cumene hydroperoxide as well as by molecular oxygen and 
NADPH, and that CYP2B4 can produce all three isomers in ratios which vary 
both with the nature of the oxygen donor and with time (table 3.8). Perhaps 
the most interesting fact is that no hydroxylation products could be detected 
when iodosobenzene was used as the oxygen donor, when it was added at the 
beginning of the reaction or after approximately 8 minutes, when the formation 
of the ferryl complex was complete.
The changes in the product ratios proposes a pertinent question as to whether 
these changes indicate a change in the reaction mechanism or merely a change 
in the structural constraints around the active site. This has been well studied in 
the case of the soluble methane monooxygenase (MMO) which, like cytochrome 
P450 can catalyse the hydroxylation of alkanes (including methane) using either 
molecular oxygen with NADH and a reductase and usually a third protein called 
component B, or hydrogen peroxide, termed systems I and II respectively. It 
has, however, a more complex (aPy)2 structure containing two p,-oxo bridged 
di-iron centres as the active site. Both systems I and II cause the same extent 
of chiral inversion during the hydroxylation of chiral l-^H , 2H, 3H]-ethane, 
which was taken as evidence that "the nature of the chemistry of the reactions 
catalysed by systems I and II is the same". Increasing differences in the ratios 
of isomers produced were, however, observed with increasing size of the alkane 
(ti):<o-l ratios of approximately 0.7 and 13.3 for hexane with systems I and II 
respectively), which may be attributed to conformational changes at the reduced 
level in the reaction involving molecular oxygen. The variation observed in the 
product ratios with time but fixed oxygen donor (fig 3.14) can hardly be 
ascribed to a change in mechanism, while the variation with oxygen donor
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(table 3.8) is no greater than the differences observed between systems I and II 
of methane monooxygenase. Different families of enzymes (CYP4A1, CYP2B4 
and CYP2E1) also produce a different ratio of products with the same substrate, 
namely lauric acid (Hrycay et al 1976; Romano et al 1988), and testosterone 
(Sonderfan et al 1987) and the same oxygen donor (O2 and NADPH). It can 
therefore be concluded that such differences in product ratios cannot be used as 
evidence for differences in the nature of the key hydroxylating intermediate.
The yield of product is shown to increase roughly linearly with an increase in 
lauric acid concentration (fig 3.16), but falls off with increased hydrogen 
peroxide concentration (fig 3.15), this suggests that the rate of enzyme 
inactivation shows a greater than linear dependence on hydrogen peroxide 
concentration. The rate of hydroxylation is pH independent over the pH range 
7.5-9.0, but increases below pH 7.5 (table 3.10), whilst the product ratio 
remains unchanged throughout. Since the pK of lauric acid is expected to be 
approximately 5.0, and the increase in rate at lower pHs can probably be 
ascribed to a higher degree of occupancy of the hydrophobic substrate-binding 
cavity by the undissociated acid compared to the dissociated anion, without any 
significant change in structure or mechanism around the active site. The basic 
reaction rate at pH 7.5-9.0 can therefore be described as pH independent and 
shows roughly a linear dependence of lauric acid concentration and would show 
a linear dependence on hydrogen peroxide concentration if the degradation of the 
enzyme could be suppressed. Intrepretation of the kinetic data indicates that the 
reaction between lauric acid and hydrogen peroxide occurs via the anionic form 
of lauric acid (LA") and undissociated hydrogen peroxide (H2O2) and not 
between undissociated lauric acid (HLA°) and hydrogen peroxide in its anionic 
form (H02‘). The fact that no spectral intermediate could be seen in the UV-Vis 
spectrum either during the slower reaction of hydrogen peroxide alone (fig 3.7) 
(i.e bleaching) or during the faster reaction in the presence of lauric acid
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provides good evidence for assuming that anionic lauric acid (LA") and at lower 
pH undissociated lauric acid (HLA°) reacts directly with undissociated hydrogen 
peroxide. This is supported by the failure of the ferryl intermediate produced 
from the reaction of iodosobenzene with CYP2B4 to react with lauric acid. The 
only other study of the pH dependence of a cytochrome P450 catalysed reaction 
involving hydrogen peroxide appears to be the oxidation of aminopyrine by 
hydrogen peroxide catalysed by CYP2B4 (Nordblom et al 1976). The results 
observed a gradual increase in the rate of reaction with an increase in pH. 
From these results it was postulated that the HO2 '  species was involved, with 
an increase in pH causing an increase in the rate of reaction. However, the rate 
of reaction only increased by a mere factor of 2 for the pH range 6.0-8.0 and 
not by the expected factor of 102. Their results do in fact provide good 
evidence for a reaction involving the undissociated hydrogen peroxide and not 
the H 02- species.
CONCLUSION.
The pH-independent binding observed when the two neutral bases pyridine and 
N-acetylimidazole in association with the corrected log K values for the binding 
of the anion cyanide (CN") to CYP2B4, suggests that the sixth ligand present 
in the resting state of the enzyme is the water molcule (FeOH2) and not the 
hydroxide ion. The results in this chapter on the role of a peroxide complex in 
both lauric acid hydroxylation and haem degradation by CYP2B4, confirm and 
extend the results of Coon (CYP2B4 catalysed reaction of cyclohexane), Akhtar 
and co-workers (reactions involving 17a-hydroxyandrogen and cytochrome 
P450i7a ) on other cytochrome P450 catalysed reactions. The results also 
provide a natural explanation for the apparently close relationship between 
reactions 1-3
0 2 + 2H + RH=>ROH + H2Q (1); 02 + 2H=>H20 2 (2); H20 2 + RH=>ROH + H20(3)
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and bleaching, and also demonstrate a common denominator in at least the initial 
step of haem degradation between cytochrome P450 and haem oxygenase (with 
Cys and His as the proximal ligand respectively). It also demonstrates a further 
common denominator in the ability of hydrogen peroxide to hydroxylate alkanes 
when associated with a sufficiently strong acid such as a proton (H3 O2+ in 
HF) or certain Lewis acids such as Fe?+.
The main aim of this chapter was to test whether the key intermediate involved 
in hydroxylating a "solubilised" alkane such as lauric acid is a complex of the 
iron (Fe) with a one oxygen ligand (i.e ferryl complex) or a two oxygen ligand 
(H2O2  or HO2"). In light of the described experimental results and arguments, 
including comparisons with relevant data on other enzymes, it is proposed here 
that the balance of evidence strongly favours, but cannot conclusively prove, the 
Fe3+H2Q2 complex as the key reactive intermediate.
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CHAPTER 4 
Coordination of ligands by the Fe2+ ion
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4.1 INTRODUCTION
In the ferric state (Fe(ni)), the spectrum of cytochrome P450 includes the 
presence of a  and p bands, along with an absorption maximum of either 418 
or 390 nm depending on whether the enzyme is in a low 6 coordinate or high 
5 coordinate spin state. These two states of the P450 enzyme appear to exist in 
an equilibrium (Schenkman et al 1981). The addition of carbon monoxide to 
reduced cytochrome P450 causes a remarkable change in the spectrum; the Soret 
band intensifies and moves from 418 to 450 nm, no a  band appears and the p 
band is seen around 550 nm. This distinctive feature of a substantially red- 
shifted Soret band at 450 nm in the Fe(II)-carbon monoxide derivative, is in 
contrast to that seen in myoglobin at 430 nm, and is associated with the 
presence of Cys in its anionic form RS" as the proximal ligand (Guengerich 
1991). The binding of certain ligands, such as the isocyanide derivatives (Fen- 
CNR) shows two bands in the Soret region, at approximately 430 and 455 nm 
(single band in myoglobin at 434 nm), associated with the presence of reversible 
pH-dependent states or conformers (Imai and Sato 1967a). These were later 
denoted I and II with bands at 455 and 430 nm respectively, with conformer I 
favoured by high pH (Tsubaki et al 1989). These changes observed with ethyl 
isocyanide are distinct from the almost irreversible change of cytochrome P450 
to cytochrome P420 (denatured form). In cytochrome P420, it is thought that a 
His residue has replaced Cys as the proximal ligand, which then behaves 
spectrally like myoglobin as a normal haemoprotein; reduced cytochrome P420 
gives only one Soret peak between 428-432 nm on combination with ethyl 
isocyanide (Wells et al 1992). Furthermore, pH has no effect on this spectrum, 
which indicates that the anomalous properties of cytochrome P450 disappear 
when it is converted to P420 (Wells et al 1992).
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Two banded spectra may also be produced by other ligands such as pyridine 
(Imai and Sato 1967a), other isocyanides (Jefcoate and Gaylor 1969a), 
phosphites, phosphonites and phosphinites (Dahl and Hodgson 1978a), but not 
by compounds such as CO (450 nm), CN'(436 nm), 0% (419 nm) or imidazole 
(428 nm) (Imai and Sato 1967a-b). The binding of oxygen is known to be 
anomalous; it shows a Soret band at 419 nm rather than as expected at ~430 
nm, and is close to that exhibited by myoglobin (418 nm), but very different 
from that of chloroperoxidase at 430 nm (Sono et al 1985) which possesses 
Cys (RS") as the proximal ligand. It therefore seems likely that P450-O2 should 
be assigned to conformer II, due to its Soret peak, in addition to the fact that 
in microsomal P450, oxygen reacts preferentially with conformer II of the ethyl 
isocyanide complex (Imai and Sato 1966b) and lowering the pH promotes 
reaction with oxygen in competition with carbon monoxide (Ichikawa et al 
1967). The unusual properties of coordinated oxygen can be linked to the 
presence of a lone pair of electrons on the uncoordinated a  atom, which is 
associated with an unexpectedly high nucleophilicity on the donor atom, termed 
the a  effect as with a strong hydrogen bonding to the lone pair of electrons.
The proximal ligand in cytochrome P450 is known to be a Cys in its thiolate 
RS" form (Guengerich 1991). However, it has been proposed by Kahl and co- 
workers (1976) that in the reduced form this thiolate ligand exists in an 
equilibrium with its undissociated thiol form (RSH), and that this equilibrium 
can be represented by the following equation (1), where X denotes the distal 
ligand (RNC, pyridine etc) and subscripts I and II the two conformers, H+ can 
either represent a free proton in solution or a proton transferred from some 
neighbouring site.
[RS" => Fe (II) <= X] i + H+ <=> [RSH' => Fe (II) <= X] n (1)
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Recent work (Norris et al submitted for publication) with the iron porphyrin 
model microperoxidase 8 and sulphur ligands, has shown that the thiol/thiolate 
proximal ligand is readily accessible trans to the His residue in the reduced 
state. To investigate whether as previously proposed that the ligand in conformer 
II is the undissociated thiol, and that conformer I contains thiolate as its 
proximal ligand, the technique of EXAFS (Extended X-ray Absorption Fine 
Structure) will be used to confirm the ligand present in each of the 
conformational states.
There are two main theories concerning the two conformation states present in 
the ferrous form of the enzyme. It is the aim of the work in this chapter to 
investigate the role of the two conformation states of cytochrome P450. It has 
been proposed that hydrophilic compounds can form a single spectrum 
consisting of conformer I or II while hydrophobic compounds formed the 
double Soret spectra (Imai and Sato 1967a). This theory seems illogical since 
phosphonites, which are hydrophilic in nature produce double peaked spectra 
(Dahl and Hodgson 1978a). The second theory suggested that re bonding was 
involved in the production of the double peaked spectrum, however N- 
octylamine which cannot re bond can produce spectra containing two peaks 
(section 4.4.1). Since a similar effect is seen for pyridine and isocyanides in 
producing a spectrum consisting of two peaks, this indicates that metal to re 
bonding plays little or no role in producing this spectrum.
Recent work carried out on the coordination of three families of nitrogen bases 
by both an Feçqi) porphyrin (Hamza and Pratt 1994a) and a Co(ni) corrinoid 
(Hamza and Pratt 1994b) have shown that the equilibrium constants K for 
coordination increases with the basicity pK of the ligand according to the 
relationship log K = a.pK + b, with similar values for a for all three families 
but values of b falling in the order azoles>azines>amines. The value of log K
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may be further increased in the case of hydrazine, hydroxylamine and pyridazine 
through operation of the so-called a  effect. In order to confirm that Jt bonding 
does not participate in producing this spectrum, a wider range of bases was 
chosen for study, which included amines which do not undergo Jt bonding and 
azoles and azines which are known to undergo jt bonding. The nitrogen bases 
shown in Figures 4.1 and 4.2 will be used to test the effect on equilibrium 
(1), firstly, of increasing electron density on the Fe (by increasing the pK of 
the base) and secondly, of ligands which may model a key feature of 
coordinated O2 , in other words, the strong hydrogen bonding to a distal group 
(His E7 in haemoglobin) which is known to enhance the binding of O2 to 
haemoglobin, myoglobin and protein-free Fe(n) porphyrins (Jameson and Ibers 
1994). The a  effect, a term originally applied to enhanced nucleophilic reactivity 
observed when the donor atom is attached directly to another electronegative 
atom carrying one or more lone pairs of electrons (Edwards and Pearson 1962), 
will be investigated using compounds such as hydroxylamine, hydrazine and 
pyridazine which all can act as models for this aspect of coordinated oxygen.
The transfer of the second electron in the cytochrome P450 catalytic cycle has 
been proposed to occur via a proton relay system involving a distal Thr/Ser 
residue (Gerber and Sligar 1994). As mentioned previously differences exist 
between cytochrome P450 and thromboxane synthase in that thromboxane 
synthase lacks the Thr and Ser residues, this enables investigation into the 
possible role of the Thr/Ser residues in the binding of hydroxylamine and 
trifluoroethylamine and comparing the results to those obtained with CYP2B4. 
The binding of nitrogen bases to different isozymes of cytochrome P450 will 
also be investigated during this chapter in order to establish any differences in 
the ratio of conformers between the different families.
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STRUCTURES OF THE NITROGENOUS BASES.
Fig 4.1 Six-membered azines.
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Fig 4.2 five-membered azoles»
N
H
•Nj
Imidazole
■N
H
-N
■I
N
1,2 3 -Triazole
N
N
H
1,2,4-Triazole
NOz 
 N
X J
4-Nitroimidazole
X i
CH,
GN
àHc
5-Chloro-N-Methylimidazole N-Methylimidazole
-----N
fcHs
O
N-Acetylimidazole
115
4.2 MATERIALS.
These were described in section 2.2 and 3.2 for substances such as sodium 
dithionite. Additional chemicals and suppliers not mentioned previously are listed 
below. All materials were obtained from the sources cited and were of at least 
analytical grade and were used as received.
Aldrich Chemical Company. (Gillingham, Dorset, UK)
Aminopropionitrile, 4-aminopyridine, bromoethylamine, 5-chloro-N- 
methylimidazole, 4-cyanopyridine, dimethylaminopyridine, hydrazine, 
hydroxylamine, methylamine, nitroimidazole, N-octylamine, 4-picoline, pyrazine, 
pyridazine, pyrimidine, 1,2,3 triazole and trifluoroethylamine.
Fisons Scientific Equipment (Loughborough, Leicestershire, UK)
Acetonitrile.
Sigma Chemical Company. (Poole, Dorset, UK)
Aminoacetonitrile, imidazole, methylimidazole and 1,2,4 triazole.
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4.3 METHODS
Preparation of microsomal, partially purified and pure CYP2B4.
The samples of cytochrome P450 used for the experiments in this chapter were 
prepared as previously described in section 2.3.3.
4.3.1 Spectrophotometric assays.
Total protein content.
Total protein content of the cytochrome P450 samples was measured by the 
method of Lowry et al (1951) as previously described in section 2.3.10.
Total cytochrome P450 content.
The total amount of cytochrome P450 in the microsomal, partially purified and 
pure CYP2B4 samples were measured by the method of Omura and Sato 
(1964a) as previously described in section 2.3.10.
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4.3.2 The effect of pH on the binding of azines, azoles and
amines to reduced P450.
All investigations were carried out on a Uvikon 860 dual beam 
spectrophotometer.
The effect of pH on the binding of nitrogen containing compounds to 
cytochrome P450 was carried out using microsomal suspensions. The
microsomes were diluted in 0.2 M potassium phosphate buffer at the stated pH, 
so that the final concentration of cytochrome P450 in the sample cuvette was
1.0 pM at a temperature of 25 ° C.
The microsomal suspension was reduced by the addition of a few mgs of 
sodium dithionite, and subsequently divided into two 1.5 ml cuvettes and a 
baseline recorded. The compound under investigation was then added to the 
sample cuvette, so that the final concentration in the cuvette was 50 mM, except 
in the case of azoles, where lower concentrations were used ( 1 - 1 0  mM). A 
spectrum was then recorded. This procedure was carried out at the following 
pHs; 6.0, 6.5, 7.0, 7.5 and 8.0, using pure cytochrome P450 as well as
microsomes.
4.3.3 The effects of varying pH on the reduced P450 difference
spectrum in the presence of azines.
The effects of varying pH on the difference spectrum of reduced P450 with 
azines was investigated using pyridine.
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(1) pH change prior to pyridine binding.
Microsomes were diluted in 0.2 M potassium phosphate buffer, pH 6.5. The 
resulting suspension was reduced by the addition of a few mgs of sodium 
dithionite, divided equally between two 1.5 ml cuvettes and a baseline recorded. 
The suspensions in both the sample and reference cuvettes were transferred to 
individual beakers and the pH was adjusted to 7.0 by the addition of 0.2 M 
potassium phosphate buffer, pH 9.0 containing sodium dithionite in order to 
ensure that the sample remained reduced. To adjust the pH from the initial pH 
(6.5), to the final pH (7.0), accurately, the exact volume of buffer required had 
been previously calculated by titration, using a pH meter to monitor the change. 
When the suspension in the reference and sample cuvettes were at pH 7.0, the 
cuvettes were autozeroed and pyridine was added to the sample cuvette, so that 
the final concentration of the ligand was 50 mM. The spectrum was then 
recorded. This procedure was also repeated for the following pH changes:-
7.0 => 7.5
7.0 => 6.5
7.5 => 7.0
Decreases in pH were obtained by the addition of 0.2 M potassium phosphate 
pH 3.0 containing sodium dithionite.
(2) pH change after pyridine binding.
The procedure outlined above was used for this experiment, with the exception 
of where pyridine was added to the sample cuvette and a spectrum was 
recorded before pH adjustment.
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4.3.4 Determination of binding constants of nitrogen — containing 
compounds to reduced cytochrome P450.
The binding constants of azines (pyridine and pyridazine), azoles (5-chloro-N- 
methylimidazole) and amines (trifluoroethylamine and hydroxylamine) were 
investigated using the methodolgy described below
The determination of the binding constant for pyridine was carried out using 
0.2 M potassium phosphate buffer, pH 6.5 and a microsomal sample of 
cytochrome P450. Microsomes were diluted to give a final concentration of 1.0 
pM. The diluted microsomal suspension was reduced with a few mgs of 
sodium dithionite, divided equally between two 1.5 ml cuvettes and then a 
baseline was recorded between 400 nm and 500 nm. Pyridine was subsequently 
added to the sample cuvette so that the final concentration in the cuvette of 
pyridine was 1.0 mM. The spectrum was then recorded. Further aliquots of 
pyridine were added to the same cuvette, so that the concentration in the cuvette 
was increased by 1.0 mM on each addition. The above procedure was also 
repeated using partially purified and pure cytochrome CYP2B4. The 
determination of the binding constant of pyridazine, 5-chloro-N-methylimidazole, 
imidazole, trifluoroethylamine and hydroxylamine were carried out using the 
previously described procedure for pyridine except that partially purified 
cytochrome CYP2B4 was used initially instead of microsomes, but the final 
concentration of cytochrome P450 remained the same (1.0 pM).
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4.3.5 The effects of time and ligand concentration on the binding 
of nitrogen compounds to reduced P450.
These experiments were carried out using 0.2 M potassium phosphate buffer, pH 
8.0. The compounds investigated included pyridine and pyridazine (azines), 4- 
nitroimidazole (azole) and N-octylamine (amine). The same methodology was 
used for all compounds and is outlined below.
Microsomes were diluted to a final concentration of 1.0 pM using the buffer 
stated above, this microsomal suspension was then reduced with sodium 
dithionite and the baseline recorded. The compound under investigation was 
added to the sample cuvette so that the final concentration in the sample cuvette 
was either 20, 50, or 100 mM for pyridine, 0.1 mM for 4-nitroimidazole and 
0.5 mM for N-octylamine. The spectra were then recorded. After this had been 
carried out, the cuvette was allowed to stand at room temperature for 30 
minutes, and the spectra re-recorded. Carbon monoxide was bubbled through the 
sample cuvette at a rate of 1 bubble per second to produce a CO-difference 
spectrum. Pyridazine was also used in this time course experiment, but was 
carried out at pHs 6.0, 7.0 and 8.0, using a final concentration of 37 mM 
pyridazine.
4.3.6 Binding of nitrogen containing compounds to different 
cytochrome P450 isozymes.
The binding of nitrogen containing compounds to reduced cytochrome P450 
derived from clofibrate and isoniazid treated animals was carried out using 
pyridine, imidazole, trifluoroethylamine and hydroxylamine.
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Microsomes were diluted in 0.2 M potassium phosphate buffer, pH 6.0, 7.0 and
8.0 to give a final concentration of 1.0 pM. The microsomal suspension was 
reduced with sodium dithionite, divided equally between two 1.5 ml cuvettes and 
then a baseline was recorded. The compound under investigation was 
subsequently added to the sample cuvette to give a final concentration of 50 
mM, except in the case of imidazole where the final concentration was 10 mM. 
The spectra were then recorded.
4.3.7 Competition between carbon monoxide, pyridine and 
imidazole for the reduced cytochrome P450.
Competition experiments on the reduced cytochrome P450 were carried out using 
0.2 M potassium phosphate buffer, pH 7.0.
Microsomes were diluted to a final concentration of 1.0 pM, reduced with a few
mgs of sodium dithionite and then divided equally between two 1.5 ml
cuvettes. A baseline was subsequently recorded. Carbon monoxide was bubbled
through the sample cuvette (1 bubble per second) and the spectrum was re­
recorded. Pyridine was then added to the sample cuvette, to give a final 
concentration of 50 mM in the cuvette and the spectrum was re-recorded. The 
procedure was repeated, but pyridine was added prior to carbon monoxide 
addition. This procedure was repeated using imidazole at concentrations of 1 mM 
and 10 mM with either pyridine or carbon monoxide added both before and 
after the imidazole addition.
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4.3.8 Identification of the proximal ligand present in the two 
conformational states of cytochrome P450.
EXAFS.
EXAFS (extended X-ray absorption fine structure) analysis was carried out to 
investigate the nature of the proximal ligand involved in the binding of 
nitrogenous bases to cytochrome P450.
The binding of certain ligands to cytochrome P450 can produce spectra which 
represent conformers I and II. In order to investigate the nature of the proximal 
ligand involved in the formation of these different conformers, nitrogen bases 
which only produce a single conformer were used for these studies, namely
1,2,3 triazole (conformer II) and cyanopyridine (conformer I).
Initial investigations were carried out using a concentrated solution of partially 
purified cytochrome P450 in the presence of either ligand, but the signal 
produced by EXAFS was too weak to enable any calculations to be carried out.
In order to produce a detectable EXAFS signal, a solution of partially purified 
P450 was concentrated down using aquacide to 5 ml, the smallest volume 
possible. A 1 ml aliquot of this concentrate was then centrifuged at 100,000 g 
(45,000 rpm) for one hour, using a Ti 70 rotor in an ultracentrifuge. The 
resulting pellet was resuspended in 0.2 M potassium phosphate buffer, pH 6.0. 
The remaining concentrate was already in 0.2 M potassium phosphate buffer, pH
7.5. A variation in the pH was used to enable the formation of only one 
conformer when the appropriate ligand was bound to the reduced cytochrome 
P450, i.e cyanopyridine (conformer I), pH 7.5, 1,2,3 triazole (conformer II), 
pH 6.0.
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A portion (1 ml) of the concentrate at pH 7.5, was centrifuged at 100,000 g for 
one hour. The resulting pellet was then transferred to an EXAFS cell (volume 
125 pi) and rapidly frozen in liquid nitrogen. The frozen cell was attached to a 
cryostat maintained at - 70 ° C whilst EXAFS analysis was carried out over a 12 
hour period. Whilst EXAFS analysis was being carried out on the initial ferric 
sample, a second 1 ml sample of the concentrate was reduced with a few mg's 
of sodium dithionite at pH 7.5. Cyanopyridine, was subsequently added to the 
concentrate, so that the final concentration was 10 mM. This solution was now 
centrifugated at 100,000 g for one hour. The resulting pellet was then 
transferred to another EXAFS cell and rapidly frozen in liquid nitrogen. The cell 
was left in liquid nitrogen until required.
The ligand that produced conformer II was prepared as outlined above, except 
that the ligand was added to 0.2 M potassium phosphate buffer, pH 6.0, to 
give a final concentration of 1 mM
Dénaturation check.
Before EXAFS analysis could be carried out investigations were performed on 
the concentrate to establish whether dénaturation had occurred during pellet 
preparation.
Cyanopyridine or triazole was added to a portion (200 pi) of the concentrate in 
the appropriate buffer at the concentration to be used during EXAFS analysis. 
The suspension was reduced, using sodium dithionite and centrifuged at 
100,000g for one hour. The resulting pellet was resuspended in 2 ml of the 
appropriate buffer, and placed into a sample cuvette and reduced. Extra ligand 
was then added to this cuvette and the spectrum recorded. The reference cuvette 
contained an equal amount of respun reduced concentrate. Carbon monoxide was
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then bubbled through the sample cuvette and a spectrum re-recorded
4.3.9 Investigation into the role of the Threonine residue.
4.3.9.1 Preparation of thromboxane synthase.
The methodology employed for the preparation of thromboxane synthase from 
human platelets was based on a procedure developed by Needleman et al 1976.
Human platelet-rich plasma from 20 pints of blood was centrifuged at 200 g in 
a Beckman J6  for 10 minutes in order to remove the red blood cells. The 
resulting supernatant was centrifuged at 10,000 g for 6  minutes in a Beckman 
J2-21 to precipitate out the platelets. The resulting platelet pellet was divided 
into three unit fractions and was stored frozen at - 70°C. The pellet concentrate 
(1 unit) was thawed and suspended in 3 ml of 100 mM Tris-HCl buffer, pH
7.5. This suspension was shell frozen rapidly (in dry ice/acetone) and then 
rapidly thawed. Once thawed it was homogenised in a glass-glass Potter 
homogeniser on ice. This procedure was repeated 3-4 times to maximise 
breakage of the cells. The resulting homogenate was centrifuged at 5,000 g for 
15 minutes in a Beckman J2-21 centrifuge to remove the cell debris. The 
resulting supernatant was centrifuged at 100,000 g for 1 hour in a Beckman 
ultracentrifuge. The resulting pellet was gently washed with 100 mM Tris-HCl 
buffer, pH 7.5 and resuspended in 0.5 mis of ice cold Tris-HCl buffer, pH 7.5 
and homogenised. This procedure was repeated for all the units and stored at - 
70 °C until required.
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4.3.9.2 Determination of the total protein and haem content.
The total protein content of the platelet microsomes was determined using the 
methodology of Lowry et al 1951. Microsomal haem content in the platelets 
was determined using the method of Paul et al 1953, employing the reduced 
minus oxidised difference spectrum in pyridine/sodium hydroxide. A baseline 
was recorded between 530 nm and 570 nm with a freshly prepared 
pyridine/0.3M sodium hydroxide (1:2 v/v) mixture in both the reference and 
sample cuvettes. Once recorded, a portion (50 pi) of sample was diluted in 
pyridine/sodium hydroxide mixture so that the final volume in the cuvette was 
1ml. The solution was then reduced with a few mgs of sodium dithionite, and 
a difference spectrum was recorded against pyridine/sodium hydroxide. Haem 
content was calculated using AE555.543 of 19.5 mM.
4.3.9.S Binding of ligands to reduced thromboxane synthase.
All binding experiments were carried out on a Kontron Uvikon 942 
spectrophotometer. The platelet homogenate was diluted in 0.2 M potassium 
phosphate buffer, pH 7.0, so that the final protein concentration in the cuvette 
was 4 mg/ml. The resulting suspension was reduced with a few mgs of sodium 
dithionite and divided equally between two 0.5 ml quartz cuvettes. A baseline 
was recorded between 390 and 500 nm. Initial binding experiments were carried 
out using carbon monoxide, where after recording the baseline carbon monoxide 
was bubbled through the sample cuvette for 1 minute and the spectrum 
repeatedly scanned for up to 30 minutes (10 x 3 minute scans). This was 
carried out in order to establish whether time had any effect on the spectrum. 
Once carbon monoxide binding had been established, the binding of nitrogen 
bases such as, pyridine, hydroxylamine and trifluoroethylamine was investigated. 
This was carried out by the addition of the ligand to the reduced sample in the
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sample cuvette so that the final concentration was 50 mM in the case of 
pyridine and trifluoroethylamine and 10 mM for hydroxylamine. An equal amount 
of buffer was added to the reference cuvette. The spectra were repeatedly 
recorded for up to 50 minutes (10 x 5 minute scans) to establish the effects of 
time on the spectrum profile. Once this had been carried out, carbon monoxide 
was bubbled through the sample cuvette in order to determine whether the 
compound under investigation possessed any denaturing effects.
4.3.10 Ligand binding at the ferric level.
The binding of cyanide and two neutral bases (pyridine and N-acetylimidazole) 
were previously carried out in section 3.3.2 in order to determine the nature of 
the sixth ligand. Investigations into the binding of other nitrogen bases 
belonging to the following three families, azines, azoles and amines were carried 
out using partially purified CYP2B4 at a concentration of 1 pM.
The binding of nitrogen containing compounds to oxidised 
cytochrome P450.
Investigations into the binding of nitrogen containing compounds to oxidised 
cytochrome P450 were carried out initially, using partially purified cytochrome 
P450 at a concentration of 1.0 pM. The same procedure was used for each 
family of nitrogen compounds, the only difference being in the final 
concentration of ligand used.
The binding of pyridine, cyanopyridine and pyridazine to ferric cytochrome was 
investigated using 0.2 M potassium phosphate buffer pH 7.5. After the baseline 
had been recorded, the P450 suspension was placed in the sample cuvette, 
autozeroed and the spectrum recorded. Pyridine was then added to the sample
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cuvette, so that the final concentration was 50 mM. The spectrum was re­
recorded. Similar experiments were carried out using cyanopyridine and 
pyridazine at final concentrations of 10 mM and 50 mM respectively. The 
binding of imidazole and N-acetylimidazole to ferric cytochrome P450 was 
investigated using the procedure described for the azines, except that, the final 
concentrations of imidazole and N-acetylimidazole were 200 mM and 100 mM, 
respectively. The binding of hydrazine, hydroxylamine, methylamine, 
trifluoroethylamine and aminoacetonitrile to ferric cytochrome P450 was 
investigated using the above procedure described for the azines. All the 
compounds were added to the sample cuvette at a final concentration of 50 mM 
with the exception of aminoacetonitrile which was added at a final concentration 
of 150 mM. The binding of methylamine and hydroxylamine to ferric 
cytochrome P450 was also investigated under nitrogen. Prior to the recording of 
the oxidised spectrum of P450, nitrogen was bubbled into the sample cuvette in 
order to obtain a deoxygenated atomosphere. After the spectrum was recorded 
the ligand under investigation was added to the cuvette using a syringe under 
nitrogen, then the spectrum was re-recorded. The sample cuvette was 
subsequently left for 20 minutes and the spectrum re-recorded, in order to 
determine the effect of time, on the oxidised spectrum of cytochrome P450 on 
ligand binding.
4.3.11 Determination of binding constant of nitrogen containing 
compounds at the ferric level.
Binding constants were determined for the following nitrogen containing 
compounds with ferric cytochrome P450, namely, pyridazine, imidazole, 
trifluoroethylamine and hydroxylamine. A general procedure was employed for 
these determinations as outlined below :-
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Partially purified cytochrome P450 was diluted to give a final concentration of
1.0 pM. After the baseline had been recorded using buffer, the partially purified 
cytochrome P450 suspension was placed in the sample cuvette and the spectrum 
recorded. Various amounts of the ligand were then added to the sample cuvette, 
whilst equal volumes of buffer were added to the reference cuvette. Titration of 
ligand to oxidised cytochrome P450 was carried out at the following pHs 6.5,
7.5 and 8.5 for all the ligands stated above.
4.3.12 The effect of time and addition of extra ligand to the 
oxidised binding spectrum of P450.
The effect of time and addition of extra ligand was previously investigated using 
the azine pyridine and reduced CYP2B4 and was found to cause dénaturation 
(section 4.3.5). In view of this it was decided to investigate the effect of time 
and extra ligand on ferric CYP2B4 using the azines (pyridine and 
cyanopyridine), azoles, (imidazole and N-acetylimidazole), and amines 
(aminoacetonitrile, hydrazine, hydroxylamine, methylamine and 
trifluoroethylamine).
The same procedure was used for all the ligands under investigation. Partially 
purified cytochrome P450 was diluted to give a final concentration of 1.0 pM. 
A baseline was recorded using buffer, then an aliquot of the cytochrome P450 
suspension was added to the sample cuvette. The spectrum of the oxidised 
P450 was subsequently recorded. The ligand under investigation was added to 
the sample cuvette whilst a corresponding volume of buffer was added to the 
reference cuvette, and then the spectrum was re-recorded. After the spectrum 
had been recorded, the sample cuvette was left at room temperature for 15 - 20 
minutes, after which the spectrum was re-recorded. A further aliquot of ligand 
was then added to the sample cuvette in order to determine whether a further
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wavelength shift could be detected.
4.4 RESULTS.
4.4.1 The effect of pH on the binding of nitrogen bases to
reduced CYP2B4.
When azines are bound to reduced cytochrome P450 (table 4.1); it can be seen 
that pH has an affect on the ratio of the conformers that are formed. In most
cases the addition of azines causes the formation of a single Soret banded
spectrum, corresponding to one or other of the conformers. However, in other 
instances, the addition of azines causes the production of a double Soret banded 
spectrum, where the conformers appear to be in a pH-dependent equilibrium, 
with low pH (6.0) favouring the formation of conformer II, whilst a high pH
(8.0) favoured the formation of conformer I (fig 4.3). Some azines such as
dimethylaminopyridine appeared not to bind to reduced CYP2B4 at any of the 
pHs used. The binding of carbon monoxide immediately after the binding of the 
base produced a spectrum with only one peak at 450 nm, indicating that no 
dénaturation had taken place. At all pHs investigated the binding of azoles to 
reduced CYP2B4, produced a spectrum showing a single peak (table 4.2). For 
most of the azoles this single peak was at a wavelength of 422-429 nm, 
however, the binding of 0.1 mM nitroimidazole caused a peak at the wavelength 
443 nm which increased in intensity with time. From these results it appears 
that for the majority of the azoles used, when bound to reduced cytochrome 
these compounds tend to favour conformer II, with the exception of 
nitroimidazole which forms conformer I. For all the azoles investigated, 
equilibrium was established within the time of mixing with the exception of 
nitroimidazole. On standing at room temperature no further shift in wavelength 
was observed for the azoles with the exception of 5-Cl-N-methylimidazole where 
dénaturation was observed.
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abs
4 564 25
wavelength (nm)
Fig 4.3 Spectra produced on the binding of pyridine to dithionite-reduced microsomes at 
various pHs. a) pH 6.0, b) pH 7.0, c) pH 8.0.
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Compound pKa 6
PH
7 8
Dimethylaminopyridine 9.8 - - -
4-Aminopyridine 9.1 422 424 425
4-Bicoline 6.0 423* 446 424* 446 422* 446
Pyridine 5.2 424* 445 424 446 423 446*
Pyridazine 2.3 428 426 425
4-Cyanopyiidine 1.9 424 443* 443 442
Pyrimidine 1.1 444 443 442
Pyrazine 0.4 423 444* 424 443* 443
T able 4.1: The effect of pH on the conformers formed when azines bind to reduced
CYP2B4. The base was added at a final concentration of 50 mM.
* major conformer present.
- no binding.
Compound pKa 6
pH
7 8
Methylimidazole 7.2 ND 429 ND
Imidazole 7.1 430 428 429
N-Acetylimidazole 3.6 ND 430 ND
1,2,4-Triazole 2.3 426 426 426
1,23-Triazole 2.1 422 422 423
Nitroimidazole -0.1 445 443 443
T able 4 .2: The effect of pH on conformer formation when azoles are bound to reduced 
CYP2B4. All bases were added at a final concentration of 10 mM with the exception of 
nitroimidazole which was added at 0.1 mM.
ND- not determined.
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The binding of a majority of amines to reduced cytochrome P450 showed a 
single peak in the difference spectra between 418-431 nm or 442-444 nm (table 
4.3). However, the binding of N-octylamine was very different with a two 
banded spectrum being produced at pH 7.0 and 8.0. The appearence of the 
double spectrum at pH 7.0 (peaks at 426 and 443 nm) only lasted for 40 
seconds, with an increase in time producing a corresponding increase in the 
formation of the peak corresponding to conformer II (426). While at pH 8.0 
the initial spectrum consisted of a single peak at 426 nm and with time (10 
minutes) the spectrum at this pH consisted of two peaks at wavelengths 426 
and 447 nm. This slow change from a single conformer to a spectrum 
representing a mixture of conformers indicates that a slow reaction is taking 
place. The binding of N-octylamine was carried out in three different solvents 
(water, methanol and DMSO) with the same spectra seen with each solvent. The 
binding of N-octylamine using water as the solvent produced good isosbestic 
points at pH 7.0 clearly showing the change from a mixture of conformers to a 
single conformer with time (fig 4.4). The binding of ammonia only produced a 
spectrum at higher pH while methylamine did not produce a spectrum. These 
results were attributed to the pH used being well below the pKa value. The 
effect of lowering the pH on the binding of bromoethylamine and 
hydroxylamine caused the intensity of the peak to be reduced.
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Compound pKa 6 6.5
PH
7 7.5 8 8.5
N-Octylamine 10.65 427 428 426 443* ND 425 447** ND
Methylamine 10.6 - - - - - -
Ammonia 9.3 - - - - 434 431
Bromoethylamine 8.5 - 432 432 431 428 429
Hydrazine 1 8.1 - - - 434 431 ND
Hydroxylamine 1 6.0 418 420 418 420 420 ND
Trifluoroethylamine 5.7 442 442 443 442 443 ND
Aminoacetonitrile 5.3 443 444 443 442 443 442
Table 4.3: The effect of pH on the binding of amines to reduced cytochrome P450.
* wavelength changes with time (426), ** wavelength shifts from 426 at start to 447. 
ND not determined, - no binding. * indicates bases that exhibit a  effect.
a  d s  
0. 040
abs
-0 .040
470445420390
Fig 4 .4  A spectrum showing the slow change from conformer I to conformer II which
occurs on the binding of N-octylamine to reduced CYP2B4 with time at pH 8.0. 
a) conformer I b) conformer II
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4.4.2 The effect of varying pH on the difference spectrum 
produced by pyridine.
These present studies were undertaken to ascertain whether changing the pH in 
both directions (eg 7.0<^6.5 and 7.0<=>7.5) after reduction was affected by the 
presence of pyridine added after or before change in pH. A change in the pH, 
either by increasing or decreasing the pH, produced on binding of pyridine a 
spectrum resembling that of the new pH, e.g if the initial pH was 7.0, the 
spectrum would consist of a mixture of conformers, if the pH was now 
changed to pH 6.5, the spectrum would now resemble that of pH 6.5, with 
conformer II the major form present, although the intensity of the peaks would 
be reduced due to dilution (fig 4.5). Varying the pH after pyridine was bound 
to the reduced cytochrome P450 was found to produce similar spectra to what 
was expected, in that pyridine already bound to the cytochrome P450 did not 
block the change between conformers. In both cases the binding of pyridine 
was instantaneous with no further slow change in the ratio of conformers. From 
these results the addition of pyridine before or after pH change did not prevent 
the interconversion between the two conformers. This interconvertibility between 
the conformers was also found to be reversible, however reversibility was 
limited due to dilution.
4.4.3 Determination of a relationship between pKa and the 
binding of nitrogen bases at fixed pH.
A relationship was found to exist between pKa and the wavelength observed 
when nitrogen bases bind to reduced CYP2B4 at pH 7.0. For the majority of 
the bases studied, those with a high pKa favoured the formation of conformer
II. While those bases with a low pKa favoured the formation of conformer I 
(table 4.4-6). However, in the case of pyridazine, its low pKa value suggests
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d)
J
4 00 4ÎÏ. - ' 0  •> • '•••■
Fig 4.5 Spectra showing the pH-dependent change in the pyridine difference spectra of
reduced microsomal CYP2B4
a) i) pH 6.5 b) i) pH 7.0
ii) pH 6.5 =3» 7.0 ii) pH 7.0 => 6.5
c) i) pH 7.0 d) i) pH 7.5
ii) pH 7.0 => 7.5 ii) pH 7.5 => 7.0
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that it should favour conformer I, however, our experimental data indicates that 
conformer II was formed. The bases dimethylaminopyridine, methylamine and 
ammonia did not appear to bind to reduced cytochrome P450 at the pH used, 
which was indicated by the lack of detectable peaks due to the pH used being 
below their pKa values. Pyridine, 4-picoline and N-octylamine produced a 
mixture of conformers at pH 7.0, with conformer I being slightly more 
favoured than conformer II (table 4.4 and 4.6). The mixture of conformers (I 
and II) produced by N-octylamine at pH 7.0 was only observed for the initial 
40 seconds, with the peak representing conformer II increasing with time and 
reaching a maximum after two minutes.
Compound pKa conformer 1 conformer 2 Ratio 
Ai : An
Dimethylaminopyridine 9.8 — — —
4-Aminopyridine 9.1
-
423 <c 0 .2
4-Picoline 6 446 423 0.5
Pyridine 5.2 446 423 1.25
Pyridazine * 2.3 - 427 < 0.1
4-Cyanopyridine 1.9 443 _ ^ 1 0
Pyrimidine 1.1 443 - £ 1 0
Pyrazine 0.4 443 £  10
Table 4.4: Relationship between pKa and formation of conformers I and II with azines at 
pH 7.0.
- no binding, * show a  effect.
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Compound pKa conformer 1 conformer 2 Ratio 
Ai :Ah
Methylimidazole 7.2 — 429 <c 0.1
Imidazole 7.1 - 429 ^  0.1
N-Acetylimidazole 3.6 - 430 3  0.1
1,2,4 Triazole 2.3 - 426 < 0.1
U 3  Triazole 1.2
-
422 < 0.1
4-Nitroimidazole -0.1 446 - > 1 0
Table 4.5: Relationship between pKa and the formation of conformers I and II with azoles
at pH 7.0. - no binding observed.
Compound pKa conformer 1 conformer 2 Ratio 
Ai : An
N-Octylamine 10.65 - 426-7 < 0 .1
Methylamine 10.6 - - -
Ammonia 9.3 - (431) * (<0 .1)
Bromomethylamine 8.5
-
428-32 <  0 .2
Hydrazine 1 8.1 - (431) * (<0 .1)
Hydroxylamine 1 6 - 419 < 0.1
Trifluoroethylamine 5.7 442 - > 1 0
Aminoacetonitrile 5.3 442 -
oA\
Table 4.6: Relationship between pKa and formation of conformers I and II by amines at pH 
7.0.
- no binding, * binding only at higher pH (8.5-9.0), 1 bases that show a  effect.
4.4.4 Determination of binding constants.
The apparent binding constants for a series of nitrogen bases were determined 
by the addition of small volumes of stock ligand to the sample cuvette, and 
equal amounts of buffer to the reference cuvette. The absorbance values 
observed on each ligand addition were ascertained. In all cases, binding appeared 
to be instantaneous and the average absorbance values from duplicate 
experiments were taken and used to construct log-log plots, from which the 
values of K were calculated (table 4.7). The curves produced in each case 
corresponded to the binding of one molecule of base per Fe (figs 4.6-8). The 
binding constant for pyridine was carried out using a microsomal sample of 
CYP2B4, because when pure CYP2B4 was used there was an increase in 
dénaturation as shown by the increase in absorbance at 426 nm (fig 4.6). The 
calculated binding constants values for pyridazine, hydroxylamine and 
trifluoroethylamine were found to be pH independent as illustrated by table 4.7. 
The binding constant value for hydroxylamine was obtained by estimating the 
end point, due to a decrease in absorbance at the higher concentrations of 
ligand (fig 4.8).
Compound / pH
Binding constant values (Mr1)
6 6.5 7 8
Pyridine — 560 — 160
Pyridazine 13 - 2 0 28
Hydroxylamine - - 6309 7943
Trifluoroethylamine 22 41
Table 4.7 A table showing the calculated binding constants of nitrogen bases to reduced 
CYP2B4 at various pHs. - not determined
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0.014-,
0.012-
0.01-
0.004-
0.002-
50 10 15 20
Pyridine conc (M x 10-3)
Fig 4.6 A graph showing the increase in the mixture of conformers (+11; o f )  formed on 
the binding of pyridine to reduced CYP2B4 at pH 6.5.
r-0.5
-1.5 -0.5
- - 0.5
— 1
— 1.5
Log [pyridazine] M
Log A abs
Fig 4.7 A log-log plot of pyridazine concentration against AA using reduced partially 
purified CYP2B4 at pH 6.0 (•), 7.0 (o) and 8.0 (+).
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0.025-,
0.02
0.015-
5
0.01-
0.005-
0.1 0.2 0.30
conc (mM)
Fig 4.8 A graph showing the initial increase in absorbance observed versus concentration of 
hydroxylamine added to a sample of reduced CYP2B4 at pH 7.0, and the decrease observed at 
higher concentrations of hydroxylamine.
1-0.5
—0.5
— 1
—1.5log [NH20H] M
Log A abs
Fig 4.9 A log-log plot of hydroxylamine concentration against AA at pH 7.0 (•) and pH 
8.0 (o) using reduced partially purified CYP2B4.
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4.4.5 The effects of concentration and time on the observed 
difference spectra at fixed pH.
Concentration
For the majority of azines, azotes and amines used in this study, variation in
ligand concentration did not affect conformer formation as indicated by the
observed difference spectra (tables 4.8). In the case of the azines, namely
pyridine, pyrazine and 4-picoline which produced a mixture of conformers I and 
II on binding to reduced cytochrome P450, a variation in ligand concentration 
had no effect on the conformers formed, although at high concentrations of 
pyridine (100 mM) higher levels of conformer II was found to be formed. This 
was later attributed to dénaturation, since when carbon monoxide was 
immediately bubbled through the cuvette, formation of a peak at 420 nm was 
revealed. In the case of the azoles, 4-nitroimidazole and N-acetylimidazole, 
binding spectra were only obtained at low concentrations of the ligand (0 .1  and 
5 mM respectively). Binding of 4-nitroimidazole at high concentrations (10 mM) 
was not observed due to its insolubility at these high concentrations, whilst for 
N-acetylimidazole high background interference was observed which was due to 
its intense colour at concentrations above 25 mM which may be responsible for 
the difficulty in obtaining a difference spectra.
Time.
Time course experiments have revealed that in the majority of cases, time has 
no effect on conformer formation when ligands such as N-acetylimidazole, 
methylimidazole, nitroimidazole, 1,2,4 triazole and trifluoroethylmine were bound 
to reduced cytochrome P450, i.e there is no change in type of conformer with 
respect to time and no dénaturation as indicated by a lack of a peak at 420 nm
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in the carbon monoxide spectrum. They all produced a single peak at 450 nm. 
However, this does not hold true for pyridine, pyridazine, 5-chloro-N- 
methylimidazole or N-octylamine. Pyridine was found to produce a peak at 420 
nm which was later attributed to dénaturation, since the peak was obtained 
without the addition of carbon monoxide. In the case of the other ligands 
mentioned, namely pyridazine and 5-chloro-N-methylimidazole, the bubbling of 
carbon monoxide through the sample cuvette produced two peaks in the 
difference spectrum at 421 and 450 nm. This was indicative of CYP2B4 
dénaturation over a period of time, even though the dénaturation was only 
observed when carbon monoxide was present. In the case of pyridazine, low 
pH caused the dénaturation of CYP2B4, whilst at pH 8.0, only a single peak 
at 450 nm was observed on the binding of carbon monoxide, indicating that low 
pH increases the rate of dénaturation.
Compound pH Concentration
(mM)
Initial
peak(s)
Time
(minutes)
Final
peak(s)
Peak(s) after 
carbon monoxide
Pyridine 7 50 422 445* 0 422 446* 450
7 50 422 445* 30 422* 445 421 450*
8 100 422* 446 30 421* 446 421* 450
Pyridazine 7 50 425 0 425 450
7 50 425 20 426 421 450
5 - d i ­ 7.0 50 424 0 424 421 449
methyl
imidazole 7.0 50 424 10 424 422 449
N- 7.0 0.5 426 446 0 426 446 449
octylamine
7.0 0.5 426 446 5 426 449
Table 4.8.: The effect of time on the ratio of conformers formed when nitrogen bases bind 
to reduced cytochrome P450.
* major conformer present
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4.4.6 Binding of nitrogen bases to different cytochrome P450 
fam ilies.
CYP4A1 and CYP2E1, which are induced by clofibrate and isoniazid 
respectively were chosen for these experiments due to their availability.
Compound isozyme Wavelengths observed 
6.0 (ratio A%/Ap)
at pH 
7.0 (ratio Aj/An) 8 .0  (ratio Ai/Ap)
Pyridine 4A1 425* 447 (s0.2) 425 446 (1.0) 424 447* (2.2)
2B4 425* 449 ($0.2) 424 447 (1.3) 424 446* (1.5)
2E1 425* 449 ($0.2) 424 447 (0.7) 424 446* (1.8)
Imidazole 4A1 429 ($0.1) 428 (<0.1) 429 (<0.1)
2B4 430 ($0.1) 428 (<0.1) 429 (<0.1)
2E1 428 ($0.1) 427 (<0.1) 427 (<0.1)
Trifluoro 4A1 444 (WO) 443 W 0) 443 W 0 )
ethylamine 2B4 442 W 0) 442 W 0) 442 W 0 )
2E1 443 W 0) 444 W 0) 443 WO)
Hydroxyl 4A1 421 ($0.1) 419 ($0.1) 421 ($0.1)
amine 2B4 418 ($0.1) 418 ($0.1) 420 ($0.1)
2E1 421 ($0.1) 420 ($0.1) 422 ($0.1)
Table 4.9: The binding of nitrogen bases at a concentration of 50 mM to different 
cytochrome P450 families at the ferrous level.
* major conformer
Similar difference spectra were obtained for the binding of nitrogen bases to 
reduced cytochrome P450 samples derived from phénobarbital (2B4), clofibrate 
(4A1) and isoniazid (2E1) treated animals at pH 7.0 (table 4.9). Of all the 
bases studied, pyridine was the only base to produce a mixture of conformers 
on binding to the different cytochrome P450 families. Furthermore, when 
pyridine was bound to all the families under investigation, at low pH, formation 
of conformer II was favoured, whilst at high pH, conformer I was favoured. 
In the case of hydroxylamine, for all cytochrome P450 families studied, a 
decrease in pH was parallelled by a decrease in the intensity of the conformer II.
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However, in the case of imidazole and trifluoroethylamine, this decrease was not 
observed. These two compounds produced peaks at 429 and 442 nm, 
respectively. The binding of all bases was instantaneous at the concentration 
used (50 mM).
4.4.7 Competition.
Carbon monoxide (CO) was found only to produce one peak at 450 nm when 
bound to reduced cytochrome P450 and this binding was not affected by a 
change in pH (6 -8 ). When pyridine was bound to reduced cytochrome P450 a 
difference spectrum consisting of two peaks was observed. When this solution 
was bubbled with carbon monoxide only one peak at 450 nm was seen. This 
finding is similar to imidazole when it was bound to reduced cytochrome P450, 
a single peak was seen at 429 nm in the difference spectrum, but after carbon 
monoxide addition this single peak was shifted to 450 nm. These initial 
experiments suggests that cytochrome P450 has a higher affinity for CO than 
pyridine or imidazole. When imidazole was added prior to pyridine addition the 
spectrum obtained changed from a single peak spectrum to the characteristic two 
peaked spectrum of pyridine. Thus, it appears the affinity order of these ligands 
is
CO > pyridine > imidazole
4.4.8 Identification of the sixth ligand.
EXAFS.
The technique of EXAFS was attempted in order to determine the nature of the 
ligand, thiol or thiolate, involved in the binding of nitrogen bases to reduced 
CYP2B4. The nature of the ligand was investigated using various samples of
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CYP2B4. Native ferric CYP2B4, ferrous CYP2B4 with the ligand cyanopyridine 
bound, which produces conformer I only and ferrous CYP2B4 with the ligand 
triazole bound, which produces conformer II only. Ferric cytochrome P450 was 
red in colour prior to the addition of the nitrogen bases and reduction by 
sodium dithionite. However, on reduction and addition of cyanopyridine the 
cytochrome P450, solution turned black, and on addition of triazole the solution 
turned a lighter shade of red when compared to the ferric cytochrome P450.
EXAFS analysis was carried out by Dr. Diakun, and showed that the Fe in 
ferric CYP2B4 at -70 °C was 5 coordinated, which is contrary to the findings of 
other authors, namely Dawson et al (1982) who suggested that the Fe existed 
in a 6  coordinated state. Analysis of the cyanopyridine and triazole bound 
cytochrome P450 revealed the Fe to be in a 5 coordinated state with a slight 
difference between the two samples. However, whether this difference was due 
to the presence of a thiol or thiolate ligand could not be determined. The 
unexpected result showing the ferric cytochrome P450 to be in a 5 coordinated 
state meant that results from this experiment could not be validated and suggests 
that low temperatures such as -70 °C may have affected the coordination state of 
the Fe.
4.4.9 Investigation into the role of the threonine residue.
Total protein and haem content.
From initial investigations it was found that the platelet homogenate contained 52 
mg/ml of protein, with an actual haem content of 0.8 mg/ml. These values 
compared favourably with those reported by other authors (Haurand and Ullrich 
1985), who reported a protein content of 50 mg/ml with a haem content of 0.9 
mg/ml. All the following experiments were carried out with 4 mg/ml of protein
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in the sample cuvette.
Binding of ligands to reduced thromboxane synthase.
Microsomal samples of reduced thromboxane synthase in the presence of carbon 
monoxide have been reported to produce a spectrum consisting of two peaks 
with wavelengths ranging from 421-427 and 450-454 nm, some authors have 
suggested that the peak at 427 nm was due to the presence of 1- 
benzylimidazole, a well known thromboxane synthase inhibitor (Ullrich and 
Haurand 1983; Cinti and Feinstein 1976). Pure thromboxane synthase has been 
shown to produce only one peak at 450 nm when it was used as the enzyme 
source in the presence of carbon monoxide (Haurand and Ullrich 1985). It has 
not been established whether the two peaks on the binding of carbon monoxide 
to the reduced microsomal preparations of thromboxane synthase indicates the 
presence of denatured P420 as well as P450 or some other ligand possibly 
carbon monoxide in conformer II. If the peak is attributed to the presence of 
the second conformer, this is the first time it has been seen. The binding of 
carbon monoxide to reduced pure thromboxane synthase has been reported to be 
very slow, with final completion of the binding occurring after 30 minutes. The 
slow formation of the P450 peak was attributed to the presence of 
benzylimidazole which competes with carbon monoxide as a ligand for the 
enzyme (Ullrich and Haurand 1985; Cinti and Feinstein 1976).
The binding of carbon monoxide to the microsomal preparation of thromboxane 
synthase produced during the purification process outlined in section 4.3.9.1 
was found to be instantaneous, producing a spectrum consisting of two peaks at 
451 and 422 nm (table 4.10), whose absorbance and relative intensity did not 
change over 10 minutes. The binding of azines to the reduced enzyme produced 
spectra (table 4.10) similar to those reported for the binding of these bases to
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CYP2B4 (table 4.1). The addition of pyridine at pH 6.0, produced a spectrum 
consisting initially of two peaks (422, 447) in a ratio of 2:1, with the major 
peak representing conformer II. The intensity of this peak increased with time at 
this pH with a concomitant decrease in the 447 nm peak (conformer I). The 
addition of carbon monoxide to the sample produced a shift in wavelength from 
447 to 451 nm and from 422 to 420 nm, with the 420 peak as the predominant 
peak which is indicative of dénaturation. The binding of pyridine to reduced 
thromboxane synthase at pH 7.0, produced a spectrum consisting of two peaks 
in equal proportions, however, with time the peak representing conformer II 
increased, indicating dénaturation had taken place. The binding of the amines, 
hydroxylamine and trifluoroethylamine to thromboxane synthase produced spectra 
similar to those reported for CYP2B4 (table 4.3). The addition of 
hydroxylamine produced a spectrum consisting of one peak at 419 nm which 
increased in intensity with time. The addition of carbon monoxide produced a 
spectrum with a peak at 420 nm and no peak at 450 nm, indicating dénaturation 
had occurred. The addition of trifluoroethylamine produced a spectrum consisting 
of two peaks of equal intensity, although identification of these two peaks was 
difficult. The addition of carbon monoxide to the sample produced a spectrum 
clearly showing two peaks at 453-454 nm and 419-420 nm, however the 
production of these peaks occurred against an initial spectrum consisting of two 
peaks. Since the initial spectrum of reduced thromboxane synthase consisted of 
two peaks no conclusive results can be ascertained from the binding of nitrogen 
bases to reduced thromboxane synthase.
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ligand PH Peaks
(nm)
Ratio of peaks 
450:420
Peaks after addition of 
carbon monoxide (nm)
Carbon monoxide 8 451 (450-452) 
422 (420-424)
1 : 1 ND
Pyridine 6 4 4 7  (446-449) 
422* (420-425)
1 : 2 451 (450452) 
420 (419421)
7 4 4 7  (445-449) 
422 (420-425)
1 : 1 ND
Hydroxylamine 7 418419 420421
Trifluoro­
ethylamine
7 4 4 7  (446-448) 
425 (424426)
1 : 1 454 (453455) 
(419420)
Table 4.10 The peaks produced by the binding of bases to thromboxane synthase at various 
pHs. ND not determined.
4.4.10 Ligand binding to ferric CYP2B4.
The absolute spectrum of oxidised CYP2B4 has a Soret peak at 417 nm. The 
effect of binding different bases to oxidised CYP2B4 at different pHs was 
attempted to ascertain whether, as in the case of reduced P450 (table 4.1-3), 
pH has any effect on the degree of shift in wavelength observed on binding. 
Of all the bases used, pyridine, imidazole, N-acetylimidazole, methylamine, 
hydrazine and N-octylamine caused the greatest shift in wavelength all at a final 
concentration of 50 mM (table 4.11). The same shift in wavelength was 
observed for the forementioned bases at all pHs used. The effect of time on the 
spectra obtained on the binding of bases to oxidised CYP2B4 was also 
investigated to determine whether any further slow reaction was taking place. It 
was found that after the initial binding of the nitrogen base, incubation at room 
temperature was found to have little effect on the spectral profile obtained.
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Compound Peak value at pH (nm)
6.5 7 7.5 8
Pyridine 420 420 420 420
Pyridazine 417 417 417 417
Cyanopyridine 417 417 417 417
Imidazole 421 421 421 421
N-Acetyl
imidazole
421 422 421 421
N-octylamine 422 422 422 422
Methylamine 420 420 420 420
Hydrazine 420 420 420 420
Hydroxylamine 417 417 417 417
Trifluoro­
ethylamine
418 418 418 418
Table 4.11: The effect of pH on the binding of nitrogen bases to oxidised CYP2B4.
4.4.11 Determination of binding constants.
The binding constants for pyridine and N-acetylimidazole had previously been 
determined in section 3.4.2 and were found to be pH-independent (table 3.3; fig 
3.5-6). The binding constants for these two compounds were determined in 
conjunction with identifying the sixth ligand in ferric CYP2B4. The binding 
constants for the binding of hydroxylamine and trifluoroethylamine to reduced 
CYP2B4 (table 4.7) were so different that it was decided to calculate the
binding constant at the ferric level. It was found that at pH 7.0 that the
binding constants for both these amines were very similar (table 4.12),
however, the value obtained for hydroxylamine was much lower than that for 
the binding to the reduced state and indicates that the binding to oxidised 
CYP2B4 was more difficult than to the reduced enzyme.
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Binding constant values (M-l)
Compound / pH 6.5 7 8.5
Hydroxylamine ND 8 ND
Trifluoroethylamine ND 13 ND
Table 4.12 A table showing the apparent binding constants for the binding of nitrogen 
bases to oxidised CYP2B4.
ND not determined
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4.5 DISCUSSION
Pyridine when bound to cytochrome P450 in the reduced state can act as a 
denaturing agent converting P450 to P420 (Imai and Sato 1967a), as well as a 
ligand to the metal. Therefore, studies on the coordination of ligands to 
cytochrome P450 were carried out against a background of dénaturation.
Furthermore, confusion arose during these studies where a given ligand
exhibited similar Soret bands to cytochrome P420 on binding to cytochrome
P450, i.e conformer II formation. However, the two can be readily
distinguished by the reaction with carbon monoxide.
The binding of the three families of nitrogen bases, namely the azines, azoles
and amines to reduced CYP2B4 produced Soret bands within the range 419 -
429 nm or 442 - 447 nm (tables 4.1-3), which can be reasonably assigned to
conformer II and I respectively. When the ligands expected to show the a  
effect (pyridazine and hydroxylamine) are not taken into account, the better 
donors (high pKa) favour the formation of conformer II in all three families, 
but shown most clearly by the azines for both partially purified and pure 
CYP2B4. The binding of pyridine, imidazole and trifluoroethylamine to the 
cytochrome P450 isozymes CYP2E1 and CYP4A1, showed an identical pattern 
to that observed with CYP2B4, in that those bases with a high pKa favoured 
the formation of conformer II and those with a low pKa favoured formation of 
conformer I. While hydroxylamine produced conformer I as was the case with 
CYP2B4. Although most of the nitrogen bases produced one peak in the Soret 
region corresponding to either conformer, some of the ligands studied produced 
a mixture of the two conformers, namely pyridine, 4-methylpyridine (picoline) 
and N-octylamine (table 4.1-3). The binding of pyridine and to a lesser extent 
picoline showed a pH-dependence, with low pH (6.0) favouring formation of 
conformer II and high pH (8.0) favouring conformer I. Similar changes in the
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difference spectrum could be obtained by changing the pH over the pH range
6.5 => 7.5 in either direction after both reduction and the addition of pyridine 
i.e the pH dependence is labile and reversible even after the coordination of 
pyridine.
It was found that the ratio between the conformers II and I produced on the 
binding of pyridine to reduced CYP2B4 at a fixed pyridine concentration 
increased with pH suggesting that one proton (H+) was involved which is 
similar to the results shown that the binding of ethylisocyanide involved one 
proton (Peisach and Mannering 1975). Whereas at fixed pH the ratio was 
independent of pyridine concentration. These results were in contrast to those 
reported for ethylisocyanide where at fixed pH the ratio of conformers varied 
with concentration of isocyanide (Dahl and Hodgson 1978a-b). The binding of 
pyridine to reduced CYP2B4 was found to be a fast reaction which is in 
contrast to reactions reported for CYP2E1 and Lysine mutated CYP2E1 with 
pyridine in which the reaction was reported to be very slow (ie complete 
formation of the spectrum occurred over a period of time) (Imai et al 1994).
In contrast to the binding of pyridine to reduced CYP2B4 the binding of N- 
octylamine was very different in that several slow reactions were observed at 
pH 7.0 and 8.0 (table 4.3). At pH 7.0 a mixture of conformers was observed, 
but this only lasted for the initial 40 seconds. With time the spectrum resembled 
that of conformer II with the peak at 426 nm. In contrast at pH 8.0, the initial 
spectrum resembled conformer II, but with time (10 minutes) a spectrum 
consisting of two peaks at 426 and 446 nm was observed. These results with 
N-octylamine suggest that the formation of the conformers was very sensitive to 
pH and that both conformers can be obtained at the same pH. It can be 
concluded from this that the presence of these conformers is very dependent on 
subtle conformational changes and/or binding of a second N-octylamine molecule
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in the active site.
It has been previously suggested that hydrophilic compounds can either form 
conformer II or conformer I on binding to reduced P450 (Imai and Sato 
1967a). However the results obtained from these studies (tables 4.1-3) suggest 
that there is no obvious correlation between the ratio of conformers (Aj/Au) and 
the hydrophobicity of the ligand. The fact that with both the amines which
cannot jt bond and the heterocycles (azines and azoles) high pKa favours
conformer II and shows that the major factor involved must be the increase in 
a  donor power of the base represented by increase in pKa and/or lowering the 
pH (increase in H+), it also suggests that any metal to ligand Jt bonding 
probably plays a minor role (tables 4.4-6). However, jt bonding may play an 
important role in the binding of triple bonded C ligands (e.g CO and CN).
Carbon monoxide produces conformer I whilst cyanide produces a peak at 432
nm for the complex P450 Fe(ii)-CN", which is virtually the same as that of 
cyanomyoglobin (431 nm) (Miyake et al 1969), and suggests that it can be 
ascribed to conformer II.
Hydroxylamine and pyridazine are anomalous in their binding to reduced 
CYP2B4, they both favour the formation of conformer II instead of conformer I 
as would be expected from their pKa's (table 4.5-6). The spectrum of the 
oxygen derivative, (Fe(n)-C>2) is also known to be anomalous, showing a Soret 
band at 419 nm which is close to that of myoglobin (418 nm), but very 
different from that of chloroperoxidase, which also possesses Cys in its anionic 
form (RS") as the proximal ligand. A common denominator appears to exist 
between oxygen, pyridazine and hydroxylamine, which is most probably 
associated with the presence of a lone pair of electrons on the uncoordinated a  
atom. All these ligands show an unexpected stabilisation of conformer II, and 
both hydroxylamine and oxygen contain an oxygen atom as the a  atom and
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produce a Soret band at the same wavelength (419 nm). Coordination of the 
very hydrophilic hydroxylamine in the hydrophobic cavity of cytochrome P450 
was unexpected and implicates strong hydrogen bonding to the invariant distal 
Thr/Ser residues. This in turn suggests that hydrogen bonding to the lone pair 
of electrons on the a  atom may be involved in the stabilisation of conformer II 
by oxygen, hydroxylamine and pyridazine. The presence of the a  effect and the 
relationship between pKa and the production of the conformers are both shown 
here for the first time. The parallel shown by hydroxylamine to oxygen with 
the stabilisation of conformer II, which is associated with the a  effect (either 
electronic or polar/hydrogen bonding) suggests that hydroxylamine is an ideal 
model for the anomalous behaviour of oxygen.
The apparent binding constants for a number of nitrogen bases, namely, 
pyridine, pyridazine, trifluoroethylamine, and hydroxylamine with reduced 
CYP2B4 were determined by the fairly rapid titration of reduced microsomes 
with the nitrogen bases at either pH 6.0, 7.0 or 8.0, with the exception of 
pyridine (pH 6.5 and 8.0) (Table 4.7). The binding of all the bases appeared 
to be instantaneous and the curves obtained from duplicate experiments 
corresponded to the binding of one base per Fe. The calculated binding constant 
value (K) for pyridine at pH 6.5 of 560 M"1 (i.e log K = 2.8, Kd= 1/K = 1.7 
mM) is in full agreement with the value of Kd ~ 2.0 mM reported by Imai and 
Sato for pyridine, but considerably less than that for ethylisocyanide (Kd = 4.1 
pM, K = 2.4 x 105 M"1) (Imai and Sato 1967a). The calculated binding constants 
for pyridazine, trifluoroethylamine and hydroxylamine were found to be pH 
independent which highlights anomalies between the different bases which 
produce conformer II only (hydroxylamine) and conformer I only 
(trifluoroethylamine) (table 4.7). These results compare with and contrast results 
shown by other authors on the binding of oxygen and carbon monoxide 
(Dolphin et al 1979) and isocyanides (Ichikawa and Yamano 1968). The binding
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of oxygen and carbon monoxide and the ratios produced were found to be pH 
dependent while the binding (log K) of isocyanides was found to be pH 
independent. These results reflect anomalies observed on the binding of ligands 
to reduced P450. Although there was not a significant difference between the 
binding constants for the nitrogen bases belonging to the same families, the 
value for the very hydrophilic hydroxylamine (6000-8000 M-1) is very high 
when compared to that obtained for the fairly hydrophobic trifluoroethylamine 
(22-40 M-1) and is very anomalous and highly unexpected since the active site 
is very hydrophobic.
Elucidation of the nature of the proximal ligand, either thiol/thiolate present in 
conformer II and I was attempted using the technique of EXAFS. The different 
conformers were formed by the addition of ligands, triazole (conformer II only) 
and cyanopyridine (conformer I only) to reduced CYP2B4. EXAFS analysis of 
these samples as well as a ferric sample of CYP2B4, revealed that the nature 
of the iron in the conformer samples was 5 coordinated. However, the Cys 
ligand whether thiol or thiolate could not be conclusively determined. The 
apparent formation of the 5-coordinated ferric state indicates that temperature has 
an affect on the coordination state of the enzyme
Reduced chloroperoxidase has the spectral properties of a thiolate-ligated 
monooxygenase, but its functional abilities are predominantly those of a 
peroxidase, such as those of histidine-ligated horseradish peroxidase (Hewson 
and Hager 1978). The binding of isocyanides to chloroperoxidase produces a 
single peak at 452 nm (Sono et al 1985), which contrasts to the double Soret 
spectrum observed with cytochrome P450 (Imai and Sato 1966a-b). The single 
peak produced on binding of isocyanides to chloroperoxidase can be assigned to 
conformer I and is due to the presence of Cys as the thiolate (RS-). The 
production of this single peak suggests that the formation of conformer I in
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CYP2B4 on the binding of nitrogen bases with a low pKa is due to the 
presence of the Cys ligand in its thiolate form.
As previously mentioned, of all the members of the three families of nitrogen 
bases studied, pyridine, pyridazine and 5-chloro-N-methylimidazole when bound 
to reduced CYP2B4 acted as a denaturing agents. However, this phenomenon 
has yet to date not been studied for binding of nitrogen bases to ferric 
CYP2B4. Our investigations suggested that the binding of different nitrogen 
bases to the ferric form did not cause any dénaturation (table 4.11), even when 
the sample was incubated at room temperature for a period of time as indicated 
by the lack of a peak at 416 nm (P420 in the ferric state) (White and Coon 
1982), and by the subsequent reduction with dithionite and reaction with carbon 
monoxide producing one peak at 450 nm. This indicates that the ferric form of 
the enzyme is more robust than the reduced form of the enzyme (i.e 
dénaturation occurs easier in the reduced state).
4.6 CONCLUSION.
The emerging picture suggests that RS" and RSH are required at different stages 
of the catalytic cycle and that this requirement is met by provision of the 
suitably poised equilibrium (1),
[RS" => Fe (II) <= X] i + H+ <*> [RSH6 ==> Fe (II) <= X] n (1) 
which can be manipulated through the associated conformation change. It has 
already been suggested that this conformation change may play an important role 
in transfer of the second electron (Tsubaki et al 1989), and that a proton-relay 
system including the distal Thr/Ser is involved in this transfer (Gerber and 
Sligar 1994). The results in this chapter emphasise the general availablility of a 
proton-dependent equilibrium between two conformers, and establishes that this 
is associated with a significant change in the electron density on the Fe(II) ion.
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In addition, the results in this chapter further demonstrate the anomalies that can 
occur especially in the rates of reaction (cf pyridine and N-octylamine) and the 
pH independence observed for all the log K values. Two general trends are 
observed for the first time in this chapter in that conformer II is favoured by 
an increase in bascity (pKa) and that the a  effect stabilises conformer II in 
contrast to the pka value. In respect of the a  effect the results show that 
oxygen is not alone in its anomalous behaviour, with hydroxylamine providing a 
perfect model for oxygen and providing evidence for oxygen anomalous 
behaviour.
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CHAPTER 5
General Discussion
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5.1 GENERAL DISCUSSION.
There is considerable interest in the diversity of reactions catalysed by the 
cytochrome P450 family of haemoproteins, where the proximal ligand is the Cys 
thiolate anion (RS") which is in contrast to the His imidazole ring common to 
other haemoproteins such as haemoglobin, myoglobin, haem oxygenase and the 
peroxidases. One of the most interesting reactions of cytochrome P450 is the 
hydroxylation of alkanes and unactivated alkyl side chains which is characterised 
by the following reaction
0 2 + 2H + RH => ROH + H20  (1)
where 2H represents the two reducing equivalents supplied by NADPH via a 
specific cytochrome P450 reductase enzyme. This hydroxylation reaction involves 
the reduction of the enzyme (Fe34- to Fe2+), followed by coordination of 
oxygen (02) and reduction of the oxygen to a key hydroxylating intermediate. A 
number of questions concerning this reaction remain unanswered, especially
1) the nature of the key intermediate,
2) the role of the reduced iron ion (Fe2+).
As hydrogen peroxide can be produced from the reaction of oxygen and 
hydrogen, (0 2 + 2H + 2e =*> H20 2) (2), and the fact that this hydrogen 
peroxide so produced can react with substrates (RH) to produce the 
hydroxylated product (H20 2 + RH => ROH + H20) (3), the general reaction 
(1) can in principle be studied as two segments and can therefore contribute to 
providing answers to the posed questions.
To investigate the hydroxylation reaction involving cytochrome P450, a substrate 
was required which possessed a finite solubility and could be used in a 
standard assay. All these criteria were exhibited by lauric acid. The hydroxylation 
of lauric acid using various oxygen donors and sources of cytochrome P450 
was found to produce the hydroxymetabolites co, m-l and œ-2 in varying ratios
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(table 3.8), which compares favourably with those reported by other authors 
(Cajacob et al 1988; Romano et al 1988; Ellin and Orrenius 1976). The 
hydroxylation of lauric acid by hydrogen peroxide using pure CYP2B4 produced 
the hydroxymetabolites m-l and m-2 in the ratio 3:1, with no m metabolite. This 
is the first example of a purified enzyme catalysing the hydroxylation of lauric 
acid with hydrogen peroxide.
The key hydroxylating intermediate of reaction (1) and (3) has never been 
detected and there is no agreement as to whether the key intermediate retains 
intact the 0 - 0  bond derived from molecular oxygen or hydrogen peroxide as 
coordinated H2O20 or HQ2", or whether it possesses only a single oxygen atom 
as the formally pentavalent iron-oxene or ferry 1 (Fe03+) complex which is 
analogous to compound I of the peroxidases (Guengerich 1990; 1991). It has 
recently been shown that the reaction of iodosobenzene with CYP2B4 produces 
the elusive ferry 1 intermediate which is represented by the production of a new 
peak in the spectrum at approximately 390 nm (Blake and Coon 1989). The use 
of iodosobenzene to form the ferry 1 intermediate therefore provides a means of 
testing whether the key intermediate in the reactions involving hydrogen peroxide 
(bleaching and lauric acid hydroxylation) was a single oxygen unit (Fe03+) or a 
peroxide (H2O2/HO2"). We have tested for a single versus two oxygen unit in 
both haem degradation and lauric acid hydroxylation by hydrogen peroxide.
A comparison of the rates of decrease in absorbance at 417 nm using 15 mM 
hydrogen peroxide, 0.1 mM iodosobenzene and 0.1 mM iodosobenzene followed 
by the addition of 15 mM hydrogen peroxide added after a period of 8  minutes, 
showed that the reactions with hydrogen peroxide produced a gradual but 
eventually complete bleaching of the chromophore (fig 3.7). This decrease in 
absorbance followed first order kinetics in the reaction of haem and hydrogen 
peroxide and was pH-independent, with no indication of any new band or
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intermediate, in addition to the diminishing band of the starting Fe3+ complex at 
417 nm. This was the first study of kinetics of haem degradation with pure 
CYP2B4 or apparently any cytochrome P450.
In contrast to this, the reaction with iodosobenzene rapidly produced a new 
spectrum, which showed a weak band at 385 nm (fig 3.9; 3.11) which remains 
relatively unchanged with time (fig 3.9). This is in agreement with the findings 
of Blake and Coon (1989). The inhibition of the bleaching of the chromophore 
by the prior reaction with iodosobenzene (fig 3.9) indicates that the pathway for 
bleaching in CYP2B4 does not involve the ferry! complex. The bleaching or 
inactivation of the cytochrome P450 enzyme showed parallels to the action of 
hydrogen peroxide on haem oxygenase (Wilks and Ortiz de Montellano 1993). 
This degradation was attributed to a two oxygen unit (Fe-OOH) and not the 
ferry 1 intermediate, also the formation of the ferryl intermediate was also found 
to inhibit haem degradation by hydrogen peroxide. The degradation of the haem 
in haem oxygenase and CYP2B4 by hydrogen peroxide involving a two oxygen 
unit appears to be a common denominator between the two enzymes which is 
irrespective of the proximal ligand (histidine in haem oxygenase and cysteine in 
CYP2B4). Comparison of the yields of hydroxylated products (table 3.8) from 
experiments involving CYP2B4 (1 pM), lauric acid (0.05 mM) at pH 7.5 which 
were allowed to react for 10 minutes with either hydrogen peroxide (15 mM), 
or iodosobenzene (0.1 mM) with lauric acid added first or added after 8  minutes 
(formation of ferryl intermediate) clearly revealed product formation from the 
reaction with hydrogen peroxide, but none from the reaction with 
iodosobenzene, even with lauric acid added after 1 0  minutes with a minimum 
ratio of > 2 0 0  for the yield of products with hydrogen peroxide compared to 
the reaction with iodosobenzene. These results indicate that the CYP2B4 
catalysed hydroxylation of lauric acid by hydrogen peroxide does not involve the 
ferryl intermediate and neither iodosobenzene or the preformed ferryl intermediate
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complex are able to hydroxylate lauric acid at any significant rate. Vaz and co- 
workers have reported that a CYP2B4-catalysed reaction (4), where R is 
cyclohexyl and R-H is cyclohexane, was supported by hydrogen peroxide but 
not by iodosobenzene (Vaz et al 1991).
RCHO + H2Q2 => (R-H) + HCOOH (4)
They concluded that the "generally accepted pentavalent iron oxene is not the
oxidant" and proposed an initial addition of some Fe3+-coordinated peroxide to 
the aldehyde carbonyl group. It has also been concluded by Akhtar and co­
workers (1994) that the products formed from certain reactions of steroids 
catalysed by cytochrome P450i7a could only be explained by the reaction of 
some Fe3+ peroxide complex with a ketone carbonyl group.
Simultaneous monitoring of the changes in the CYP2B4 spectrum with hydrogen 
peroxide, and an increase in the formation of the hydroxylated products showed 
that the rate of inactivation of the enzyme (ti/2 = 1 0  minutes) is faster than the 
rate of chromophore bleaching (ti/2 = 12 minutes). The shorter ti /2 and the
change in ratio of the products from approximately 0 :1:1 at the start of the
reaction to approximately 0:3:1 at the end (table 3.7; fig 3.14) indicates that 
hydrogen peroxide attacks one or more amino acids residues in the active site to 
cause some conformation change and then reacts with the porphyrin ring and 
that the product ratio is sensitive to conformational changes.
A key question remains as to whether the reaction involving O2 and 2H 
proceeds through the same intermediate as hydrogen peroxide. The effect of 
changing the oxygen donor on the ratio of the hydroxylated products has been 
well studied in the case of the non-haem methane monooxygenase which, like 
cytochrome P450, can hydroxylate alkanes using either oxygen with NADH and 
a reductase or hydrogen peroxide alone (Froland et al 1992). All the evidence 
from these reactions indicates a common (but unidentified) hydroxylating
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intermediate. The ratio of products (m-l, m-2) from hexane for example, changes 
from 0.7 with oxygen to 13.3 with hydrogen peroxide; this was ascribed to a 
conformational change at the reduced level in the former case. The hydroxylation 
of lauric acid using CYP2B4 was found to produce the metabolites (m, m-l) in 
a ratio of 1:2 (table 3.8), which compares with published ratios 1:4 and 1:8 
(Cajacob et al 1988; Tanaka et al 1990). The relatively minor variations in 
product ratios observed with CYP2B4 (between oxygen and hydrogen peroxide 
as oxygen donors) clearly do not exclude, and if anything support, the 
formation of a common hydroxylating intermediate for both reactions (1) and 
(3), i.e with hydrogen peroxide and O2 + 2H as the oxygen source.
The nature of the sixth ligand in the resting state of the cytochrome P450 
enzyme is still under debate; it is thought to be a solvent molecule either in the 
form of a water molecule (Hilderbrant et al 1994) or a hydroxide ion (Banci et 
al 1994). In order to investigate the nature of this sixth ligand, pH-dependent 
binding studies were carried out utilising the bases pyridine and N- 
acetylimidazole and the anion CN". Since the pK of HCN is 9.2, the linear 
increase in log K values observed on the binding of cyanide to partially purified 
samples of CYP2B4 (fig 3.3) with pH (below the pK), indicates that the 
observed equilibrium, where good isosbestic points were obtained (fig 3.1a-e), 
corresponds to the coordination of free CN" with the corrected pH-independent 
values of the true log K given in table 3.2. Analysis of the changes in 
absorbance elicited by pyridine and N-acetylimidazole, with increasing 
concentration showed that additional equilibria intrude above 50 % conversion. It 
has recently been shown that that substrate free cytochrome P450cam can bind 
two molecules of pyridine, one binds to the metal (K ~ 104  M_1), whilst the 
other binds in the hydrophobic pocket (K ~ 103 M-1) (Banci et al 1994). It can 
be assumed that the deviations observed on the binding of pyridine and N- 
acetylimidazole to CYP2B4 reflect the binding of an additional molecule in the
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hydrophobic pocket, subsequent to coordination of the first to the ferric iron ion 
(Fe3+). These three ligand binding constants for pyridine, cyanide and N- 
acetylimidazole appear to the first reported for the Fe3+ state of any mammalian 
cytochrome P450. The calculated binding constants for all three compounds were 
pH-independent, thus suggesting that the sixth ligand is a water molecule 
(FeOH2).
When the pH-dependent conformational change is ignored, any equilibria 
involving the substitution of coordinated water by an anion or bases would both 
be expected to be pH-independent, as observed experimentally (table 3.2-3). It 
is however difficult to envisage such equilibria involving the substitution of a 
coordinated HO" could be pH-independent for both anions and bases, since this 
would require some special, presumably not merely coulombic interaction which 
could differentiate HO" from CN", thiolates and probably most of all other 
anions. Until there is definite evidence for such a mechanism, it seems 
reasonable to conclude that the low spin, 6 -coordinate form of Fe3* cytochrome 
P450 with a Soret band at 417 nm possesses water as the distal ligand.
In contrast, all peroxidases only coordinate anions with the compulsory uptake 
of a proton according to the following equation, where P represents the protein, 
including the site which binds the proton, and (OH2) indicates that the iron may 
be 6 -coordinate with water as the ligand or 5-coordinate.
P.Fe3(OH2) + X" + H" +HP.Fe3 .X" + H2Q 
The binding constant for butyl isocyanide by the Cys-ligated chloroperoxidase 
remains unchanged over the pH range 3 - 6  (Sono et al 1986). Whilst for all 
the anions studied, from strong acids (HI) to weak acids (HCN) a pH 
dependence of the apparent binding constant was shown, which is related to the 
pK and indicates coordination of the undissociated HX or the equivalent 
coordination of X" to the metal and binding of H+ at some second site. The
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compulsory binding of an anion with the uptake of a proton, and the related 
proton-coupled reduction of the Fe3+ ion, by all peroxidases probably reflects 
the mechanism for "activating" hydrogen peroxide. In other words, this 
represents the conversion of the relatively unreactive H2Q2 into the more reactive 
HO2", even at physiological pH by the co-operative coordination of HQ2'  to the 
metal and the binding of H+ at a second site. The availability of protein-free 
models for the proton-coupled reduction of Fe3+ porphyrins has clarified the 
role of coulombic interaction in such proton-coupled equilibria. Cytochrome P450 
lacks the peroxidase mechanism for activating hydrogen peroxide to form a 
ferry 1 intermediate, which involves the H+-coupled coordination of anions, in 
agreement with evidence against the role of FeO3* in either haem degradation or 
lauric acid hydroxylation.
The results in chapter 3 indicate that in both haem degradation and lauric acid 
hydroxylation the key intermediate, which initiates attack on the organic 
substrate, is not the ferry 1 complex (FeO)3+ and therefore must be closely 
related to the reagent hydrogen peroxide, either as H2O2 (pK 11.2) or HO2" 
coordinated to the ferric iron (Fe3+). The experimental results (section 3.4.11) 
have shown that the hydroxylation of lauric acid was pH independent over the 
pH range 7.5-9.0, and that haem degradation was also pH independent (fig 
3 .8 ), with the rate of bleaching increasing with hydrogen peroxide concentration 
up to at least 0.6 M hydrogen peroxide (table 3.4). The reaction of hydrogen 
peroxide with lauric acid at pHs below 7.0 produced an increase in the rate of 
hydroxylation, but significantly no change in the ratio between the co-1 and m-2  
products. This increase in the rate at pHs close to that of the pK of lauric acid 
(HLA) is probably due to an increase in the amount of lauric acid binding in 
the active site. However, an increase in hydrogen peroxide concentration only 
causes a small increase in the yield of hydroxylated lauric acid per unit time 
(table 3 .9 ), presumably due to an increase in the rate of enzyme inactivation.
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The simplest explanation of all these observations involves the reversible 
formation of coordinated hydrogen peroxide according to equation (5), where 
only the distal ligand is given.
The hydroxylation of lauric acid (denoted by RH) as in (6 ), which only differs 
from the mechanism proposed by White and Coworkers (1980) in that they 
proposed fission of the 0 -0  bond to generate a free HO radical which attacked 
the substrate in a subsequent step while we propose that fission occurs only in 
step with the hydrogen atom transfer.
H2Q2 + [H2O => Fe^] => H2O + [H2Q2 => Fe^] (5)
RH + [HO-OH=>Fe3]=>R- + H20  + [HO-=^ >Fe4]=>ROH + H20  + [Fe3]=>ROH + 
[H20=î>Fe3] (6 )
These results also highlight a common denominator in the ability of hydrogen 
peroxide to hydroxylate alkanes when associated with a sufficiently strong acid, 
whether the proton; for example H^O2^ in hydrogen fluoride, which can react 
well below 0° C (Olah et al 1977), or certain Lewis acid such as Fe3+ in 
cytochrome P450. The results with H gC ^ suggests that other oxygen donors, 
including iodosobenzene (PhIO) are activated by hydrogen abstraction from RH 
by a coordinated oxygen donor, loss of Phi and return of HO to the radical 
R", without prior conversion to the ferryl intermediate (Fe03+); this might 
explain the short lived burst of hydroxylation of lauric acid by iodosobenzene 
catalysed by whole microsomes (Gustafsson et al 1979). Alkanes may also be 
hydroxylated by oxo complexes as shown for a well-characterised complex of 
R u03+ isoelectronic with Fe03+ (Che et al 1991), but this remains to be 
established for cytochrome P450. There has been a natural tendency to assume 
one common intermediate for all combinations of oxygen donors, substrates and 
isoenzymes of cytochrome P450; the situation may be more complex and more 
direct evidence is required.
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The enzymatic cycle includes the binding of the substrate, reduction of the iron 
from Fe3+ to Fe2+, reaction with oxygen, uptake of a second electron and 
reaction with the substrate (eg hydroxylation). The nature of the key intermediate 
has previously been discussed, and now the possible role of the reduced iron in 
this cycle will be discussed along with the possibility that some nitrogen bases 
may be analogues for oxygen and could explain the anomalous behaviour of 
oxygen.
The binding of nitrogen bases belonging to the three different families (azines, 
azoles and amines) mostly produced in all three families a single Soret band at 
either 419-429 nm or 442-447 nm which can be reasonably assigned to
conformer II and I, respectively. However, not all of the bases examined
produce a single peak in the Soret region. As previously established for the 
isocyanides (Imai and Sato 1967a), which produced a mixture of the 
conformers, pyridine, pyrazine, N-octylamine and 4-methylpicoline all produced 
spectrum consisting of the two conformers (tables 4.1, 4.3). The ratio of the 
two conformers formed was affected by pH, with conformer II favoured by 
low pH and conformer I by high pH. The production of the two-peaked spectra 
was found to exist in a pH equilibrium which could be shifted in favour of 
one conformer by a change in pH (increase or decrease) (fig 4.5). The 
discovery of this reversible equilibrium supports the work previously proposed 
by other workers (Imai and Sato 1967a). The binding to reduced CYP2B4 of 
the nitrogen bases was found to be instantaneous and fast with the one exception 
of N-octylamine, which was very different. The binding of N-octylamine 
produced several slow reactions at pH 7.0 and 8.0 with the ratio of conformers 
formed being very sensitive to pH, and even both formed at the same pH (fig 
4.4). These results suggest that the presence of the conformers is very 
dependent on a subtle conformational change and/or binding of a second N-
octylamine in the active site.
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The work carried out on CYP2B4 and these three families of bases found that
when the compounds expected to show the a  effect were not taken into
account, the better donors (i.e those with high pK) favoured the formation of 
conformer II in all three families. This was most clearly shown by the azines 
(tables 4.4-6). In contrast, those ligands with a low pK favoured the formation 
of conformer I. Previously it had been suggested that hydrophilic compounds 
can form either conformer I or conformer II (Imai and Sato 1967a+b),
however, these results (tables 4.4-6) indicate that there is no obvious correlation
between the ratio of absorbance (Ai/Ap) and the hydrophobicity of the ligand as 
initially suggested. The parallel between the amines and heterocycles re­
emphasises that the major factor involved must be the a  donor power of the 
base (i.e bascity) and not n bonding since the amines cannot jt bond, whilst 
the heterocycles can. However, ji bonding may play an important role with C- 
ligands. The formation of a single band for the P450 Fe(n)-CN' complex at 432 
nm and a pK of 9.2 can assign cyanide to conformer II. The triple bonded C- 
ligands therefore provide another graded series of increasing donor (and
decreasing acceptor) power from carbon monoxide (conformer I only) through
isocyanides (I and II) to cyanide (II only). The C and N-ligands together
provide a self-consistent pattern in which the equilibrium ( 1) can be
systematically displaced to the right by protonation and/or increasing the electron 
density on the iron in four families (azines, azoles, amines, and triple-bonded 
C-ligands.
[RS“ =3» Fe(ii) <= X]i + H+ <=> [RSH° => Fe(II) <= X]n (1)
The binding of pyridazine and hydroxylamine was found to be anomalous, with 
both favouring the production of conformer II instead of conformer I as 
expected from their pKa as in the case of trifluoroethylamine and cyanopyridine. 
As previously stated (section 4.1) the binding of oxygen to reduced cytochrome 
P450 is also known to be anomalous, producing a peak at 419 nm which is
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close to that of myoglobin (418), but very different from chloroperoxidase 
(which also contains Cys in its anionic form RS~), which produces a red-shifted 
peak at 430 nm (Sono et al 1985). The anomalous binding of these compounds 
can be attributed to the presence of a lone pair of electrons on the 
uncoordinated a  atom (termed the a  effect). However, all three ligands show 
the unexpected stabilisation of conformer II and both hydroxylamine and oxygen 
have an oxygen as the a  atom and produce a spectrum at 419 nm. The similar 
results of stabilising conformer II observed with hydroxylamine make it an ideal 
model to study the anomalous effect of oxygen, from which it can be 
concluded that there is an activation mechanism for oxygen to stabilise 
conformer II.
It has been postulated that the proximal Cys ligand is either in the thiol (RSH) 
or thiolate (RS") form (Kahl et al 1976), which can exist in an equilibrium 
(RSH RS" + H+). Recent work carried out using the iron porphyrin 
microperoxidase 8  (MP8 ) in the reduced state and sulphur ligands has shown 
the thiol/thiolate ligands to be readily accesible trans to the His residue (Norris 
and Pratt 1995 in press). Identification of which form of the cysteine residue is 
present in the two conformers of CYP2B4 was attempted using the technique of 
EXAFS. However, the technique did not produce any conclusive results, in that 
the native ferric enzyme and the reduced ligand bound enzyme produced EXAFS 
signals showing the enzyme to be in a 5-coordinated state. This was attributed 
to the low temperature (-70 °C) used in the experiment. Although further work 
is required it can be assumed that conformer II contains Cys in its thiol form 
and conformer I contains the thiolate form, which exist in an equilibrium (1). 
This equilibrium provides a means for explaining the associated conformational 
change and provides a mechanism for changes in electron density on the iron. 
Furthermore, this equilibrium supports the suggestion by Traylor and co-workers 
(1981) that the dissociation and loss of superoxide (O2") would be promoted by
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the strong donor RS-, thus, there may therefore be a conflict of interest 
between the need for RS- at one stage of the enzymic cycle and for a poorer 
donor at another (ie. coordination of molecular oxygen).
The binding of oxygen to cytochrome P450 appears to be associated with 
hydrogen bonding to the distal Thr/Ser residues (Gerber and Sligar 1994). The 
coordination of the very hydrophilic hydroxylamine in the hydrophobic cavity of 
cytochrome P450 with a log K value higher than for the hydrophobic 
trifluoroethylamine (table 4.12) is unexpected and suggests strong hydrogen 
bonding to the distal Thr/Ser. This in turn suggests that hydrogen bonding to 
the lone pair of electrons on the a  atom may be involved in the stabilisation of 
conformer II by oxygen, hydroxylamine and pyridazine. In addition to the 
Thr/Ser residues present in the active site being implicated in the binding of 
oxygen, they may also be involved in a conformational change which may play 
an important role in the transfer of the second electron (Tsubaki et al 1989) in 
conjunction with a proton relay system (Gerber and Sligar 1994). These two 
residues are in fact absent from those cytochrome P450s that handle endogenous 
hydroperoxides and which do not therefore involve reduction to Fe2+ and 
interaction with oxygen (Song et al 1993). The use of one of these cytochrome 
P450s, namely thromboxane synthase to investigate the role of the Thr/Ser 
residues and anomalies involving the a  effect, however, was inconclusive due 
the production of two peaks in the reduced carbon monoxide spectrum (table 
4.10).
In summary, the results in chapter 4 emphasise the general availability of a 
proton-dependent equilibrium between the two conformers and establish that this 
equilibrium is associated with a significant change in the electron density on the 
Fe(ii) ion. Furthermore, hydrogen bonding to the distal Thr/Ser may play a key 
role in the coordination of oxygen as well as hydroxylamine and pyridazine.
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The similar results observed for hydroxylamine and pyridazine show that 
oxygen is not alone in its anomalous behaviour and that hydroxylamine is an 
ideal model for oxygen and provides an automatic explanation for oxygen's 
anomalous behaviour (ie a  effect). The emerging picture also suggests that RS" 
and RSH, or another weak donor are required at different stages of the enzymic 
cycle; conformer II (uptake of oxygen) and conformer I (uptake of second 
electron), and that this requirement is met by the provision of the suitably 
poised equilibrium (1), which can be manipulated through the associated 
conformational change.
The results presented on the role of a peroxide complex in both lauric acid 
hydroxylation and haem degradation by CYP2B4 confirm and extend the results 
of Vaz et al (1991), Akhtar et al (1994) and Blake and Coon (1989) on 
cytochrome P450 catalysed reactions and provide a natural explanation for the 
apparently close relationship between general reactions (1) and (2 ) and bleaching 
of cytochrome P450. These results also demonstrate a common denominator in 
at least the initial step of haem degradation between cytochrome P450 and haem 
oxygenase and demonstrate further a common denominator in the ability of 
hydrogen peroxide to hydroxylate alkanes when associated with a sufficiently 
strong acid such as H3 O24" or certain Lewis acids such as Fe34-. By analogy, it 
could be expected that coordination to Fe3* could activate donors such as 
iodosobenzene (PhIO) towards hydroxylation via analogous reactions involving 
hydrogen abstraction from the substrate (RH) by the coordinated oxygen atom, 
loss of Phi, transfer of hydroxide to the radical (R), without prior conversion 
to the pentavalent ferryl complex. In the past there has been a tendency to 
assume a single intermediate for all combinations of oxygen donors, substrates 
and isoenzymes, however, the situation may be more complex and direct 
evidence for or against the nature of the key intermediate in other reactions is 
clearly needed.
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